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I. INTRODUCTION 
I 
I This progress report from the Biomedical Computer Laboratory (BCL) 
summarizes activities during the period from July 1, 1984 through June 30, 
1985. The Biomedical Computer Laboratory collaborates with research 
investigators throughout the Washington University School of Medicine and 
I 
its affiliated hospitals in the application of advanced computer techniques 
to problems in biology and medicine. This often requires work in areas 
stretching from basic physiology through mathematical models to equipment 
I 
design. Our orientation is interdisciplinary with the recognition that 
effective communication for workers with differing backgrounds comes only 
through extended collaboration and mutual respect. 
I 
The vigorous development and evolution of specialized computer 
systems for use in the solution of research and clinical problems has 
continued to be the central focus of,BCL activities. Several systems now 
in clinical use have seen a progression from exploratory pilot studies, to 
major developmental project, to local clinical trial, to clinical trials in 
multiple locations, to public availability through commercial manufacture.I Perseverance in this sometimes tedious chain of development has found reward in the effective fielding of specialized computer systems to the 
medical community. 
I One class of computer applications requires strong coupling of the 
computer to its environment for digital signal processing. These 
applications typically involve the use of commercially availableI minicomputers and microprocessors in conjunction with specialized hardware 
I 
designed and built locally. We have pursued many such applications by 
bringing signals from hospital wards and research laboratories to BCL by 
means of either analog or digital tape recordings or telephone lines and, 
more frequently, by taking the computers to the investigator's laboratory 
or the patient's bedside. More recently, an emphasis at BCL has been on 
the development of a flexible digital communication capability for linkingI data sources and information destinations with research-oriented computational resources at BCL as well as at collaborators' sites. 
I Of particular importance to current and future BCL projects is the development, in a closely related sister lab (Computer Systems Laboratory, 
I 
or CSL), of a capability for the design and fabrication of custom very­
large-scale integrated (VLSI) circuits. The realization of such circuits 
through collaboration with CSL is already opening up new opportunities for 
I 
solving problems intractable with conventional computing devices.The CSL 
has as its goal the development of innovative approaches to computing that 
will have important implications for medicine and biology in the future. 
I 
For those classes of applications dominated by information 
processing requirements, provisions have matured from telephone lines 
linking our minicomputers to the large IBM Systems at the Washington 
I 
University Computing Facilities, through development and support of a 
minicomputer based MUMPS system, to the establishment of independent groups 
such as the Medical Computing Facility and the Medical Computing Service 
Group which serve the local medical complex. Diverse needs continue to be 
met by these various options as well as by an increasing number of 
independent computing facilities within medical school departments.
I
 
I 
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Still another class of applications requires extensive use of large­
scale computational services. Many investigators are assisted in their 
research through the use of generalized numerical, non-numerical, and 
statistical routines. Such work is sometimes carried out by staff members I 
of BCL, but primarily by members of the Division of Biostatistics under the 
direction of Dr. Dabeeru C. Rao, and the University Computing Facilities 
whose director is Robert J. Benson. I 
Over the years, the BCL has enjoyed collaborations with most 
departmental divisions within the medical school but has also found support 
and enrichment through close ties with other facilities throughout the I 
University. These arrangements are of benefit both to the BCL and to 
graduate students who find projects and employment among the activities in 
the laboratory. The Department of Computer Science is under the direction 
of Dr. Jerome R. Cox, Jr., past Director of the BCL. Strong ties with the I 
Department of Electrical Engineering are sustained through the Engineering 
School's Biomedical Engineering Program and common interests in digital 
signal processing techniques. The Department of Electrical Engineering is I
chaired by Dr. Donald L. Snyder, past Associate Director of BCL. 
Two years ago, Washington University established an interschoo1 
Institute for Biomedical Computing. The new Institute encompasses the I 
Biomedical Computer Laboratory and the Computer Systems Laboratory in an 
organizational setting designed to recognize and foster the joint interests 
in biomedical computing of the School of Medicine and the School of IEngineering and Applied Science. The purpose of the reorganization is to 
recognize that the development and application of advanced computing and 
engineering technology to problems in biomedical science are essential 
components of the research and teaching activities of Washington I 
University. Accordingly, attention has been given to the development of a 
stable organizational structure that will 1) provide a means by which the 
primary academic affiliations of its faculty can be in an organizational Isetting with an adequately broad commitment to research and teaching in 
biomedical computing; 2) establish a formal administrative connection to 
the School of Engineering and Applied Science that will facilitate the 
involvement of its students and faculty in research and instructional I 
activities in biomedical computing; 3) establish mechanisms for 
adminstration, funding, and review of appointments, promotion, and tenure 
for the academic staff of this activity; 4) foster organizational and Iprocedural coherence between the Biomedical Computer Laboratory and the 
Computer Systems Laboratory by placing them within a common administrative 
structure; 5) create a focal point for interdisciplinary teaching and 
student research, both in the School of Medicine and the School of I 
Engineering and Applied Science, in areas that do not fit comfortably into 
existing departments; and 6) encourage a scholarly environment for the 
activities of the two computer laboratories that will promote and encourage Iteaching, research, and publication as vehicles for personal development 
and academic contribution. 
In addition to current BCL and CSL space on the Medical School I 
campus, space for part of the activities of the Institute has been provided 
on the Engineering School campus by completion of a fifth-floor addition to 
Lopata Hall in December of 1983. This new space (about 6000 square feet), 
called the Edward L. Bowles Laboratory, is immediately adjacent to the I 
Departments of Computer Science and Electrical Engineering. 
I 
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The Institute for Biomedical Computing (IBC) has replaced the former 
Washington University Computer Laboratories (WDCL) which was a less formal 
federation of BCL and CSL plus working groups within the Departments of 
Computer Science and Electrical Engineering. Dr. Charles E. Molnar, 
Director of the Computer Systems Laboratory, and Dr. Lewis J. Thomas, Jr., 
Director of the Biomedical Computer Laboratory, have been appointed asI respective Director and Associate Director of the Institute. Both BCL and 
I 
CSL continue to retain their identities and internal organizations. 
Accordingly, this Progress Report addresses activities centered primarily 
within BCL. 
Planning and policy development of the Institute are overseen by a 
Governing Board, the membership of which is drawn from both Schools. TheI present composition of the Governing Board is: 
J. R. Cox, Jr., Chairman, Department of Computer Science 
I N. Daw, Professor, Department of Cell Biology and Physiology and Department of Ophthalmology 
R. G. Evens, Head, Department of Radiology 
M. K. King, Dean, School of MedicineI D. M. Kipnis, Chairman, Department of Internal Medicine E. L. MacCordy, Associate Vice-Chancellor for Research 
J. M. McKelvey, Dean, School of Engineering and Applied Science 
I C. E. Molnar, Director, Computer Systems Laboratory P. Needleman, Head, Department of Pharmacology D. L. Snyder, Chairman, Department of Electrical Engineering 
L. J. Thomas, Jr., Director, Biomedical Computer Laboratory 
I 
I To aid in long-range planning of the health-related activities of 
the Institute, a National Advisory Panel is convened periodically. 
Particular attention is given to the confluence of important needs in 
biology and medicine with the technical advances capable of meeting these 
I 
needs. Successful development may suggest implementation on a larger, 
perhaps national scale. The present composition of the National Advisory 
Panel is: 
I 
Peter H. Abbrecht, M.D., Ph.D., Professor of Physiology and Medicine, 
Uniformed Services University of the Health Sciences, Bethesda, Maryland 
Howard L. Bleich, M.D., Associate Professor, Beth Israel Hospital, 
Harvard Medical School 
I Wesley A. Clark, A.B., Consultant, Sutherland & Sproull Associates, 
New York, New York, 
I James N. Gray, Ph.D., Tandem Computer Company, Cupertino, California 
I 
Frank E. Heart, M.S.E.E., Vice President and Director, Computer Systems 
Division, Bolt, Beranek & Newman, Cambridge, Massachusetts 
David M. Kipnis, Professor and Chairman, Department of Internal Medicine, 
Washington UniversityI Brian W. Matthews, Ph.D., Professor, Institute of Molecular Biology, 
University of Oregon 
I
 
I
John M. Smith, Director, Sponsored Research Division, Computer Corporation 
of America, Cambridge, Massachusetts 
Eugene A. Stead, Jr., M.D., Florence McAlister Professor of Medicine, I
Department of Medicine, Duke University 
Carlos Vallbona, M.D., Chairman, Department of Community Medicine, 
Baylor College of Medicine I
 
I
 
I
 
I
 
I
 
I
 
I
 
I
 
I
 
I
 
I
 
I
 
I
 
I
 
I
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II. SOURCES OF SUPPORT
 
During the period covered by this report the primary source of 
support for the Biomedical Computer Laboratory was from two grants from the 
National Institutes of Health, Division of Research Resources. 
RR 01380 A Resource for Biomedical Computing.
 
RR 01362 Tissue Characterization via Ultrasonic Imaging.
 
NHLBI contract N01 HV 72941 continues to fund a Holter Monitoring 
Core Laboratory to support a Multicenter Investigation of Limitation of 
Infarct Size. 
Collaboration with other investigators often involved work already 
supported by other grants and contracts. 
Public Health Services. 
AM 07296 Cell Biological Approaches to Diabetes Research, 
CM 47696 Evaluation of High Energy Photon External Beam 
Treatment Planning, 
EY 03703 Chromatic Static Perimetry in the Diagnosis of Glaucoma, 
GM 28232 Physical Mapping of Yeast Chromosomal DNA, 
HL 12839 Erythrocyte Deformabi1ity and Vascular Pathophysiology, 
HL 13851 Cyclotron Produced Isotopes in Biology and Medicine, 
HL 17646 Study of Ischemic Heart Disease, 
HL 25430 Characterization of Left Ventricular Diastolic Function, 
HL 25944 Time-of-F1ight Positron Tomography for Cardiac Imaging, 
HL 28995 Adrenergic Factors and Arrhythmogenic Metabolites, 
HL 28998 Tissue Characterization with Ultrasound, 
NS 06833 An Interdisciplinary Stroke Program, 
RR 01379 Research in VLSI Systems for Biomedical Applications. 
National Science Foundation Grant. 
ECS-82-15181 Study of Time-of-F1ight Tomography 
Research support was also received from the following industrial 
collaborators. 
I
 Biosensor Corporation, Brooklyn Center, Minnesota,
 Computer Services Corporation (CSK), Tokyo, Japan,
 
Mead Johnson, Evansville, Indiana. 
I
 
I
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III. PERSONNEL 
EMPLOYEES I 
Personnel employed by the Biomedical Computer Laboratory during the 
period covered by this report were: IDirector 
Lewis J. Thomas, Jr., M.D .• and Associate Director of Institute for 
Biomedical Computing, and Associate Professor of Biomedical I 
Computing, Anesthesiology, Physiology and Biophysics, Biomedical 
Engineering, and Electrical Engineering IAssociate Director 
G.	 James Blaine III, D.Sc., and Associate Professor of Biomedical 
Computing in the Institute for Biomedical Computing, and Affiliate I 
Associate Professor of Electrical Engineering and Computer Science 
Senior Research Associates I 
Jerome R. Cox, Jr., Sc.D., and Professor of Biomedical Computing in 
the Institute for Biomedical Computing, and Chairman and Professor 
of Computer Science, and Professor of Electrical Engineering, and ISenior Research Associate, Computer Systems Laboratory 
Harold W. Shipton, C.Eng., and Professor of Biomedical Engineering 
in the Institute for Biomedical Computing, and Chairman and 
Professor of Biomedical Engineering I 
Donald L. Snyder, Ph.D., and Professor of Biomedical Computing in 
the Institute for Biomedical Computing, and Chairman and Professor 
of Electrical Engineering, and Senior Research Associate, Computer ISystems Laboratory 
Business Manager I 
Virginia M. Bixon, B.S. 
Research Associates I 
R.	 Martin Arthur, Ph.D., and Professor of Biomedical Computing in 
the Institute for Biomedical Computing, and Professor of 
Electrical Engineering I 
Kenneth W. Clark, M.S. 
Daniel R. Fuhrmann, Ph.D., and Assistant Professor of Electrical 
Engineering IRobert O. Gregory, D.Sc., and Professor of Electrical Engineering 
Kenneth B. Larson, Ph.D. 
James G. Miller, Ph.D., and Professor of Physics, and Associate 
Director for Biomedical Physics, Laboratory for Ultrasonics, and I 
Research Associate Professor of Medicine 
Michael I. Miller, Ph.D., and Assistant Professor of Biomedical 
Computing in the Institute for Biomedical Computing, and Assistant IProfessor of Electrical Engineering 
Frederick U. Rosenberger, D.Sc., and Associate Professor of 
Biomedical Computing in the Institute for Biomedical Computing I 
I
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I Research Assistants 
I David E. Beecher, M.S., and Lecturer in Computer Science Steven R. Broadstone, B.A., B.S. 
John C. Chabut, B.S., B.A.
 
John D. Gorman, B.S.
I Russell E. Hermes, M.S.
 Patrick H. Johnston, M.A. 
Joanne Markham, M.S., and Research Instructor in Medicine 
I
 Stephen M. Moore, M.S.
 Jack G. Mottley, Ph.D. 
John M. Ollinger, M.S. 
I Kenneth B. Schechtman, Ph.D., and Instructor in Biostatistics in Preventive Medicine, and Research Instructor in Medicine Tom O. Videen, Ph.D. 
I Engineering Assistant Stanley R. Phillips, A.A.S. 
I Technical Assistant 
Alexander W. Stangl 
I Electronic Technician 
Deborah A. Schwab 
I Librarian
 
I
 Monica W. Shieh, M.L.S.
 Secretaries 
I Rebecca J. Bozesky Shirley A. Gonzalez-Rubio 
Polly E. Raith 
I The following members from other departments and divisions have joint appointments with the Biomedical Computer Laboratory to facilitate 
collaboration and enhance interdisciplinary research: 
I H. Dieter Ambos, Research Assistant Professor of Medicine 
(Cardiology) 
A. Maynard Engebretson, D.Sc., Associate Professor of ElectricalI Engineering in the Department of Speech and Hearing, and the 
I 
Faculty of Arts and Sciences 
William M. Hart, Jr., M.D., Ph.D., Associate Professor of 
Ophthalmology 
Rexford L. Hill, III, M.S., Associate Professor of Computer 
Applications in Radiology 
David G. Politte, Research Assistant in RadiologyI John W. Wong, Ph.D., Assistant Professor of Radiation Physics in Radiology 
I
 
I 
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In addition, the following people worked at the laboratory for 
brief periods: 
George L. Engel, B.A., B.S.
 
Abdelkader Gacem, M.S.
 
Sudjiwo Husodo, B.S.
 
Rosalie J. Paisley, M.S.
 
David F. Sandel, B.S.
 
RESEARCH COLLABORATORS 
During the period covered by this report the following investigators 
from other laboratories, departments, or institutions, collaborated with 
BCL staff members on problems of joint interest. 
D. R. Abendschein, Ph.D., Medicine 
H. D. Ambos, Medicine 
T. R. Baird, Medicine 
D. G. Barr, Radiation Sciences 
S. R. Bergmann, M.D., Ph.D., Medicine 
D. R. Biello, M.D. Radiology 
Y. R. Bosch, M.S., Computer Systems Laboratory 
T. J. Chaney, M.S., Computer Systems Laboratory 
P. B. Corr, Ph.D., Medicine and Pharmacology 
M. R. Courtois, M.A., Medicine 
S. R. Devries, M.D., Medicine 
R. D. Edelman, B.S., Computer Systems Laboratory 
J. O. Eichling, Ph.D., Radiology 
P. R. Eisenberg, M.D., Medicine 
R. G. Evens, M.D., Radiology 
D. C. Ficke, B.S., Radiology 
L. Fields, M.D. Medicine 
K. A. A. Fox, M.B., Ch.B., Medicine 
P. T. Fox, M.D., Neurology and Radiology 
M. S. Frank, M.D., Genetics 
M. H. Gado, Mo.D. Radiology 
E. D. Galie, R.N., Medicine 
R. A. Gardner, Ph.D., Mechanical Engineering 
E. M. Geltman, M.D., Medicine 
R. Genton, M.D., Medicine 
Y. D. Gillette, Ph.D., Computer Sciences 
R. M. Glueck, M.D., Medicine 
A. M. Grace, Medicine 
R. L. Grubb, Jr., M.D., Neurological Surgery 
Y. B. Harms, B.S., Radiology 
Y. M. Hart, Jr., M.D., Ph.D., Ophthalmology 
K. H. Haserodt, M.S., Computer Science 
P. Herscovitch, M.D., Neurology and Radiology 
G. R. Hoffman, B.A., Radiology 
T. J. Holmes, D.Sc., Radiology 
J. T. Hood, Sr., B.S., Radiology 
S. Igielnik, Ph.D., Medical Computing Facilities 
A. S. Jaffe, M.D., Medicine 
G. C. Johns, B.S., Computer Systems Laboratory 
R. G. Jost, M.D., Radiology 
M. A. Kass, M.D., Ophthalmology I 
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E. W. Kiebler, M.S., Computer Systems Laboratory 
M. R. Kilbourne, Ph.D., Radiology 
R. M. Knabbe, Ph.D., Medicine 
R. Kopitsky, M.D., Medicine 
J. B. Kramer, M.D., Medicine and Surgery 
A. Kumar, B. Tech., Radiology 
J. L. Lauter, Ph.D., Central Institute for the Deaf 
P. A. Ludbrook, M.D., Medicine 
E. T. Macke, M.S., Computer Systems Laboratory 
J. W. Matthews, D.Sc., Computer Systems Laboratory 
T. R. Miller, Radiology 
M. A. Mintun, M.D., Neurology 
C. E. Molnar, Sc.D., Computer Systems Laboratory 
M. V. Olson, Ph.D., Genetics 
D. S: Payne, Medicine 
C. A. Perez, M.D., Radiology 
J. E. Perez, M.D., Medicine 
J. L. Perlmutter, M.D., Neurology 
S. M. Pogowizd, M.D., Medicine 
D. G. Politte, M.S., Radiology 
W. J. Powers, M.D., Neurology and Radiology 
J. A. Purdy, Ph.D., Radiology 
M. E. Raichle, M.D., Neurology and Radiology 
D. C. Rao, Ph.D., Biostatistics 
M. L. Ridner, M.D., Medicine 
T. L. Rosamond, M.D., Medicine 
A. P. Rueter, B.S., Radiology 
J. E. Saffitz, M.D., Pathology and Medicine 
M. L. Sieger, B.S., Electrical Engineering 
B. A. Siegel, M.D., Radiology 
B. E. Sobel, M.D., Medicine 
J. J. Spadero, Jr., M.D., Medicine 
A. W. Strauss, M.D., Biochemistry 
S. P. Sutera, Ph.D., Mechanical Engineering 
A. G. Swift, M.A., Radiology 
M. M. Ter-Pogossian, Ph.D., Radiology 
A. J. Tiefenbrunn, M.D., Medicine 
R. G. Tilton, Ph.D., Pathology 
A. W. Toga, Ph.D., Neurology 
J. S. Turner, Ph.D., Computer Science 
D. F. Wann, D.Sc., Electrical Engineering 
M. J. Welch, Ph.D., Radiology 
R. A. Wettach, R.N., Medicine 
S. Wickline, M.D., Medicine 
J. R. Williamson, M.D., Pathology 
R. Wolf, M.D., Medicine 
K. F. Wong, M.S., Computer Science 
J. W. Wong, Ph.D., Radiology 
K. A. Yamada, Ph.D., Medicine 
A. L. Ysaguirre, Medicine 
C. Y. Yu, M.S., Radiology 
J. D. Zions, Pathology 
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Indiana University School of Medicine. Indianapolis. Indiana 
C. Fisch, M.D. 
S. B. Knoebel, M.D. I 
Jewish Hospital. St. Louis. Missouri IB. R. Hieb, M.D. 
R. E. K1eiger, M.D. 
R. J. Krone, M.D. 
R. Ruffy, M.D. I 
Massachusetts General Hospital. Boston. Massachusetts IH. K. Gold, M.D. 
H. W. Strauss, M.D. 
Pennsylvania State University. University Park. Pennsylvania I 
D. B. Gese1owitz, Ph.D. 
Peter Bent Brigham Hospital. Boston. Massachusetts I 
E. Braunwa1d, M.D. 
P. H. Stone, M.D., I 
Research Triangle Institute. Research Triangle Park. North Carolina IW. K. Poole, Ph.D. 
Roosevelt Hospital. New York. New York IH. M. Greenberg, M.D. 
University of Illinois at Chicago Circle. Chicago. Illinois I 
R. Langendorf, M.D. 
University of Iowa. Iowa City. Iowa I 
R. C. Arzbaecher, Ph.D. 
University of Kentucky College of Medicine. Lexington. Kentucky I 
B. Surawicz, M.D. IUniversity of Louisville School of Medicine. Louisville. Kentucky 
N. C. Flowers, M.D. I 
University of Texas Health Science Center. Dallas. Texas 
J. T. Wi11erson, M.D. I
 
I
 
I
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I University of Vermont College of Medicine. Burlington. Vermont 
I D. S. Raabe, M.D. 
As in the past, collaborative efforts with various commercial firms 
continue (see Section VI). This year projects of joint interest haveI involved: 
I 
Biodata Informatica and Technologica, Ltd., Brazil 
Biosensor Corporation, Brooklyn Center, Minnesota, 
Computer Services Corporation (CSK) , Tokyo, Japan, 
Mead Johnson, Pharmaceutical Division, Evansville, Indiana, 
Mennen-Medical, Inc., Clarence, New York.I
 
I
 
I
 
I
 
I
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I
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IV. PHYSICAL RESOURCES 
The Biomedical Computer Laboratory (BCL) was formed on April 15, I 
1964 and the original staff moved into 3,800 square feet (net) of 
laboratory space at 700 South Euclid Avenue in St. Louis. While remaining 
at this location, adjacent to the Washington University School of IMedicine's main building complex, the floor space has been increased to the 
present 12,000 square feet (net). As a result of the establishment of an 
interschoo1 Institute for Biomedical Computing at Washington University, 
space for part of the activities of the Institute (which encompasses both I 
the BCL and the Computer Systems Laboratory (CSL) has been created on the 
Engineering School campus by completion of a fifth-floor addition to Lopata 
Hall. This new space (about 6000 square feet), called the Edward L. Bowles ILaboratory, is immediately adjacent to the Departments of Computer Science 
and Electrical Engineering. It became available in December, 1983. In 
addition to the 700 South Euclid and Bowles Laboratory space, BCL staff 
members and systems frequently occupy other areas within the Washington I 
University Medical Center at the sites of collaborative project activities. 
During the past twenty years BCL has addressed diverse biomedical 
problems for which digital computing techniques seemed promising and I 
appropriate. A single Laboratory Instrument Computer (LINC) provided the 
original staff with an opportunity to apply digital computing to a few 
interesting problems in medicine and biology. Currently BCL has interest I
and involvement in several specialized instrumentation and computing 
systems which provide access to diverse image-data sources (modalities) and 
offer opportunities for collaborative research in biological modeling and 
algorithm development. BCL has primary responsibility for a complement of I 
computing hardware and software from a variety of system manufacturers. 
These resources include: Digital Equipment Corporation PDP-11's and 
LSI-11's, MASSCOMP Corporation MC-sOO's, California Data Products Model I13s's, and Motorola Versamodu1e M68000's. An MMS-X stroke graphics display 
system developed by the Computer Systems Laboratory, a Lexidata raster­
graphics display system and two MASSCOMP raster-graphic display stations 
are available for biomedical imaging studies. Personal-class microcomputer I 
systems have been incorporated into the design of biomedical research 
systems and numerous special-purpose devices have been developed using 
microprocessor chip-sets and microcomputer board-level assemblies. I 
A Resource-developed local area network, TERRANET, provides remote 
termina1-to-computer and inter-computer data communications at rates up to 
9600 bps. Two, thirty station networks support terminals and computer I 
systems located throughout the laboratories. Internetwork communication is 
provided between these networks and others within Washington University, 
giving access to a broad spectrum of computing equipment and services for Iuse by resource personnel. 
A machine shop and reference room are located on the 700 S. Euclid 
premises and shared with CSL. Other physical resources include a we11­ I 
stocked electronics shop, a large inventory of electronic and computer test 
equipment, a variety of digital system modules and both analog and digital
I
recording instruments. Systems for use in developing eight-bit, sixteen- Ibit and bit-slice microprocessor applications are available. 
I 
I
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I V. RESEARCH PROJECTS 
I Introduction 
The research program of the Biomedical Computer Laboratory (BCL) isI organized into several major project areas with the staff grouped into 
I 
teams whose interests are focused correspondingly. Because of the growth 
of the Laboratory's activities in the area of quantitative imaging, that 
category has been divided into three sections, each dealing with a 
different imaging modality (ultrasound, radiation-treatment planning, and 
positron-emission tomography). A total of 50 distinct project activities 
are grouped into the six project areas briefly summarized below. MoreI complete summaries are given at the beginning of each of the project-report subsections. 
I Ischemic heart disease and ECG analysis continues to be a major category of r~search activity, but the development of new algorithms for ECG processing 
I 
has become less prominent than in the past as a result of a shift in 
emphasis to exportation of the latest version of our "Argus" algorithm. As 
that work is being brought to a conclusion, the final evaluation now in 
I 
progress is showing that the revised algorithm achieves the high level of 
performance required for real-time, ambulatory ECG-monitoring applications. 
In the area of ischemic heart disease, more prominent than before are 
modeling, signal processing, and data analysis work in collaboration with 
the division of Cardiovascular Medicine as part of their broad program 
addressed to ischemic heart disease. 
I 
I Information extraction from quantitative biomedical images continues to 
increase in prominence within the BCL program. Accordingly, last year's 
organization of such activities into three categories (by imaging modality) 
is continued this year. The work in ultrasonic tissue characterization now 
I 
emphasizes the interpretation of backscattered ultrasonic energy to achieve 
quantitative estimates of tissue properties, including anisotropy and the 
state of contraction of cardiac and skeletal muscle, while parallel efforts 
are directed toward design of a system to employ adaptive beamforming for 
backscatter measurements. 
I Work in radiation treatment planning has moved ahead with enhancements and 
I 
evaluations of our "delta volume" algorithm for three-dimensional absorbed­
dose calculations, display experiments employing high-performance stroke 
graphics (MMS-X system), and the recent completion of two VLSI circuits for 
expeditious achievement of a demanding kernel of the computations (3-D ray 
tracing). New work now focuses on the physics of high-energy photon-dose 
deposition in heterogeneous media. 
I 
I For positron-emission tomography. work in support of applications and 
system improvements have continued on several fronts, but the main thrust 
of BCL activities has been in research on algorithms. Emphasis has been on 
application of the maximum-likelihood method for improving image quality 
I 
and for achieving better estimates of physiological parameters through 
studies of dynamic distributions of tracers. Important new developments 
include the application of kernel seives to address image artifacts and the 
formulation of a model for applying the maximum-likelihood method to 
single-photon emission computed tomography (SPECT). 
I
 
I 
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I
Systems for Specialized Biomedical Studies embraces a variety of projects 
that are less broad in scope either because they are in an earlier stage of 
development or because the nature of the work is necessarily more 
specialized. The biomedical-imaging theme is well represented in this I

section as well. 
Projects under Resource Development Activities are directed toward 
improving the Laboratory's capabilities for addressing the needs of I
 
multiple research studies involving various facets of biomedical imaging. 
To that end, a now dominant and integrating activity is the development of 
a distributed facility for image Rresentation, ~na1ysis and guantification I
(IPAQ). Components of the IPAQ project include (1) the enhancement of our 
computational capabilities to support the development of computationally 
demanding algorithms for information extraction from multi-dimensional 
measurement data, (2) the establishment of a coherent software environment I
 
which incorporates a set of internally consistent software tools, image 
data formats and display methodologies, (3) the extension of our digital 
communication capabilities to include the sites of collaborators' data I
sources and information destinations, and (4) the exportation of 
specialized, tailored subsystems and/or satellite workstations which may 
incorporate custom-designed, very-large-scale integrated (VLSI) circuits in 
order to achieve practical realizations of especially demanding I
 
computations. 
I
 
I
 
I
 
I
 
I
 
I
 
I
 
I
 
I
 
I
 
-19­ I
 
I
 
I Individual Projects 
I A. Ischemic Heart Disease and ECGAna1ysis 
Some of the projects reported in this section continue longstanding 
work in high-speed ECG analysis. In other projects, modeling and signa1­I processing endeavors in the field of cardiology have supported 
I 
collaborations which address other aspects of ischemic heart disease, such 
as myocardial metabolism and blood flow, the e1ectrophysio1ogic 
characterization of abnormal myocardial depolarization, various 
antidysrhythmic drug studies, infarct-size modification, and the study of 
ventricular diastolic mechanics. 
I A real-time computer-based arrhythmia monitoring system, called 
I 
Argus, in operation in the Barnes Hospital Coronary Care Unit from 1969­
1975, was replaced in 1975 by "Argus/Sentinel," a commerc ia11y available 
version developed through collaboration with the Mennen-Greatbatch Company. 
The experience garnered with Argus led directly t~ the development of a 
I 
I 
system, called Argus/H, for the high-speed (60 times real time) processing 
of long-term ECG recordings. Argus/H has since processed several thousand 
recordings for a study of ventricular arrhythmias in survivors of 
myocardial infarction and several hundred recordings for a host of other 
studies. Extensive evaluations have verified the integrity of the analysis 
algorithms, proven the value of the quantified results as compared to 
conventional manual-scanning techniques, and confirmed the consistency of 
I 
results on reprocessing. The importance of such issues stimulated the 
development of a stochastic model for the performance evaluation of event 
detectors. 
I 
By the mid-1970's, it was apparent that Argus/H could not support 
rigorous algorithm development, could not efficiently process the now more­
popular dual-channel recordings, and could not meet the demand for the 
I 
system from the growing volume of recordings resulting from interes~s in 
therapeutic trials of antiarrhythmic agents and interventions designed to 
protect the ischemic myocardium. A newer system, called Argus/2H, emerged 
in 1977 and was duplicated in 1978. The two Argus/2H systems have 
processed long-term ECGs for national multicenter clinical studies of 
interventions to limit infarct size and of post-infarction riskI stratification. The systems also provide the power and flexibility 
I 
necessary for work on algorithm revision and on new signal-processing 
strategies and they have further served the analysis and documentation 
needs of other work to generate an annotated digital ECG database for the 
evaluation of automated arrhythmia detectors. Newer signal-processing 
strategies employing frequency-domain analysis of the ECG are now bearing 
fruit and have led to a continuing industrial collaboration to implementI the algorithms in a CMOS processor for real-time dysrhythmia analysis in the ambulatory setting. 
I
 
I
 
I
 
I 
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A-l. Argus Algorithm Development 
Personnel: C. N. Mead, BCL 
K. W. Clark, BCL I 
L. J. Thomas, Jr., BCL 
Support: RR 01380 IBiosensor Corporation
 
Washington University
 
I 
During the past year, emphasis has been placed on finalizing the 
complete set of Argus algorithms developed at BCL over the past 12 years 
(PR-9 to PR-20). The algorithms include enhanced QRS Idetection/delineation, and a combination of time-domain (TD) and frequency­
domain (FD) correlation and feature~extraction pattern recognition 
techniques. Stabilization of the algorithms represents the termination of 
BCL's extensive involvement in ECG processing. Specifically, the goal of I 
developing a set of automated processing strategies which perform with at 
least the degree of accuracy as the original Argus/H algorithms (PR-ll, A­
16) after human editing has been achieved. Realization of this objective 
has underscored BCL's belief that the revised Argus algorithms (referred to I 
as Argus/R) have attained a level of maturity that warrants their export to 
the commercial sector. In particular, BCL has been working with the 
Biosensor Corporation of Brooklyn Center MN to transfer the complete set of I
Argus/R algorithms to a CMOS microprocessor environment (see Industrial 
Collaboration). Details of the Biosensor system and preliminary evaluation 
results of Argus/R on both t£e AHA and MIT annotated ECG databases (Tables 
1 and 2) have been reported. I 
Since September of 1984, code modules for couplet/run detection, 
channel-independent signal-quality assurance testing, and atrial Ifibrillation detection have either been developed or enhanced. 
Additionally, the original l28-point FFT routine was rewritten to process 
64-point data sets, thereby allowing for the routine processing of either 
the traditional 5l2-msec data window (64 pts. @8 msec intervals (every I 
other sample» or a shorter 256-msec window (64 pts. @4 msec intervals». 
The use of the 64-point transform window with a variable-length data set 
solved one of the final remaining difficulties with Argus/R, i.e. the Iapplication of the algorithm to ECGs with high heart rates (> l35/min) in 
which event-to-event proximity caused significant transform window boundary 
discontinuities. Because the current FD algorithms require no information 
above 30 Hz, the use of a 5l2-msec window sampled at 8-msec intervals does I 
not degrade the algorithm's performance compared to the original 128 pt. 
version. A final evaluation is in progress. IArgus/R is coded in assembly language and runs on DEC PDP ll-34's. 
Because the code has not been optimized for processing speed nor has any 
attempt been made to use existing hardware FFT chips, analysis is quite 
slow, in the range of 2-10 x real time. Although the amount of post­ I 
processing human interaction time is negligible for Argus/R when compared 
to Argus/H, application of Argus/R to routine high-speed Holter tape 
analysis would still require substantial hardware and software revision. 
At present, BCL has no plans to undertake such revisions. Except for the I 
final evaluation now in progress, BCL plans no further work in high-speed 
ECG processing. I 
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1.	 C. N. Mead, K. W. Clark, J. C. Platt, and L. J. Thomas, Jr., "Argus 
Algorithm Development: A Decade of Progress - Results of Final System 
Evaluation and Implementation in a CMOS Environment," Proceedings of 
the IEEE Conference on Computers in Cardiology, IEEE Catalog No. 
84CH2078-4, Park City, UT, pp. 197-200, September 18-21, 1984. 
EVALUATION RESULTS: AHA Database 
Tape Ar&1:!UH Ar&1:!UR 
Class Unedited Edited (Unedited) 
1 sensitivity n.a. n.a. n.a. 
specificity .974 1.000 .995 
2 sensitivity .962 .980 .987 
specificity .992 1.000 .999 
3 sensitivity .779 .927 .963 
specificity .996 1.000 .999 
4 sensitivity .648 .984 .979 
specificity .997 1.000 .997 
6 sensitivity .743 .968 .973 
specificity .999 1.000 .999 
7 sensitivity .806 .964 .982 
specificity.996 1.000 .999 
All sensitivity .799 .964 .976 
specificity .991 1.000 .999 
59 Tapes: 10 per class, #2002 excluded 
Notes: 5-minute learning period. 
All annotated fusion beats excluded. 
"n.a." - not applicable. 
Argus/R Coup1et-and-Run Detection Sensitivity 
Per-Tape Average (Gross Average) 
932 Couplets .974 (.986) 
379 Runs .928 (.967) 
Table 1. AHA tape classes are: 1 - No PVCs, 2 - Unifoca1 PVCs, 3 = 
Mu1tifoca1 PVCs, 4 - Bigeminy, 6 - Ventricular Couplets, 7 - Ventricular 
Couplets and Runs. Classes 5 (R-on-T) and 8 (Ventricular Fibrillation) are 
not yet available. All per-class and overall averages are calculated on a 
per-tape basis except for couplet and run detection, where both per-tape 
and gross averages are given. Tape #2002 was excluded because it is a 
paced-rhythm recording. 
Tape 
Class 
I
 
I
 
EVALUATION RESULTS: MIT Database I
 
Argg2LH Argg2LR
 
Unedited Edited !Unedited
 
1 sensitivity n.a. n.a.	 n.a. I
specificity 1.000 1.000 1.000
 
PPV n. a. n. a .. n.a.
 
2 sensitivity .713 .780 .836 (.929*)
 
specificity .979 1.000 .999
 I
 
PPV .387 1.000 .950
 
3 sensitivity .748 .900 .914
 
specificity .988 .996 .993
 I
PPV	 .881 .997 .960
 
All	 sensitivity .736 .859 .887 (.919*)
 
specificity .990 .998 .997
 
PPV .711 .985 .957
 I
 
43 Tapes: class 1 - 14, class 2 - 10, class 3 - 19 
Notes:	 Tapes #102, #104, #107, #217, #207 excluded. 
10-minute learning period. 
All annotated fusion beats excluded. 
"n.a." - not applicable. 
PPV - positive predictive value. 
I
 
I
 
I
Argus/R	 Coup1et-and-Run Detection Sensitivi~ 
Per-Tape Average (Gross Average) 
312 Couplets .915 ( .907) I
45 Runs .861	 (.844) 
I
 
Table	 2. MIT database was divided into classes based on PVC content for I
the last 20 minutes of the annotated records as: class 1 - No PVCs,
 
class 2 - 1-25 PVCs, and class 3 - >25 PVCs. Evaluation began after a 5­

minute TD ARGUS learning period followed by as-minute FD CYCLE learning
 
period. Tapes #102, #104, #107, and #217 were excluded because of paced
 I
 
rhythms; Tape #207 was excluded because the event of interest was
 
ventricular flutter, which is sensed only as a pause in QRS events.
 I
*	 Tape #123 contained only 3 PVCs, all interpolated. These were labeled by 
Argus/R as "Unclassified" because unless a similar morphology has 
occurred as a "classic" isolated PVC, six occurrences of an interpolated 
PVC are necessary before it is "learned" as a definite PVC. The I
 
supplemental numbers are recomputed averages with tape #123 excluded. 
I
 
I
 
I
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 A-2. Holter Tape Processing 
I Personnel: K. W. Clark, BCL C. N. Mead, BCL 
A. W. Stangl, BCL 
I Support: RR 01380 Biosensor Corporation 
Mead-Johnson 
I 
During the past year, BCL processed fewer than 100 Holter ECG 
recordings; all of these came from a multicenter drug study sponsored byI Mead-Johnson (see VI, Industrial Collaboration). The contract with Mead­Johnson expires in October, 1985. 
I For the Multicenter Investigation of the Limitation of Infarct Size (MILlS) (A-8), we retrospectively analyzed a subset (50 of 298) of Holter 
recordings collected during the operational phases of MILlS (1978-1983) in 
order to detect ST-segment changes. The recordings were from patients who,I at six months after infarction, underwent an exercise tolerance test (ETT). 
I 
The objective of this pilot study was to explore correlations between the 
ETT and the Holter recordings with regard to ST-segment changes. As very 
few of the Holter recordings showed significant ST-level changes, the study 
was discontinued. 
Biosensor Corporation continues to market a portable device forI analyzing ECG signals in real time (see VI, Industrial Collaboration). The 
I 
device incorporates the frequency-domain-based Argus algorithms (A-I). As 
Biosensor has made various refinements to their implementation, they have 
analyzed many different waveforms and sent to us their results to be 
plotted and reviewed. In this manner, we have been able to assess the 
accuracy of their implementation. 
I 
I 
I 
I 
I 
I 
I 
I 
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A-3.	 Assessment of Vascular Integrity of the Myocardium Following 
Ischemic Injury 
Personnel: 
Support: 
R. G. Tilton, Ph.D., Pathology I 
R. A. Gardner, Ph.D., Mechanical Engineering 
K. B. Larson, BeL 
S. P. Sutera, Ph.D., Mechanical Engineering IJ. R. Williamson, M.D., Pathology 
J. D. Zions, Pathology 
RR 01380 I 
AM 07296 
HL 12839 
HL 17646 IThe Kilo Diabetes and Vascular Research Foundation 
IWe have continued our previously reported studies (PR 15, A-10; PR 
16, A-10; PR 17, A-7; PR 18, A-7; PR 19, A-7; PR 20, A-3) of the role of 
endothelium in the pathogenesis of the vascular hemodynamic and 
permeability changes associated with ischemia and reperfusion. In these 
studies, we employed external-detection techniques to quantify radiolabeled I 
albumin transport across the coronary vasculature under physiological 
conditions, and during reperfusion after ischemia in isolated, buffer­
perfused rabbit hearts. The resulting residue-detection data, analyzed on I
the basis of a two-compartment model of tracer transport, were used to 
estimate parameters indicative of microvascular integrity such as 
permeability and ultrafiltration conductance of the endothelium. I 
In our previous isolated-heart experiments, flow rate was held 
constant. If perfusion pressure were held constant, presumably the flow 
rate would decline and left-ventricle contractile function would not I 
recover during reperfusion. In experiments conducted during the past year, 
we have tested this hypothesis and have examined the impact of these 
vascular changes on myocardial contractile performance during reperfusion 
following ischemia. Alternate hearts were perfused under conditions of I 
constant pressure or constant flow using a modified Krebs-Henseleit buffer. 
When hearts were perfused under conditions of constant flow, myocardial 
contractile function was preserved but vascular resistance and vascular Ileakage of albumin were increased significantly during reflow after 
ischemia. During reperfusion under conditions of constant pressure, 
vascular leakage and interstitial myocardial edema were somewhat reduced, 
but flow rate also was reduced, causing deterioration of myocardial I 
contractile function. These experiments have demonstrated the potential 
importance of compromised vascular integrity, induced by ischemic injury, 
in the pathogenesis of ischemic heart disease caused by transient vasospasm Ior vascular narrowing. In experiments currently in progress, we are 
repeating the above studies using a perfusate containing 40% sheep 
erythrocytes to more closely reproduce the in vivo hemodynamic conditions. I 
In additional experiments, we are assessing the effects of galactose 
feeding (to induce polyol formation) and experimentally induced diabetes 
(alloxan) on the susceptibility of the coronary vasculature to ischemic Iinjury. 
I 
I
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 A-4. Modification of Infarct Size 
I Personnel: A. S. Jaffe, M.D., Medicine H. D. Ambos, Medicine 
P. R. Eisenberg, M.D., Medicine 
L. Fields, M.D., MedicineI E. M. Ge1tman, M.D., Medicine R. Genton, M.D., Medicine 
R. Kopitsky, M.D., Medicine 
I P. A. Ludbrook, M.D., Medicine B. E. Sobel, M.D., Medicine 
J. J. Spadaro, M.D., Medicine 
A. J. Tiefenbrunn, M.D., MedicineI S. Wickline, M.D., Medicine R. Wolf, M.D. Medicine 
I Support: RR 01380
 HL 17646
 
I Recent evidence confirming the importance of thrombosis to the 
I 
pathogenesis of acute myocardial infarction has led to an extensive 
evaluation of the utility of markers of thrombosis and the effects of 
therapy designed to induce reperfusion. Studies performed in the cardiac 
care and cardiac catheterization laboratory have been oriented toward the 
I 
diagnosis of acute thrombosis or the effects of thrombolytic agents. In 
the past we have utilized positron tomography to document improvement in 
regional myocardial metabolism induced by successful reperfusion with 
I 
streptokinase. Because of the promise of tissue-type plasminogen 
activator, a more clot specific agent, which does not induce circulating 
products of lysis that impair coagulation we began to utilize this agent in 
patients. The initial results with the melanoma derived protein (mtPA) 
I 
I 
were reported in a previous BeL progress report (PR 20, A-4). 
Subsequently, additional studies were performed to ascertain the potential 
utility of this agent. Forty-five patients with acute transmural 
infarction and angiographica11y confirmed complete coronary occlusion were 
prospectively randomized to treatment with intracoronary recombinant human 
tissue-type plasminogen activator (rtPA) or placebo. Five additional 
patients were treated with high dose rtPA for 2 hours. Twenty-five of 33 
I 
patients (75%) receiving .5 to .75 mg per kg of rtPA over 30 to 120 minutes 
developed angiographica11y documented reperfusion within 90 minutes of the 
initiation of therapy. Only 1 of 14 patients given placebo had spontaneous 
recana1izaiton within 45 minutes. The remaining 13 patients who received 
placebo were crossed over to an intracoronary rtPA group and 9 exhibited 
subsequent recanalization in 45 minutes. Levels of circulating fibrinogenI decreased after treatment by an average of only 8% from baseline and none 
I 
of the patients manifested a depletion of fibrinogen below 1 mg/dL. None 
of the patients unresponsive to rtPA (n-6) responded to intracoronary 
streptokinase. In addition, the response to intravenous rtPA appeared 
comparable to the effects of the agent infused directly into the coronary 
artery in terms of the percentage of patients achieving lysis. However, 
the time to recanalization was somewhat longer (23 ± 8 compared to 46 ± 18I minutes) when the agent was given intravenously. Thus, both intravenous 
I 
and intracoronary rtPA induced coronary thrombolysis without eliciting 
significa~t fibrinogeno1ysis in patients with evolving myocardial 
infarction. 
I 
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IBased on the data of patients treated locally (n-12) the effects of 
rtPA on coagulation and the kinetics of administration were defined. 
Serial blood samples were obtained prior to, during and after the infusion 
of rtPA and analyzed for tPA antigen (immunoassayable rtPA protein), Ifunctional fibrinolytic activity attributable to tPA, fibrinogen, 
plasminogen, alpha 2 antiplasmin, fibrin degradation products, thrombin 
time, activated partial thrombop1asmin time and protamine corrected 
thrombin time. Prior to therapy all values were normal and the plasma tPA I 
antigen levels averaged 16.5 ± 5 ngjm1. Peak plasma levels were generally 
proportional to the dose of rtPA, averaging 3,330 ± 1,201 ngjm1. Ninety 
percent of peak activity was reached in 30 minutes with a plateau reached I
within 40 minutes. Functional peak tPA activity increased monotonically in 
a comparable fashion. Curves for disappearance of tPA antigen and 
functional activity from plasma were monoexponentia1 for at least two half 
lives and were concordant. The observed half-lives were similar, averaging I 
8.3 and 9.1 minutes respectively. Changes in fibrinogen were transient and 
modest (a reduction of 17 ± 6% from baseline). Plasma alpha 2 antip1asma 
levels had declined moderately (51 ± 6% and 32 ± 7%) from pretreatment Iphase at the end of the infusion of rtPA. Prothrombin time, protamine­
corrected thrombin time and assay of fibrinogen degradation products 
corroborated the lack of a lytic state. Thus, desirable levels of rtPA can 
be achieved consistently with short term infusions and wifhout the I 
induction of a systemic lytic state which might induce bleeding. 
Based on these initial data a large national trial (Thrombolysis and IMyocardial Infarction, TIMI) was initiated comparing rtPA in a dose of .8 
mgjkg infused over a 3 hour period (40 mg first hour followed by 20 mg over 
the subsequent 2 hours) to intravenous streptokinase in a dose of 1,500,000 
units. The study was initiated in 13 clinical centers. Eligible patients I 
were taken to the cardiac catheterization laboratory and given intravenous 
heparin after placement of an arterial sheath. Left ventriculography was 
performed and coronary angiography thereafter. The infarct related artery 
was studied last. Two-hundred micrograms of nitroglycerin were injected I 
into the coronary artery prior to the infusion of thrombolytic therapy. 
Repeat injections were made at 10, 20, 30, 45, 60, 75, and 90 minutes after 
the start of intravenous therapy. The primary endpoint of the study was I
the number of patients with total occlusion (grade 0) which progressed to 
partial or complete reperfusion (grades 2 or 3) by 90 minutes. Thereafter 
all care was standardized. Three hundred sixteen patients were studied, 26 
of whom were not treated because they failed to meet angiographic criteria I 
for treatment. Seventy-six of the 290 remaining patients did not have 
total occlusion and therefore though treated were not analyzed as part of 
the primary end point. Of the 214 patients with total occlusion (grade 0) I99 were assigned to tissue-type plasminogen activator and 115 to 
streptokinase. Baseline clinical and arteriographic findings were similar 
between the two treated groups as was the time from the onset of chest pain 
to the start of drug infusion (287 minutes for rtPA and 286 for I 
streptokinase). Of the patients with total occlusion at baseline, 60% of 
those assigned to rtPA had achieved grade 2 or 3 reperfusion by 90 minutes. 
This is in contrast to only 35% of those assigned to streptokinase I(P<.OOl). When patients with grade 0 and grade 1 occlusion are considered 
together the relative percentages to reach grade 2 or 3 were 66% compared 
to 36% (P<.OOOl). There were no clear cut differences in the instances of 
fatal or central nervous system hemorrhage in either group. Hematoma at I 
the cath site was common occurring in 43% of patients receiving rtPA and 
47% of those receiving streptokinase. Gastrointestinal bleeding was noted I 
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 in 6% and 10% of the rtPA and streptokinase groups respectively. This was 
largely due to the large doses of heparin utilized during subsequent 
I managament since fibrinogen depletion was quite rare in patients receiving rtPA. 
These data confirm the increased efficacy ~f rtPA in the treatmentI of patients with acute myocardial infarction. Not only was rtPA less apt 
I 
to deplete fibrinogen but it was also more efficacious, probably due to its 
specific binding. For this reason intravenous rtPA has been chosen to be 
utilized for the continuing phases of the large national TIMI trial. 
As a way of assessing the potential utility of thrombolytic and 
anticoagulant therapy in patients with acute ischemic heart disease, weI have for years pursued the study of markers of thrombosis such as platelet 
I 
factor 4 and beta thromboglobulin (platelet degranulat~on proteins) in an 
attempt to find a marker for thrombotic events. Recently we have 
evaluated the utility of fibrinopeptide A (FPA) , 16 amino acid peptide 
cleaved by the action of thrombin with fibrinogen as a marker. The 
sensitivity of this marker for thrombosis is well established in patients 
with acute thrombosis but its use to assess coronary thrombosis in vivo hasI not been tested explicitly. Since fibrinogen turnover is rapid during the 
I 
early phase of thrombosis, we reasoned that during acute thrombotic 
episodes, FPA might be elevated. A quality control system similar to that 
described above was utilized to obtain samples in 83 patients with acute 
myocardial infarction. Patients sampled early had marked elevations in 
I 
FPA. Thirty of 39 patients (77%) with transmural myocardial infarction 
admitted within 10 hours of the onset of symptoms had markedly elevated 
levels (>8 ng/ml). In contrast, among patients in whom samples were 
I 
obtained "later than 10 hours after the onset of symptoms, only 2 of the 14 
patients had elevations greater than 8 ng/ml. One of these patients had a 
mural thrombus present at the time of admission and the other had severe 
pericarditis. Among 10 patients who underwent angiography within 7 hours 
I 
I 
of the onset of symptoms, all had total thrombotic occlusion. In each, FPA 
was elevated (mean - 64.4 ± 26.6 ng/ml) and in 9 of the 10 levels were 
greater than 8 ng/ml. All of the 13 patients in whom samples were obtained 
very early «3 hours of the 13 hours after the onset of symptoms) had 
values of more than 8 ng/ml. FPA elevations did not correlate with infarct 
size as measured with creatine kinase. FPA declined in patients with 
transmural infarction over the initial 24 hours. In response to heparin, 
I 
FPA fell markedly, compatible with inhibition of ongoing intravascular 
thrombin activation. The abrupt response to heparin suggests strongly that 
the likely source of the initial thrombin activation was coronary 
I 
thrombosis. Three patients had recurrent injury during follow-up. In 
each, transmural injury was accompanied by reelevation of FPA. Studies are 
being initiated to assess whether this mar~er of thrombosis is of utility 
in defining the risk for recurrent injury. 
I 1. B. E. Sobel, E. M. Geltman, A. S. Tiefenbrunn, A. S. Jaffe, J. J. Spadaro, M. M. Ter-Pogossian, D. Collen, and P. A. Ludbrook, "Improved 
Regional Myocardial Metabolism After Coronary Thrombolysis with 
I Tissue-Type Circulation, 
2. D. Collen, 
I Weisfeldt, B. 
I 
Plasminogen Activator (t-PA) or Streptokinase," 
vol. 69, pp. 983-989, 1984. 
E. J. Topol, A. S. Tiefenbrunn, H. K. Gold, M. L. 
E. Sobel, R. C. Leinbach, J. A. Brinker, P. A. LUdbrook, 
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The overall concept of the research is that potential arrhythmogenic 
metabolites accumulate in ischemic tissue and exert deleterious effects on 
membranes and that their effects may be exacerbated by the concomitant I
 
influences of the adrenergic nervous system. Over the past several years 
studies have been completed demonstrating a major electrophysiological role 
of a-adrenergic stimulation during myocardial ischemia as well as I

reperfusion. In addition, it has been demonstrated using radioligand 
binding procedures that there is a reversible increase in al-adrenergic 
binding sites in ischemic and reperfused myocardium. More recently, we 
have demonstrated that a-adrenergic blockade specifically attenuates the I
 
increase in intr\cellular calcium associated with reperfusion in reversibly
 
injured tissue. Studies performed in our laboratory have also indicated
 I
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I that 1ysophosphatides, including 1ysophosphatidy1cho1ine (LPC) and 
ethanolamine (LPE) accumulate in ischemic myocardium in situ and have been 
imp1ic~ted as potential mediators of arrhythmogenesis in the ischemic 
heart. 
Previous findings indicate that exogenous LPC (20-100 ~M) inducesI e1ectrophysio1ogic alteration in vitro. To assess whether the compartment 
I 
in which LPC resides is a critical determinant of its e1ectrophysio1ogic 
effects, intracellular micropressure injection of LPC was performed with 
simultaneous recording of the transmembrane action potential in superfused 
canine Purkinje fibers. Microe1ectrode injector properties were calibrated 
by measuring the diameter of the droplet prior to and after cell impalement 
at a series of pressures yielding a proportional re1ese of LPC (r-.99), andI the concentration delivered calculated based on measured total cell volume. 
I 
Intracellular delivery was verified by the generation of slow response 
action potentials after injection of cyclic AMP in tissue depolarized with 
10 mM KC1. Intracellular LPC, in concentrations as high as 500 ~M (n-18) 
did not induce discernible e1ectrophysio1ogic alterations (RMP - -81 ± 1 to 
I 
I 
-80 ±1 mV; amplitude - 122 ± 2 to 118 ± 3 mV and APD - 285 ± 10 to 293 ± 
11 ms). Very high concentrations of LPC, 2.5 mM (n-1~~, induced a slight 
but rapidly reversible depolarization (RMP - -81 ± 1 to -73 ± 2 mV) and 
decrease in amplitude (122 ± 2 to 110 ± 4 mV) attributable to changes in 
volume. Thus, e1ectrophysio1gic effects induced by LPC are markedly 
dependent on the locus of accumulation. Since e1ectrophysio1ogic 
derangements can be induced by LPC in the extracellular compartment at 
I 
I 
relatively low concentrations compared to that required in the 
intracellular compartment, concentrations of phospholipids in cardiac lymph 
during ischemia were assessed in 7 dogs. In each animal, a cannula was 
inserted into the supracardiac lymph vessel identified with Evan's Bt~e dye 
injected into the left vf~tricu1ar apex. Less than 4% of C-PC 
(phosphatidy1 choline) or C-LPC incubated in cardiac lymph for 30 min at 
4°C or 90 min at 37°C was catabolized (n-5). Lymph was collected on ice at 
15 min intervals throughout 2 hr of ischemia induced by LAD coronary 
ligation, extracted in CHC11 :CH 0H (2:1) and phospholipids separated by HPLC. Prior to ischemia, PC constituted the major phospholipid (79 ± 2%). 
Substantial quantities of sphingomyelin (11 ± 2%) and LPC (6 ± 1%) were 
present. With ischemia, LPC concentration increased 135% from 84 ± 5 to 
197 ± 34 ~M (n-7, P<.Ol) judging from the measured concentration andI dilution determined with constant infusion of dye into the LV apex. In 
I 3
I 
contrast, PC concentration and efflux did not change. Thus, LPC increases 
in interstitial fluid concomitant with ischemia to levels sufficient to 
induce e1ectrophysio1ogic derangements. Studies are currently underway to 
delineate the effects of selective inhibitation of PLA in vivo during2ische~a with simultaneous three-dimensional cardiac mapping from 240 
sites to assess whether the e1ectrophysio1ogic effects of ischemia areI blunted. 
I 
A recent series of studies was completed to determine whether 
endogenous long-chain acyl carnitines alter e1ectrophysio1ogic function 
during hypoxia. Sarcolemmal long-chain acyl carnitines and transmembrane 
action potentials were measured in neonatal rat myocytes rendered hypoxic 
with or without blockade of synthesis of long-chain acyl carnitines withI pheny1a1ky1oxirane carboxylic acid (POCA, 10 ~M), an inhibitor of carnitine 
I 
acy1transferase. Local concentrations in the sarcolemma of endogenous 
long-chain acyl carnitines were determined by quantitative electron 
microscopic autoradiography. Hypoxia increased long-chain acyl carnitines 
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by more than 5-fo1d (radioactivity inc~easing from 25 ± 9 in controls to 
139 ± 77 (SD) dpm/~g protein) but not with POCA (radioactivity - 11 ± 4 
dpm/~g protein). The long-chain acyl casnitines in s~rco1emma increases 
70-fo1d with hypoxia from 2 to 140 x 10 mo1ecu1es/~m, but not with POCA. I 
Increased long-chain acyl carnitines in hypoxic cells was associated with 
decreased resting potential (RP) to -25 mV and abolition of depo1arizations 
in contrast to the case in hypoxic but POCA-treated cells (RP - -64 ± 14 vs I76 ± 10 mV in controls; action potential amplitude - 77 ± 17 vs 97 ± 9 mV). 
These results strongly implicate endogenous long-chain acyl carnitines as a 
mediator of e1ectrophysio1ogic impairment secondary to hypoxia. The effect 
of POCA and oxfenacine, another inhibitor of carnitine acy1transferase are I 
currently being evaluated in vivo during ischemia in an attempt to reverse 
or modify the e1ectrophysio1ogic alterations and associated arrhythmias. ITo delineate the e1ectrophysio1ogic mechanisms underlying 
arrhythmias induced by ischemia, a computerized, three-dimensional mapping 
syst~ with simultaneous 8-1eve1 transmural recording from 232 bipolar 
sites was used to characterize ventricular tachycardia (VT) after LAD I 
coronary artery ligation in feline hearts in vivo. Within 5 min of 
ischemia, sinus rhythm was characterized by delayed subendocardial to 
epicardial total activation time (70 ± 5 vs 25 ± 1 ms prior to ischemia) 
and the appearance of reverse activation from the epicardium to the mid­ I 
myocardium were present during sinus rhythm. Spontaneous -VT always arose 
in the subendocardium (n-5) adjacent to the site of the delayed epicardial 
to midmyocardia1 conduction of the previous beat. Maintenance of VT was Idue to further delayed endocardial to epicardial conduction (102 ± 9 ms) 
with areas of block in the ischemic zone as well as further subsequent 
delayed epicardial to myocardial conduction. Thus, VT during ischemia is 
due to intramural reentry. Currently, studies are being performed to I 
assess, for the first time, the e1ectrophysio1ogic mechanisms responsible 
for the deleterious effects of catecho1amines during ischemia. IWe have previously demonstrated that sustained monomorphic 
ventricular tachycardia (SMVT) during chronic canine myocardial infarction 
is secondary to intramural reentry and is critically dependent upon4
epicardial conduction delay and block. The present study assessed the I 
mechanisms responsible for nonsustained polymorphic VT (NSVT) in dogs 3 to 
5 days following transient LAD coronary artery occlusion (n-5) with a 
computerized mapping system whic~ analyzed activity simultaneously from 232 Iepicardial and intramural sites. In contrast to SMVT, reentry during NSVT 
elicited by programmed stimulation was confined to the midmyocardium and 
subendocardium, with only passive epicardial activation. NSVT was 
maintained when reentrant wavefronts reached nonrefractory endocardium to I 
initiate successive beats. Polymorphism was attributable to different 
endocardial exit sites between each beat. Endocardial activation time 
during the last paced beat preceding VT was similar in SMVT and NSVT (92 ± I13 vs 89 ± 10 ms). In contrast, epicardial activation time was prolonged 
in dogs with SMVT compared with NSVT (170 ± 16 vs 91 ± 12 ms, P < .01). 
This indicates that NSVT can result from reentry confined to the 
midmyocardium and subendocardium and depends less on transmural electrical I 
dysfunction. These results also identify a mechanism accounting for the
 
frequently lethal VT seen after nontransmura1 infarction in man.
 I 
1.	 A. D. Sharma, J. E. Saffitz, B. I. Lee, B. E. Sobel, and P. B. Corr, 
"Alpha-Adrenergic Mediated Accumulation of Calcium in Reperfused I 
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 Myocardium," Journal of Clinical Investigation, vol. 72, pp. 802 - 818, 
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I 2. P. B. Corr, R. W. Gross, and B. E. Sobel, "Amphipathic Metabolites and 
Membrane Dysfunction in Ischemic Myocardium," invited review for 
Circulation Research, vol. 55, pp. 135-154, 1984. 
I 
I 3. F. X. Witkowski and P. B. Corr, "An Automated Simultaneous Transmural 
Cardiac Mapping System," American Journal of Physiology, vol. 247, pp. 
H66l-H668, 1984. 
4. J. B. Kramer, J. E. Saffitz, F. X. Witkowski, and P. B. Corr, 
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I The research .in this project is designed to define the kinetics of 
positron-emitting radiotracers that are potentially useful for the 
noninvasive characterization of myocardial perfusion and metabolism.I Studies in this project are conducted in isolated rabbit hearts perfused 
I 
with washed sheep erythrocytes suspended in a modified Krebs-Henseleit 
buffer, and in open-chest dogs with controlled, extracorporeal circulation. 
Both of these animal preparations have been used extensively in our 
laboratories, and presage the implementation of approaches of proven value 
in studies using positron-emission tomography. The development of 
accurate, quantitative, noninvasive measurements of myocardium metabolismI and perfusion are dependent on the characterization of the factors that can 
I 
influence tracer kinetics. Since fatty acid is the major fuel of 11he 
myocardium, we have continued our studies on the characterization of 1- C­
palmitate. 
Assessment of myocardium metabolism with radiolabeled palmitate and 
positron-emission tomography has generally assumed that the clearance ofI radiolabel from the myocardium is attributable solely to the efflux of the 
I 
products of oxidative metabolism. However, interpretations would differ if 
this assumption differed with altered metabolic states, such as ischemia or 
reperfusion. Accordingly, we studied 21 open-chest anesthetized dogs with 
I 
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the coronary circulation perfused with a rttracorporeal bypass pump, and 
monitored the extraction and clearance of 1- C-palmitate (administered as 
a bolus into the coronary artery) under baseline conditions. After 
radioactive decay, a second intracoronary bolus was administered during I 
ischemia (n-6) , hypoxia (perfusion at normal flow rates but with venous 
blood, (n-9) , or with maintained baseline conditions (n-6). Myocardial 
time-activity curves were measured with a beta-probe with radioactive data Ifed into the isolated-probe data acquisition system. The results of the 
time-activity curves were correlated with products of oxidative metabolism 
measured directly from analysis of the arterial and regional coronary 
venous blood. Unf.fr control conditions, 95.2 ± 3l~% (mean ± SO) of I 
initially extracted C-palmit~te was metabolized to CO while 6.2 ±2 , 2.6% back diffused in an unaltered form. In contrast, with ischemia 
(perfusion 2~! of baseline flow), only 16.9 ± 9.8% of administered tracer 
evolved as CO and 18.8 ± 11.7% back diffused (P<.OOl). Overall, from I 2 , 1-40 min. after intracoronary injection of tracer, back diffusion of 
palmitate contributed to 40.6% of the total radioactivity in the effluent 
with ischemia, 48.7% with hypoxia, but only 8.9% under control conditions. I
Despite the increased back-diffusion of non-metab~lized palmitate seen 
during ischemia and hypoxia, the overall residue of C-activity in the 
myocardium was increased, consistent with the diminished clearance observed 
in the myocardial time-activity curves and the increase in tissue lipid I 
content. These results suggest that estimates of oxidative metabolism 
based upon external detection of the clearance of radio labeled fatty acid 
must take into account the efflux of initially extracted but non­ I
metabolized fatty acid. 
Our division is currently involved in studies designed to evaluate 
the efficacy of coronary reperfusion in the restoration of myocardial I 
metabolism and function after coronary thrombolysis. To determine whether 
myocardial intermediary metabolism recovers promptly with reperfusion after 
brief (20 min) ischemia, the L1~s in 22 open-chest anesthetized dogs were Iperfused extracorporally, and 1- C-palmitate was given intravascularly 
under bas ine or repeat control con1\tions (n-6) 66 ± 11% of initially1t Iextracted C-palmitate was oxidized to CO In contrast, with ischr~ia,2 . (22% of baseline flow, n-6) only 26 ± 14% was oxidized. Recovery of CO 
was incomplete (42 ± 19%) aft ! 30 min. of reperfusion (n-7, P<.05). Bac~ 
rdiffusion of non-metab~tizedC-palmitateincreased from 10.5 to 17.2% and 
clearance of residual C-palmitate detected externally with the beta-probe Isystem was prolonged (t 2 increasing from 4.2 to 12.5 min, P<.05), and 
recovered only incompletett. Recovery of all parameters was complete in 
positive control experiments (3 min ischemia followed by 30 min 
reperfusion). Thus impairment of myocardial intermediary metabolism I 
persists after transitory ischemia followed by reperfusion, a phenomenon 
necessitating consideration for interpretation of clinical metabolic 
images. As reported (0-1), we have looked sequentially at the recovery of Iperfusion and metabolism in an intact-dog preparation of ischemia and 
reperfusion. 
S . 1 H C 1· . b . . . . 1 . b h ~nce - -pa m~tate ~s su Ject to ~n~t~a extract~on ut t en can I 
back-diffuse from either intracellular or interstitial compartments during 
ischemia, hfpoxia, or reperfusion, we studied the use of a fatty-acid 
analog, 1- C beta methyl heptadecanoic acid (BMHA). BMHA was given as a 
bolus injection proximal to an occluded circumflex marginal branch in 5 I 
open-chest, anesthetized dogs. Extraction fraction, determined by 
collection of myocardial time-activity curves with the beta-probe and the I 
I
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I isolated probe data acquisition system averaged 25 ± 5 (mean ± SO) % in 
normal, and 45 ± 15% ir ischemic zones. In normal zones, 5% of extracted 
BMRA was oxidized to CO in twenty minutes, and 3% egressed unaltered via2the coronary venous effluent. In contrast, less than 1% was oxidized while 
45% egressed unaltered from ischemic zones. Ischemia increased the 
proportion of total activity in trigylerides (from 55 ± 11 to 73 ± 8%) andI decreased the proportion in phospholipid. Thus, although BMRA has been 
I 
suggef£ed as a fatty-acid analog that would not be subject to limitations 
of 1- C-palmitate, its kinetics do not simulate those of circulating fatty 
acids. However, since BMHA accumulates predominately in tricyleride 
without undergoing substantial beta oxidation, this tracer may be useful to 
study neutral lipid pools in normal and ischemic myocardium. 
I The studies performed in the laboratory in the past year with l_llC_ 
I 
palmitate and BMRA have permitted a better understanding of the factors 
that influence the uptake of these tracers. In the coming year, we will 
continue our characterization of the kinetics of these tracers, with a 
special emphasis on the recovery of metabolism during reperfusion. Since 
I 
during ischemia and reperfusion, the myocardium may switch from fatty acid 
metabolism to utilization of carbohYffates for energy producti~~, we plan 
to begin characterizing the use of C glucose, as well as C-deoxy­
I 
glucose, in an isolated heart model preparation of ischemia and 
reperfusion. Clarification of the kinetics of these tracers under 
controlled laboratory conditions will enhance understanding of the 
tomographic data that is acquired in our studies of experimental animals 
(0-1) as well as positron-emission tomographic studies in humans (0-2). 
I 
I 1. K. A. A. Fox, O. R. Abendschein, H. O. Ambos, B. E. Sobel, and S. R. 
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Canine Myocardium: Implications for Quantifying Myocardial Metabolism 
Tomographically," Circulation Research, vol. 57, pp. 232-243, 1985. 
I 
2. O. R. Abendschein, K. A. A. Fox, R. M. Knabb, H. 011Ambos, O. R. 
Elmaleh, and S. R. Bergmann, "The Metabolic Fate of C-Beta Methyl 
Heptadecanoic Acid (BMHA) in Myocardium Subjected to Ischemia," 
Circulation, vol. 70 supplement II, p. 11-148, 1984, (abstract). 
I 3. K. A. A. Fox, O. R. Abendschein, B. E. Sobel, and S. R. Bergmann, 
I 
"Persistent Impairment of Myocardial Metabolism and Clearance of 
Labeled Fatty Acid after Brief Ischemia: Implications for Positron 
Emission Tomography (PET)," Journal of the American College of 
Cardiology, vol. 5, p. 451, 1985, (abstract). 
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Early and reliable detection of acute myocardial infarction and 
characterization of its time course are important for timely initiation of I 
therapy and evaluation of the effects of therapy. Conventional analysis of 
enzyme time-activity curves in blood is neither rapid nor a reliable method 
to assess the chronology of infarction. However, analysis of profiles of 
isoforms of creatine kinase (CK) MM isoenzyme in plasma may permit prompt I 
detection of infarction and differentiation of events punctuating the time 
course of infarction. I
In the past year, we have shown in dogs subjected to coronary artery 
occlusion that the predominant MM CK isoform in myocardium, MM if 
converted quickly and sequentially to MM and MM isoforms in plasma.B C 
A , IConversion combined with disappearance of each isoform from the circulation 
results in a consistent, time-dependent change in the proportions of 
isoforms in plasma with rapid return to the baseline proportions. Changes 
in isoform proportions are independent of infarct size and are not affected Iby marked variationii in the contours of total CK and isoform time-activity 
curves in plasma. Moreover, because of continuous elimination of MM fromA	 Iplasma, the proportions of isoforms in plasma are altered markedly by egress of modest amounts of MM from myocardium. Thus, changes in isoform 
proportions indicative of recen~ tissue damage occur very early after the 
onset of ischemia and are more sensitive to early myocardial damage than 
total CK activity in plasma. I 
Recent studies (in review) have also shown that the fraction of 
total CK activity in plasma represented by MM (MM %) changes very earlyA A
after the onset of myocardial reperfusion in conscious dogs. The rate of I 
change of MMA% in plasma after reperfusion is remarkably consistent and 
strikingly aifferent (at least 5-fo1d) from the rate in the absence of 
reperfusion regardless of the duration of preceding ischemia, magnitude of Iabsolute plasma CK activity, or infarct size. Thus, analysis of changes in 
MM % in plasma may provide an early and reliable index of myocardial 
reperfusicn.A	 I 
In order to apply isoform analysis clinically for early detection of 
reperfusion and other disparate biological events in the chronology of 
infarction, it is necessary to rigorously define the kinetics of conversion 
and elimination of isoforms in plasma in vivo. Accordingly, we have I 
initiated development of a physiologically based, mathematical model of MM 
CK isoform kinetics during myocardial infarction in dogs which will provide 
a basis for recognition of kinetic parameters characterizing different I
cardiac events. 
I 
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I Previous observations from our 1aboratory2 indicating that greater 
than 95% of total MM CK in myocardium is MM and that MM is converted 
I A Asequentially and irreversibly to MM and MM ~n plasma have led to the formulation of a three-compartmen~, vascufar model of isoform kinetics. 
For preliminary testing, we have assumed that the kinetics of isoform 
conversion are first-order. In the past year, estimates of the conversionI and disappearance rates of each isoform using the vascular model have been obtained in vivo after intravenous injection of purified MM into consciousAdogs and in vitro after incubation of purified MM in canine plasma. Close 
agreement of the in vivo and in vitro rate constants estimated from plasma 
time-activity curves by non-linear least squares approximation suggestedI A 
the suitability of the vascular model to define isoform kinetics during 
myocardial infarction. However, subsequent experiments in which theI kinetic rate constants estimated in vivo were used to simulate isoform 
I 
time-activity curves in plasma after myocardial infarction proved 
unsuccessful. The vascular model predicted that the amount of each isoform 
in plasma would be about equal over time when, in fact, the time-activity 
curves in plasma showed a progressive increase in the amount of MMB
relative to MM and MM relative to MM Judging from these preliminaryB.A C 
I 
results, it appears that a simple vascular model will not adequately define 
isoform kinetics during myocardial infarction in dogs. 
A possible explanation for the disparity between simulated isoform 
time-activity curves derived from the rate constants after intravenous 
injection of MM , and actual isoform activity curves in plasma afterI 
myocardial infarc~ion is that the input into plasma during infarction may 
consist of all three isoforms reflecting conversion of MM in more than one 
biological pool. Because we have shown that MM is the primary isoform inAboth normal and necrotic myocardium, it is reasonable to consider that 
additional poo1(s) may be located extrace11u1ar1y. 
I A 
I Preliminary experiments have been conducted to examine the isoform 
I 
converting capability of extracellular fluid. Isoforms leaving the heart 
via cardiac lymph were assessed and compared to isoforms in plasma at 6 
hours and 14 hours after coronary artery occlusion in dogs. At 6 hours, 
most of the CK activity in lymph was in the form of MM A small amount ofA. MM but no MMC was detected in lymph compared with hign quantities of MM an~ MM in plasma. However, at 14 hours, corresponding to the time of pea~I etotal K activity in plasma, more than half of the isoform activity in cardiac lymph was in the form of MM and MM. Thus, it appears thatB
conversion of isoforms occurs in cardiac lymph a~ter infarction, but at a 
slower rate than in plasma. Although the volume flow of lymph leaving theI heart is small, the amount of MM and MMC egress from the heart may be 
sufficient to account for the ~isparity observed in earlier modeling 
experiments. Accordingly, the model to define isoform kinetics in vivoI during myocardial infarction may need to include a cardiac lymph pool. 
I 
Additional experiments are planned to determine the time course of 
isoform activities in cardiac lymph and plasma simultaneously after 
myocardial infarction in dogs. For this purpose, we are developing a 
procedure for obtaining serial cardiac lymph samples from conscious dogs. 
The results of these studies should identify the input function forI isoforms entering plasma during infarction and facilitate the delineation 
I 
of the appropriate model to define the kinetics of isoforms in plasma after 
acute myocardial infarction. This model will then be employed to identify 
kinetic parameters that might differentiate acute infarction from 
I
 
I
myocardial reperfusion. recurrent infarction in previously ischemic zones. 
and extention of infarction in previously non-ischemic zones in conscious 
dogs and ultimately in human subjects. I 
1.	 H. Hashimoto, D. R. Abendschein, A. W. Strauss, and B. E. Sobel, 
"Early Detection of Myocardial Infarction in Conscious Dogs by 
Analysis of Plasma MM Creatine Kinase Isoforms," Circulation, vol. 71. I 
pp. 363-369, 1985. 
2.	 H. Hashimoto, A. M. Grace, J. J. Billadello, R. W. Gross, A. W. IStrauss, and B. E. Sobel, "Non-Denaturing Quantification of Subforms 
of Canine MM Cratine Kinase Isoenzymes (Isoforms) and Their 
Interconvers ion." Journal of Laboratory Clinical Medicine, vol. 103, 
pp. 470-484, 1984. I
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The MILlS protocol was initiated on August 1, 1978. In previous 
progress reports the goals and aims of the study as well as the end-point I 
data for propranolol have been delineated. The hyaluronidase arm of the 
study was terminated on December 31, 1983. By that time 9,444 patients had 
been screened for eligibility and a total of 985 patients had been 
randomized. Washington Universi ty contributed 244 patients (25% of the I 
overall recruitment). The primary end-point was infarct size measured by 
serial determinations of MB creatine kinase. It has previously been shown 
that there were close relationships between MB CK infarct size and the size I
of infarction as determinrd by morphometric measurements in patients who 
died early (r-.79, n-19). Ancillary end-points included mortality, 
electrocardiographic findings, pyrophosphate scintigraphy, radionuclide 
ventriculography and exercise treadmill tests. Of the 851 patients who I 
received blinded therapy, 166 who received hyaluronidase and 172 who 
received placebo were in group A (those patients eligible medically to I 
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I receive propranolol). In group B (patients not eligible to receive 
propranolol) 254 patients received hyaluronidase and 259 received placebo. 
The baseline characteristics between these groups were quite comparable 
although patients treated with hyaluronidase had slightly higher blood 
pressures. The mean time from the onset of chest pain to the 
administration of blinded therapy was 9.3 ± 0.2 hours for hyaluronidase and 
I 9.4 ± 0.2 hours for placebo. Four patients were treated within 3 hours of 
I 
the onset of pain, 26 within 4 hours and 161 within 6 hours. The numbers 
of patients in the entire group (0 to 18 hours) were such that a 20% 
reduction in infarct size index at the P<.05 level (2 sided) could be 
accomplished at a power of .82. However the power given similar 
I 
I 
assumptions to assure that early treatment had not been beneficial in the 
subgroup randomized between 0 and 8 hours was only .56. Hyaluronidase was 
well tolerated; urticaria developed in 9 patients (2.1%) compared to 2 
patients in the placebo group (.5%, P-0.04). The incidence of acute 
myocardial infarction was not altered by hyaluronidase therapy (86% for 
hyaluronidase compared to 88% for placebo-treated patients). There were no 
difference~ in the infarct size index or MB, peak MB CK between groups 
I 
(Table 1). Similarly there was no significant mortality during a 48 month 
fo11owup for the entire cohort of patients (Figure 1). There were minor 
differences in other parameters of cardiac performance including 
radionuc1ide ventricu1ograms, ECGs, stress tests performance and 
pyrophosphate images. 
I These negative results were in sharp conrast to results of other 
I 
studies with hyaluronidase and likely were in large part due to the 
relatively late administration of therapy in this study. It was clear that 
hyaluronidase given to patients with acute infarction within the confines 
of this study failed to show significant benefit. 
Although no benefit was found overall, an interesting observationI was made retrospectively in a subgroup of patients. Since at the time of 
I 
the initiation of the trial, little was known concerning reperfusion or the 
fact that rapid peaking of MB CK might be a marker of acute reperfusion, 
the possibility that patients who mainfested reperfusion would have a 
different response to hyaluronidase was not considered. Subsequently, as 
data in this area were developed, the need to evaluate this patient group 
was recognized. Accordingly, a retrospective analysis was done to assessI whether patients who fell in the first quartile of time from onset of 
I 
symptoms to peak CK behaved differently than those in the other 3 
quarti1es. Patients with early peaking of MB CK treated with hyaluronidase 
had a markedly reduced mortality over time compared to control patients who 
peaked similarly early. This effect was not seen on any of the other 
I 
quarti1es of patients. Additional effects delineated retrospectively 
included improvement in mortality and ejection fraction in patients with ST 
depression, especially for those in group B treated 8 to 18 hours after the 
I 
onset of infarction. The mechanisms for both of these effects are unclear. 
It is conceivable that early reperfusion allows hyaluronidase to reach the 
infarcted area and to prevent further extension or to reduce the initial 
size of infarction. The effects in patient with nontransmura1 infarction 
I 
may be seen similarly mediated if a partially open artery is present. The 
possibility that this finding is due to statistical artifact must be 
strongly considered. 
I
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A large number of on going data bank studies continue from the MILlS 
da~a b~nk ~~§h active participation from our contingent at Washington 
Un1vers1ty. I 
For example, Peter Stone, M.D., proposed a preliminary investigation 
of ischemia in MILlS patients who had survived 6 months post-MI and who had 
received at 6 months both an exercise tolerance test (ETT) and a 24-hour 
Holter ECG recording. Of 298 patients who had both tests performed, 94 I 
patients had exertiona1 ST-segment depression (>1 mv) on the ETT. Since 
the original analyses of the Holter recordings did not include estimates of 
ST-segment deviations, a sample of 50 of the 94 Ho1ters were I
retrospectively analyzed for significant ST-segment changes. Because the 
Holter recordings were not calibrated to measure ST-segment deviations in 
the traditional sense of absolute millivolts, ST-segment deviation was 
expressed as a percentage of QRS height, for which 25% was arbitrarily I 
chosen as significant. As only 2 of the 50 recordings showed significant 
ST-segment changes, the investigation was discontinued. I 
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I 7. J~ E. Muller, P. H. Stone, Z. G. Turi, J. D. Rutherford, C. Czei~ler, 
C. Parker, K. W. Poole, T. D. Hartwell, E. Scheiner, H. K. Gold, A. S. 
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Table III
 
PLASMA MB-CK ANALYSIS FOR ALL PATIENTS
 
Significance I
 
of the 
Difference 
Hyaluronidase Placebo (P value) I
 
MB-INFARCT SIZE INDEX 
Total Population I
 
Number of Patient~ 364 374
 
Mean (MBCK-g-eq/m ) 14.6 15.2 0.62
 I
SE 0.8 0.8
 
Range 0.0-123.5 0.0-103.0
 
Early Randomization (0.8 hrs) I
 
Number of Patients 174 171
 
Mean 16.3 16.5 0.89
 
SE 1.1 1.1
 I
 
Range 0.0--123.5 0.0-70.4 
Late Randomization (8-18 hrs) I
 
Number of Patients 190 203
 
Mean 13.1 14.1 0.54
 
SE 1.1 1.0
 I
 
Range 0.0-84.0 0.0-103.0 
PEAK PLASMA MBCK I
 
Total Population 
Number of Patients 415 429
 I
 
Mean 131.0 128.1 0.71
 
SE 5.9 5.2
 
Range 0-848 0-612
 I
 
Early Randomization (0-8 hrs) 
.Number of Patients 192 191
 I
 
Mean 154.9 148.4 0.60
 
SE 9.0 8.4
 
Range 0-848 3-612
 I
 
Late Randomization (8-18 hrs) 
Number of Patients 223 238
 I
 
Mean 110.5 111.7 0.90
 
SE 7.5 6.2
 
Range 0.754 0.454
 I
 
I
 
I
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I A-9. Model Development for Cardiac Diastolic Mechanics 
I Personnel: M. L. Ridner, M.D., Medicine M. R. Courtois, M.A., Medicine 
P. A. Ludbrook, M.D., Medicine 
J. Markham, BCL 
I 
I Support: RR 01380
 
HL 17646
 
HL 25430
 
Barnes Hospital
 
Washington University 
I During the past year, our studies of cardiac diastolic mechanics (PR 
20, A-9), i.e., the passive mechanical properties of the left ventricular 
I (LV) muscle and chamber, have continued with emphasis on evaluation of the effects of early reperfusion on the stiffness of the left ventricle (LV) in dogs where the stiffness index is computed from stress-radius 
relationships. 
I 
I Values for stress are computed from several variables measured in 
the cardiac catheterization lab including intra- and extra-cavitary 
pressures, and the radii of the cavity are calculated fr.om the area and the 
longest chord of the ventricle as measured from single-plane angiographic 
I 
silhouettes. Stress is then derived as a function of strain, and strain is 
expressed as a function of radius to yield a stress-radius relationship (a 
power function of radius) for estimating elastic stiffness of the LV 
muscle. 
Until recently, we had attempted to fit stress-radius curves overI the entire diastolic range; however the rapidly changing curvature of the early portion of the curve precludes a fit with any smo~th function. We 
are presently following the example of other researchers and fitting only 
the mid- and late-diastolic phases starting with the end of the rapidI filling phase. It has been suggested that the stress-radius curve2 reflect 
viscous effects in the rapidly filling or early diastolic phase. Curve 
fits obtained after omitting the early diastolic phase show a closer fit ofI the power function to the data. 
I 
Future efforts will be directed toward determining the portion of 
the stress-radius curve to be fit and the best function for characterizing 
the stiffness of the LV. 
I 1. A. Fester and P. Samet, "Passive Elasticity of the Human Left Ventricle: The "Parallel Elastic Element"," Circulation, vol. 50,p. 
609, 1974. 
I 2. L. Kirk, J. T. Peterson, A. Johnson, J. DiDonna, and M. LeWinter, 
I 
"Diastolic Left Ventricular Pressure-Volume and Stress-Strain 
Relations in Patients with Valvular Aortic Stenosis and Left 
Ventricular Hypertrophy," Circulation, vol. 58, no. 1, pp. 77-89, July 
1978. 
I
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A-10. SCOR	 Patient Information Database 
Personnel:	 K. B. Schechtman, BCL 
H. D. Ambos, Medicine I 
E. M. Ge1tman, M.D., Medicine 
A. S. Jaffe, M.D., Medicine 
J. Markham,	 BCL IB. E. Sobel, M.D., Medicine 
Support:	 RR 01380 
HL 17646 I 
The Specialized Center for Research (SCOR) database currently Icontains information on more than 2000 patients who suffered acute 
myocardial infarction. The data describe each patient's cardiovascular 
history, in-hospital course, and long term progress via follow-up 
examination. The data are stored as a SAS database on the University's IBM I 
System/370 computer. Data are entered using interactive SAS under the 
Conversational Monitoring System (CMS) operating system. A total of 24 
data-entry screens have been designed for this purpose. All data analysis 
and management facilities of SAS are available for interactive application. I 
Studies which have utilized the SCOR database include a 
consideration of whether coronary thrombosis in vivo is reflected by I
elevations in levels of fibrinopeptide A (FPA) in plasma; an analysis of 
the factors which are responsible for the initial success or failure of 
coronary thrombolysis; and a prospective evaluation of platelet factor IV 
plasma levels in patients with myocardial infarction suggesting that these I 
levels do not provide a definitive criterion for coronary thrombosis. 
I 
A-11. Software Support for Cardiological Image Processing I 
Personnel:	 D. E. Beecher, BCL 
E. M. Ge1tman, M.D., Medicine IT. O. Videen, BCL 
Support:	 RR 01380 
HL 17646 I 
A software system for cardiological image processing has recently Ibeen completed and is now in routine use in the Coronary Care Unit. The 
highly modular system was written in FORTRAN on a Perkin-Elmer 3230 
processor and structured for maintainability as well as portability. I 
This software system was developed for analyzing PET images of the 
heart. Regions of interest may be created in a variety of ways including 
defining high and low thresholds of activity or by drawing or subdividing 
regions free-hand with a trackball. Regions may be defined on zoomed I 
images and may be moved to new locations with the trackball. Statistical
 
analysis may be carried out on individual PET images when the regions are
 I 
I
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I 
defined. However, analysis is speeded significantly by allowing multiple 
regions to be stored and later analyzed on a series of PET images 
automatically. 
Heart imaging has some unique problems posed by the large blood pool 
and by the fluidity of the heart and movement of the chest. The automaticI analysis allows the user to enter coordinates specifying relative shifts between the images on which regions were created, the images of the blood 
pool, and the images of metabolic activity. 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
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B. Quantitative Imaging: Ultrasonic Tissue Characterization 
Although ultrasound has proven to be a useful source of diagnostic 
information, results of examinations based on current ultrasonic methods I 
are primarily qualitative and pictorial. In a collaborative effort with 
Cardiology and the Department of Physics work has continued on methods of 
tissue characterization via ultrasound. Our overall goal is to use Iultrasound for the non-invasive identification of tissue pathologies within 
two-dimensional images of tissue properties-. Specific objectives of this 
effort are 1) to investigate the magnitude and character of anisotropy in 
tissue, 2) to systematize the representation of the ultrasonic field and to I 
reduce the data needed to describe that field by determining the moments of 
the spatial distribution of energy over the receiver aperture, 3) to seek 
improvement in measurement capability of imaging systems via interactive, Iadaptive beamforming for both linear and variable-aperture transducer 
arrays, 4) to test the hypothesis that quantitative images based on 
intrinsic tissue properties can be produced with reflected ultrasound, and 
5) to construct a digital multiprocessor system to perform post-echo I 
ultrasonic estimation of attenuation, phase velocity and backscatter in two 
dimensions. IQuantitative images based on ultrasonic tissue properties have been 
made at the BCL for several years using transmitted ultrasound with a 
multiple-frequency tomographic reconstruction system. In the past year we 
added a multiuser, color-graphics workstation for generating and I
manipulation images to our processing environment (B-10), which supports 
acquisition, storage, and processing of reflected ultrasound from arrays, 
as well as transmitted ultrasound using single-element transducers. I 
Our investigation of the anisotropy of tissue was extended in four 
studies conducted over the past year. We constructed a tissue phantom from 
graphite fibers imbedded in gelatin which reproduces the fiber organization I
of muscle (B-1). The attenuation (B-2) and backscatter (B-3) of this 
phantom were studied as functions of ultrasonic frequency and angle of 
incidence of the ultrasonic beam. Predictions of the change of properties 
relative to the axis of the fibers agrees well with experimental I 
measurements, and the nature of these changes mimick those observed in dog 
myocardium and skeletal muscle (B-4). An isotropic, dispersive tissue 
model based on a single pole (relaxation frequency) was used to predict Iattenuation of material both linearly and quadratically dependent on 
frequency (B-7). 
Transducers and initial processing of received ultrasound were also I 
the subject of four studies. The frequency and angular responses of 
elements in a typical linear array were characterized (B-8). A two­
dimensional array was simulated by scanning a point-like receiver to Imeasure the spatial moments (B-5) of azimuthally sYmmetric beams (B-6). 
The point-like array significantly reduced phase-cancellation errors and 
the moments allowed beam description in terms of its energy; centroid; and 
beam width, incidence angle, and divergence angle. We are also processing I 
received ultrasonic fields by adaptively forming beams, i.e., forming beams 
in ways that depend on the insonified medium (B-9). I
 
I
 
I
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B-l. Construction of Anisotropic Tissue-Mimicking Phantoms 
Personnel:	 J. G. Mottley, BCL 
J. G. Miller, BCL 
Support:	 RR 01362 
HL 17646 
HL 28998 
Background 
1 Early investigations, ranging as far back as that of Hueter in 
1948, have indicated that the ultrasonic attenuation and speed of sound 
are different when ultrasound propagates parallel to the ~~gers of the 
muscle than when it travels perpendicular to those fibers. Due to an 
error in labeling a figure in the Hueter article, the direction of maximum 
ultrasonic attenuation relative to the fiber direction was in doubt for 
some time. Further, the articles referenced above indicate only the values 
of attenuation measured parallel to and perpendicular to the fibers, with 
no indication of the detailed angular dependence of the parameter. 
Research from this laboratory has endeavored to determine the 
angular dependence and magnitude of these anisotropic effects, in order to 
permit mor§ rational application of quantitative imaging techniques (PR 18, 
B-3, B-4). Such anisotropy in the attenuating properties of soft tissues 
could have a profound impact on the interpretation of ultrasonic images and 
on measurements which require the use of data acquired from multiple angles 
of view. In addition, the presence of anisotropic media violates the 
initial assumptions of back projection reconstructive tomography. Studies 
and simulations from this laboratory have shown that anisotropy of the 
~ttenua~if8 introduces false and misleading values into reconstructed 
~mages. ' 
Isotropic tissue-mimicking phantoms have frequently been prepared in 
this laboratory from suspensions of graphite powder in gelatin using 
procedures described by Madsen and co-workers. These "phantoms" provide 
relatively accurate mimicking of the attenuation of soft tissues such as 
liver, but do not exhibit the dependence of attenuation on the angle of 
insonification that is exhibited by tissues which are oriented into fibers, 
such as muscular tissue. We thus undertook a project to construct 
anisotropic phantoms from materials similar to those which proved 
successful in the prior experiments. We used fibers of graphite which were 
suspended in gelatin with the axes of the fibers approximately aligned with 
the procedure described below. 
Construction of Anisotropic Phantoms 
Short fibers (approximately 400 ~m long and 8 ~m in diameter) of 
graphite were obtained by washing them from lumps of fibers as supplied 
(Alpha Chemical) and were concentrated by settling and decanting. This 
water and fiber mixture was then mixed with gelatin powder (Fisher 
Scientific). The mixture was placed in a pre-heated beaker and a warmed 
cylindrical insert was submerged in the gelatin. The insert was spun while 
the beaker remained fixed, creating a velocity gradient between the beaker 
walls and the insert, and also between the bottom of the beaker and a lip 
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on the insert, with the resulting forces tending to align the fibers 
circumferentia11y. The entire apparatus was allowed to cool gradually 
while the insert was spun. I
 
When the viscosity of the mixture became large; the beaker, mixture, 
and insert were refrigerated in order to solidify the gelatin rapidly. 
Subsequently, the ring of gelatin was removed from the beaker and fixed in I
formaldehyde. After fixation, phantoms were kept immersed in water. 
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I B-2. The Attenuation of the Anisotropic Tissue Phantom as a Function of 
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I When particles are suspended in viscous fluids or viscoelastic 
media, the propagation of ultrasound is affected in several ways, includingI an increase in the absorption coefficient over that of the medium and the 
I 
existence of scattering. Further, if the particles are not totally 
symmetric (i.e., spherical), but are partially symmetric (e.g., cylinders 
or spheroids), and are suspended with their symmetry axes aligned, then the 
attenuation and backscatter can be expected to be anisotropic with respect 
to the direction of insonification (PR 18, B-4). 
I 
I The systematic theoretical investigations of Avtar S. Ahuja have approached several aspects of this problem. In a series of articles from 
1972 to 1979, Ahuja examined the phenomena of the attenuation and 
scattering due to spherical and spheroidal inhomogeneities distributed in a 
viscous fluid. The papers show a progression from calculations involving 
I 
spherical inhomogeneities to those which consider the inhomogeneities to be 
spheroidal. We summarize the results of the calculations in the early 
papers of the absorption coefficient due to "viscous relative motion" 
(described in detail below) of spherical particles, and then examine 
Ahuja's extensions of this theory to include spheroidal particles. 
I The Absorption Due to Symmetric Particles Suspended in a Fluid 
1 
I 
In 1972, Ahuja published a paper in which he formulated the wave 
equation for sound propagation in suspensions, and from this derived the 
velocity of sound. This theory was extended in 1~71 and 1974 to include 
viscous and thermal attenuation coefficients.' We will present the 
results from these papers, with slightly modified notation, and thenI consider the limit of Ahuja's results for the case of rigid particles. 
I 
We consider the case in which a fluid of density p and shear 
viscosity ~ has particles suspended in it. The particles have properties 
denoted by a subscript p (e.g., the density is p). In this section, the 
radius will be designated by the symbol, a, Pwith a «A. The number 
density of the particles, n, is assumed to be such that there are manyI particles in a cube one wavelength on a side. 
I 
The results of Ahuja's calculations show that the dominant 
absorption mechanism in suspensions is that a viscous relative motion, in 
which viscous, or transverse, waves are generated in the fluid by the 
I 
relative motion of the particles and the suspending fluid due to the 
insonifying fie1u. These transverse waves are damped rapidly, leading to 
energy loss from the incident ultrasonic beam. The amplitude of the 
I 
relative motion and the difference in phase of that motion, and thus the 
magnitude of energy loss, increase as the difference in density between the 
fluid and the particles becomes larger. 
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Ahuja's expression for the absorption coefficient due to viscous 
relative motion is 
I2 
3 
ex • t (~) ~ (2.1)~ IV1S p 2 
2 
(~ + T) + s I 
where ~ - 4/3~a3n is the fractional volume concentration of particles, T 
and s are factors which account for the shape and internal viscosity of the 
particles, I 
!' (2'1 + 3'1 p) 
T - u 
t 2 ' (2.2) 
2 I1/2 + 4a ( S!.!L) 2 + (S!.!L)
'1 + '1 + 30 30P t t I 
+39[:t( [1 +~)[(" +"p) +~] +!" [~J2 I3 s - '4(2'1 . (2.3) 
( '1 + '1 + S!.!L) 2 + (~) 2 P 30 t 3 0 t I 
Here the leading term of t in T is the inertia coefficient of a sphere, and 
0t is the viscous wave sk1n depth derived in classical viscosity theory, I 
o _ (Za) 1/2 
t pw I 
In the limit of a rigid particle, -n- ~ 0, the expressions for T and s 
'1 pbecome, I 
1 9 °t
- + -- (2.4) IT ­ 2 4 a 
and, I 
s - ~ (:t) [1 + (:t)]' (2.5) I 
and the expression for the absorption coefficient reduces to that obtained 
by other4 investi§ators through differe~t formulations, such as Epstein and I Carhart, Urick, and Urick and Ament. 
I 
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I Using the reduced forms of rand s, we calculated the absorption due 
to viscous relative motion for a fubstance which is used to manufacture 
isotropic tissue-mimicking phantoms, using the published descriptions of 
the materials. The results of these calculations are shown in Figure 1. 
I 
Fitting the summed absorption coefficient as a function of frequency over 
the range 1 to 10 MHz, we obtain a slope of 0.5 dB/(cm/MHz), a value that 
is to be compared to the published measured attenuation coefficient of 0.7 
I 
dB/(cm!MHz). Since additional signal loss mechanisms, especially those due 
to viscous absorption in the gelatin and to scattering of longitudinal 
waves to longitudinal waves, have not been included in the calculation, the 
consistency between theory and experiment seems reasonable. 
Absorption Due to Non-Symmetric Particles Suspended in a Fluid 
I Ahuja introduced the possibility of non-symmetric inhomogeneities 
into his model for viscous relative motion by distorting the particles from 
spheres of radius a into prolate or oblate spheroids and calculating theI absorption coefficient when the particle was insonified either along or 
I 
perpendicular to the major axis of symmetry of the spheroid. The 
dimensions of the particles will be denoted by a, the semiminor axis of a 
prolate or the semimajor axis of an oblate spheroid, and b, the semimajor 
axis of a prolate or the semiminor axis of an oblate spheroid. Since the 
case of interest here is that of long thin scatterers, we will limit 
further discussion to that of prolate spheroids, and refer the reader toI Ahuja's papers for information concerning oblate spheroids. 
I 
The results of the calculations of the absorption coefficient due to 
suspended spheroids are similar to those obtained for spheres, with 
appropriate modifications to the definitions of rand s, 
I o r_L+2.~ 24 b K (2.6) 
I and, 
I 9 °t 2s-4b K [ 1 OtJl+K~' (2.7) 
I In these expressions, L is the inertia coefficient of the spheroid, for a particular orientation of the symmetry axis relative to the insonifying field, and K is a shape factor. The calculation of these two factors will 
be discussed below, both for the general case and in the limit of a long
I thin prolate spheroid, i.e., ~ ~ O. We note that for b - a and appropriate Land K for a sphere, these two expressions are the same as those presented 
above for the isotropic case. 
I Drawing on the results of others,8 Ahuja writes the inertia coefficient for a prolate spheroid of eccentricity 
I e _ [1 _ a 2J1/2 
b2 ' 
I 
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as 
.t (2.8)L - 2 - r ' 
where r is calculated differently for motions parallel to and perpendicular 
to the axis of symmetry. For motions parallel to the axis, this factor is 
2 
,. _ 2<1 - e ) {l 1 [<1 + e)] _ }) II 3 2 n (1 _ e) e. 
e 
In the limit of a long thin object, 
rll -+ 2[~)2[ln(;b) - 1], 
which for all practical purposes leads to LrO. 
For fluid motion perpendicular to the axis, the factor is 
2 
r - _1 [1 _ <1_e ) In(l+e)]
1 e 2 2e l-e' . 
which reduces, in the limit of a long thin spheroid, to 
r1-+1 - [~) \n(;b) . 
In this limit we obtain L1-+l. 
Ahuja calcu~tes the shape factors K, ag~in making use of the 
results of others. With the abbreviation h - -, the shape factor for 
motion parallel to the axis is a 
[h2 1/2-1 
K II - ~ {- ~ 2h + 2h2 - [h + (2.10)2 ) 3/2 ln 
[ 
1 [h2:~)1/2]}h - 1 h -
For a long thin needle, this reduces to 
2h K~ = 3(ln2h - 0.5) 
For fluid motion perpendicular to the symmetry axis, 
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I 22h -38 { h + 1n[h + (h2 _ 1)1/2J}-1 (2.11)K1 - 3' h2 _ 1 (h2 _ 1)3/2I 
In the limit h»1, this becomes, 
I 4hK
== 3(ln2h + 0.5)'1 
I 
I In Figure 2 we illustrate the values of rand s for a range of the 
parameter bfa, with the radius taken as 4 ~m, which is equal to that of the 
fibers used in the construction of the anisotropic phantom which was 
described in Section 1, and the skin depth 0T selected to correspond to 5­
MHz sound in gelatin. We see that for this value of the radius and skin 
depth the parameters are approximately equal for propagation parallel toI the fibers and that r is approximately 1.5 times s for propagation parallel to the fibers. 
I Similarly, we calculated the absorption coefficients for propagation parallel to and perpendicular to the axis of a prolate spheroid as 
I 
functions of the ratio b/a and of frequency. The absorption coefficients 
at 5 MHz for spheroids with radius, density, and concentration 
approximating the fibers used to construct the anisotropic phantom are 
I 
shown in Figure 3, where the length of the spheroid is the independent 
parameter. The vertical line shows the value of the average b/a for the 
fibers used in the anisotropic phantom. 
I 
In Figure q we illustrate the absorption due to viscous relative 
motion of spheroids having the average length of the fibers used in the 
anisotropic tissue phantom as a function of frequency. We note that the 
I 
absorption is maximum when the sound travels parallel to the long axis of 
the spheroids, or fibers, and is a minimum when the sound travels 
perpendicular to the fibers. 
I 
We note that the absorption for both directions of insonification is 
approximately linear with frequency, having a slope of 0.62 dB/(cmoMHz) for 
insonification parallel to the fibers, and a slope of 0.52 dB/(cmoMHz) for 
ultrasound travelling perpendicular to the fiber axes. 
Measurement and Analysis Techniques in the Determination of the AnisotropyI of Attenuation 
I 
The experiments described in this section were conducted on 
cylindrical specimens. We measured both the attenuation and the 
backscatter along scan lines of samples cut from anisotropic phantoms made 
of graphite fibers in gelatin. The attenuation will be described in this 
section, and backscatter results described in the next section. 
I 
I Attenuation and backscatter were measured at several frequencies (16 
frequencies from 1.5 to 9 MHz), at many points in a scan line (from 31 to 
51 points at 1 mm spacing, depending on the specimen size). Scan lines 
were obtained at 65 angles through 360 degrees. The edges of the sample 
were detected in the scan line by finding the points on each side where the 
value exceeded 10% of the peak value. The midpoint of these two points wasI
 
I 
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taken to be the center of the object at that angle. The slope and 
intercept of the attenuation as a function of frequency were calculated at I
 
the center point. 
Results 
Figure 5 illustrates the results of these measurements. In this I
figure, zero degrees corresponds to propagation parallel to the dominant 
fiber direction. We note that the slope of attenuation is greatest along 
the fibers and minimum perpendicular to the fibers, as predicted by the 
theory and in accord with results on heart tissue previously reported from I
 
this laboratory. The ratio of maximum slope to minimum slope is 
approximately 2, in accord with the prediction of the theory. I
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Figure 1. The theoretical viscous relative motion absorption coefficient 
as a function of frequency for tissue mimicking material made from 
graphite powder suspended in gelatin. Parameters of the material were 
obtained from published sources. 
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4 ~m. the same as the graphite fibers used to construct the anisotropic 
phantom described in Section 1. The vertical lines show the value of b/a 
for the average fiber length used. 
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The theoretical absorption coefficient of 5-MHz ultrasound due 
to viscous motion of prolate spheroids suspended in gelatin for motion 
parallel and perpendicular to the axis of the spheroids. Parameters of 
spheroids are taken to be those of graphite fibers used to construct 
anisotropic tissue phantoms. 
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The dependence of the scattering from muscle ttssues on angle was 
first reported anecdotally by Wild and Reid in 1953 but the subject has I 
not received much attention in the literature since then. As in the case 
of attenuation anisotropy, dependence of the scattering properties on the 
angle of insonification can profoundly affect the interpretation of Iinformation contained in quantitative images. In this section we will 
present a method for predicting the angular dependence of the scattering 
from cylinders, a representation of the fibers used to construct the 
anisotropic phantom and of muscle fibers, and then present the results of I 
experiments designed to measure the extent of anisotropy in the backscatter 
from those phantoms (PR 18, B-5). IThe Theory of Scattering Due to Non-sYmmetric Inhomogeneities 
We examine the scattering properties of collections of 
inhomogeneities that are non-symmetric, e.g., cylindrical or spheroidal I 
particles, which are relatively well aligned, i.e" the axes of the 
cylinders or spheroids are oriented in approximately the same direction. 
This configuration does not appear to have received much attention in the Iultrasonic tissue characterization literature. The t~hnique called the 
"Time Domain Born Approximation" of Rose and Richardson described below 
can be applied to the problem in a straightforward manner. I 
Scattering From Arbitrarily-Shaped Inhomogeneities Using the Born 
Approximation IIn the calculation of scattering due to inhomogeneities, one can 
make the approximation that the properties of the particle do not differ 
greatly from those of the surrounding medium and then substitute the form 
of the incident pressure into the differential equations which govern the I
total pressure. This is referred to as the Born approximation, and has 
been applied to the estimation of the time-domain scattering response of 
single particles by Rose and Richardson. In this technique, the authors2	 Icalculated the time domain impulse response of a particle of arbitrary 
shape. In the limit of an observation point at a large distance from the 
object and for plane-wave insonification, the impulse response is related 
to the cross-section of the object in a plane perpendicular to the bisector I
of the scattering angle, as the plane is swept through the object in the 
direction of the incident wave. In symbols, the displacement response at a 
long distance, U (r,t') is given by
s I
 
I
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I A A A 1 d2 3 A A 
0Us(r,t')~; g(i,0)--2-- --2- fffd r~(r)5(t'- ~ .L.-:..-..Q r), (3.1) 
I 
c 
c dt 
A A 
where, i denotes the unit vector in the incident direction, and 0 is the 
unit vector in the scattered direction. The characteristic function ~(r)I is 1 inside the object and 0 outside and therefore delineates the object. The function g depends on the scattering angle, 
A A 2 
A A A A 5)" + 2OG(i o o) ]I g(ioo) ~l__ [ll ioo (3.2)
- 41£ P ).. + 2G ' 
I and t' is the time at which the signal is measured. 
Setting t - t' - ~, we can write the impulse response asI c 
A A A rU (r,t) 
_ 0 _""'s......__R(t,i,o)I u o 
2 A A 
A A A A A 1 d 3 (" ))
I R(t,i,o) - g(i,o)o c 2 dt2 fffd r~(r)5 t - 1 -co or . (3.3) 
I Here we have normalized by the incident pulse amplitude Uo and for the distance r. The quantity R therefore does not depend on the 1ncident pulse 
I 
amplitude nor on the distance at which the measurement is performed. R 
corresponds to the time domain signal which would be received by a 
transducer in the direction of 0 due to an incident impulse displacement 
from the direction i. 
I We recast these formulas to be more explicit functions of the scattering angle 0 by writing the projection of the incident and outgoing directions as 
A AI ioo - -cosO. 
I The angular function g(O) becomes 
g(O) 1__ [~ cosO _ 5).. + 25GCOS 20]I (3.4)41£ p ).. + 2G ' 
I from which we obtain, 
R(t,O) __ ~ __1__ [~ cosO + 5)" + 25GCOS 20] -l- d 2A(t.O)I (3.5)41£ p ).. + 2G 2 2 c dt 
I where we have introduced 
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~ ~ I 
A(t,O) _ JJJd3r~(r)5(t _ (i -co)e r ). 
IThis integral has an intuitive meaning. The signals selected by the 
impulse function 
~ ~ I 
(i - o)er - ct 
Idefines a plane in which the time of flight between the transmission and 
reception of the pulse is a constant. In the plane-wave limit, and for the 
Born approximation in which the velocity of the waveOinside the object is 
the same as outside, this defines a plane at angle 2 with the incident I 
direction. The remaining two integrations over the characteristic function 
calculate the cross-sectional area of the object in this plane. This area 
is a function of time as the selected plane sweeps through the object in Ithe direction of the incident sound. The second time derivative of this 
area leads to scattering which responds to changes in the cross-section, 
and most strongly to those shapes in which there are discontinuities in the 
cross-section which'are impulsive in the second derivative. I 
The time-domain impulse response function R(t,O) is the Fourier 
transform in the k-domain of the angular function in the frequency domain 
f(w,O). Since only the time derivative of the cross-section contains any I 
time dependence, the transform operates only on this term, and we may 
write, I 
2 
f(w,O) - g(O) ~1 F.T. [ d dt2 A(t,O)] , (3.6) I 
where F.T. [Q(t)] denotes the Fourier transform of a time domain function Q. 
From the well-known properties of the Fourier transform of derivatives, we I
obtain 
2f(w,O) - g(O) ~ (-w )F.T. [A(t,O)]. (3.7) I 
As an example, consider the sphere shown in Figure 1. To calculate Ithe backscattering from this sphere (i.e., 0 - 180°), let us write the area 
A of the sphere when cut by the plane at an angle of 90° with respect to 
the incident direction as a function of time, where the time origin is 
defined to be when the point of intersection of the plane and the incident I 
direction passes through the center of the sphere, 
2 2 2 I1l' a - c t } Ictl~a{ 
A ­ I 
o Ictl>a (3.8) 
I 
I
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Substituting this into Eq. 3.27, performing the Fourier transform, taking 
the magnitude squared, and performing the limit ka~O, we obtain the 
differential backscattering cross-section for ka«l, 
1f(w, 180°) 12 _ [S.H2SG _1_ £il] 2 1671' 2 4 (3.9)A+2G + 471' P 9 a (ka) . 
For a fluid suspending medium, G-O. Substituting the relationship for the 
Lame' constant in terms of the bulk and shear moduli, 
A - B - 2. G3 ' 
and that the compressibility is the reciprocal of the bulk modulus, we 
derive 
SA+2SG SI':. + ~ I':.Gp.
- 3A+2G I':.p 
In the Born approximation I':. XI':., and G XG. For a fluid medium this becomesP P 
P+2SG SI':.
 
A+2G - I':.
 
and we can write 
If(w,1800)1 2 SI':. _ £il] 2 1671' a 2 (ka) 4.[ 1':.. P 9 
For an object which is not totally symmetric, this expression must 
be written to include a dependence on the orientation of the object with 
respect to the "plane of measurement," the plane containing the incident 
and outgoing unit vectors. For example, we could define "obj ect angles" tP 
and ~, such that tP is the angle between an axis of symmetry of the object 
and the plane of measurement and ~is the angle in the measurement plane 
between the incident unit vector and the projection of the object's axis 
into that plane. In the case of backscattering, the scattering angle is 
taken to be fixed at 8 - 180°, and the plane of measurement reduces to a 
line. The angle ~ is then indeterminate, and the only necessary angle is 
the angle tP. 
We consider the backscattering from a cylindrical object. The 
previous equation can now be written in the form 
f(w,180°,tP) - g(1800) 1 2w2)F.T. [A(t,8) ] (3.10)-2- (-471' 
c 
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wh&re A(t,~) is the cross-sectional area of the cylinder as a function of 
time for a particular orientation of the incident sound and the axis of the 
cylinder. We will perform these calculations for backscatter from a 
cylinder of radius a and half-length b at an arbitrary angle ~ between the I 
axis of the cylinder and the direction to the transducer (see Figure 2). 
Calculation of Cross-Sectional Area of a Cylinder in a Plane at Arbitrary IAngle and Distance 
Referring to Figure 1, at angle ~ and range r, we note that there 
will be some range at which the plane first touches the cylinder. This I 
will be denoted r ,where
max 
I 
r bcos~ + asin~. (3.11)
max 
The range at which the plane goes through the point at z - b, Y - a is I 
called r l , 
r l - bcos~ - asin~. (3.12) 
I 
The plane will then pass through the origin, and subsequently pass through I 
z - -b, Y - a when r - -rl , and then exit the cylinder when r - -r . We 
subdivide the situation into four possible cases and exam~~~ each 
separately, writing the area of intersection. I 
The first possibility is the ~ - 0 0 Then the sound is incident• 
along the cylinder axis and the intersection is a circle of radius a, and 
the area A is simply IC 
2 IAC(r,~) ll'a Irl::=;b. (3.13) 
The second (simple) case is that the angle ~ is 90 0 , in which event 
the cross-section is a rectangle whose area is I 
AC(r,~) - 4[a2 _ r 2)1/\ Irl::=;a. (3.14) I 
The third case is that in which, due to the angle ~, r ~O. In this 
case, as the plane sweeps through the cylinder the area or intersection I 
will first be a truncated ellipse for rl::=;r<r ,then the area changes to 
an ellipse for Irl::=;rJ_I, and then the shapem¥~verts to a truncated ellipse 
between -r <r<-r ffaking the substitutionl . max ­ I 
bcoseP-r _ Q(r), (3.15)asin~ I 
the area is then I
 
I
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2) 1/2 -1 1I'J [Q(r) (1-Q(r) + sin Q(r) + 2 r 1<r<r - - max 
2 
_a.~ 11' \rl<lr11 (3.16) 
2) 1/2 -1 1I'J 
Ac(r,4J)·cos4J 
Q(-r) 1-Q(-r) +sin Q(-r)+ 2 -r <r<-r[ (	 max- - 1 
The fourth case is that in which, due to the choice of angle 4J the 
quantity r,< O. For this case, the area of intersection is an ellipse 
truncated af one end for Ir 1~lrl~lr I. For the range in the interval Irl~lr11, the area is an e1!ipse whi~xis truncated at both ends. The area 
is given by, 
2) 1/2 -1 11'Q(r) 1-Q(r) + sin Q(r)+ 2 -r1<r<r(	 - - max 
2} (	 2) 1/2
AC(r, 4J)-c~s4J (Q(r) 1-Q(r) +sin-lQ(r)	 (3.17) 
2) 1/2 -1 
+	 Q(-r) (1-Q(-r) + sin Q(-r) r 1<r<-r1 
1/2. -1 11'Q(-r)+ 1-Q(-r)+ + s~n Q(-r)+ 2 -r <r<r1( )	 max- ­
These functions of time for selected angles 4J are plotted in Figure 
3. For this Figure the ratio of length to diameter was chosen to be 50, 
the same as for the fibers used in constructing the anisotropic phantoms. 
The area is normalized to the maximum possible area (4ab) for the purposes 
of plotting. 
Calculation of Backscatter Properties of a Cylinder at Arbitrary Angle as a 
Function of Frequency 
The Fourier transform of the cross-sectional area as a function of 
time may be performed easily in the first two cases (4J-0° and 180°). The 
other cases are far more complex, but have been accomplished numerically. 
In the case of sound incident parallel to the axis of the cylinder, the 
backscatter differential cross-section becomes 
2If(w,180°,00)1 - 25611'6 i.kf=4 sin2(~w][g(1800)J2,	 (3.18) 
w 
where, 
OA+25Gg(1800) _ -l-	1Q 
411' P A+2G 
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From this expression, the scattering end-on to a cylinder is determined 
from the cross-section (Zhe (ka) factor) and is modulated by the distance 
between the ends (the sin (bw/c) factor). I 
For the case of ~- 90°, the backscatter differential cross-section 
is given by I 
2 2 
If(w,180°,900)1 2 - 25611"6 (ka)2(kb) Ji[~wJ[g(1800)J2. (3.19) 
w I 
Here we see that the backscattering strength is proportional to the length 
squared, and the modulation pattern is determined by the radius. I 
We performed the Fourier transforms of the cross-section vs. time 
plots of Figure 3 numerically, and then selected the frequency components 
which correspond to frequencies in our range of interest, assuming that one I
time-domain sample corresponded to one ~m in distance, for a velocity of 
sound of 1500 m/sec, and taking the dimensions of the cylinder to be a-4~m 
and b-200~m. The results of these calculations are illustrated in Figure 
4, where the power spectral component at several frequencies is plotted as I 
a function of the angle~. Here 0° corresponds to the sound incident along 
the axis of the cylinder and 90° denotes sound incident perpend}fular to 
the cyl!~der axis, and the fr~~uencies are 2 MHz (ka-3.4xlO ), 5 MHz I(8.5xlO ), and 10 MHz (17xlO ). The values at each frequency are 
normalized to the maximum at that frequency and are expressed 
logarithmically. I 
The Prediction of Backscattering Properties of a Suspension of Cylinders 
A rich structure is present in these calculated backscattering Iproperties of s single particle. If in a collection of particles the 
symmetry axes were perfectly aligned, the backscatter properties would 
scale as N, the number of scatterers in the interrogated volume. Actual 
suspensions of fibers have a distribution of lengths and not a single I 
orientation, but rather a distribution of fiber orientations which are more 
or less tightly grouped about a single direction. (The anisotropic 
phantoms studied here had an average fiber length of 400~m and a Idistribution in angle with a standard deviation of approximately 20°.) We 
calculated the angular distribution of backscatter for cylinders of 5 
different lengths (160, 180, 200, 220, and 240 ~m) and performed a weighted 
average at each angle over the lengths. To accomodate the frequency­ I 
dependent volume insonified, we multiplied by the area of a typical beam. 
Gaussians were constructed with standard deviations of 10, 20, 30, 40, and 
50° and convolved with the backscatter as a function of angle, to yield 
predictions of the angular dependence of the backscatter properties of the I 
anisotropic phantoms. 
The results of this process for the angular distribution with a I 
standard deviation of 20° are shown in Figure 5. The values at each 
frequency were then normalized to the maximum value and plotted on a 
logarithmic scale. I 
We then calculated the equivalent of the integrated backscatter as a 
function of angle of insonification by averaging the relative backscatter I 
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I over frequency for each angular distribution. The results of this are 
illustrated in Figure 6. We see that the amplitude of change of the 
integrated backscatter with angle ranges from approximately 12 dB to 6 dB, 
and that the structure seen in Figure 3 has been blurred due to both the 
angular distribution of the scatterers and the averaging over frequency. 
I Experiments to Measure the Anisotropy of the Backscatter from Tissue Phantoms 
I The experiments described in this section were designed to detect the presence of and to determine the angular dependence of anisotropy in 
the backscatter properties of tissue-mimicking phantoms. We measured both 
the attenuation and the backscatter of samples cut from anisotropic
I phantoms made of graphite fibers in gelatin. The results of the attenuation measurements are reported in Section 2 of this report. 
I Experimental Design 
I 
Both the attenuation and the backscatter were measured along scan 
lines of samples cut from anisotropic phantoms made of graphite fibers in 
gelatin. Only the backscatter at the center of the sample will be 
reported. 
I Attenuation and backscatter were measured at several frequencies (16 frequencies from 1.5 to 9 MHz) at many points in a scan line (from 31 to 51 
I 
points at 1 mm spacing, depending on the specimen size). Scan lines were 
obtained at 65 angles through 360 degrees. The edges of the sample were 
detected in the scan line by finding the points on each side where the 
value exceeded 10% of the peak value. The midpoint of these two points was 
taken to be the center of the object at that angle. The slope and 
intercept of the attenuation as a function of frequency were calculated atI the center point. 
I 
The apparent backscatter as a function of frequency, or apparent 
backscatter transfer function, was computed at the center and at the points 
on the scan line on each side of center, and these transfer functions were 
averaged. The average apparent backscatter transfer functions were 
compensated for the attenuation of the intervening tissue and the tissueI within the gate. Then the integrated backscatter was calculated at each angle. 
I Results 
The results of measurements of backscatter from the anisotropic 
tissue phantom are shown in Figure 7, along with a fit to a cosine form.I We note that the amplitude of variation with the angle of insonification is approximately 7 dB, very similar to the predicted angular variation of 
Figure 5. 
I 
I 
1. J. J. Wild and J. M. Reid, "The Effects of Biological Tissues on l5-mc 
Pulsed Ultrasound," Journal of the Acoustical Society of America, vol. 
25, pp. 270-280, 1953. 
I 
2. J. H. Rose and J. M. Richardson, "Time Domain Born Approximation," 
Journal of Nondestructive Evaluation, vol. 3, pp. 45-53, 1982. 
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Figure 1. A sphere of radius a and the plane of constant-time-of-flight 
which defines the contributions to the scattering at time t. 
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of Interrogation 
-----r­
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Cyl1nder --TI----..r.'-~/.~·~~·i'_·.;r~-----+-I_----=w~--AX1S 7.·.·::H 
~ ~ b------J 
Direction of 
Motion of Plane 
Figure 2. Schematic illustration of the geometry used for the calculation 
of backscattering from a cylinder of radius a and half-length b using the 
time-domain Born approximation. 
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Angle (degrees) 
-------: 90 
67.5 
45 
12~. 5 
TIME (1 tick=10 nsec.)
 
Figure 3. The area of intersection of a plane at angle ~ with a cylinder 
having a length to radius ratio of 50. The area is plotted as a function 
of time for angles ~-O, 22.5, 45, 67.5, and 90 degrees. 
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dimensions were a-4 ~m, b-200 ~m, and the frequencies were approximately 
2, 5, and 10 MHz. 
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 B-4.	 Anisotropy of the Backscatter of Canine Skeletal Muscle and Heart 
Tissue 
I Personnel: J. G. Mottley, BCL 
R. M. Glueck, M.D., Medicine 
I	 J. G. Miller, BCL J. E. Perez, M.D., Medicine B. E. Sobel, M.D., Medicine 
I Support: RR 01362
 HL 17646
 
HL 28998
 
I 
I The experiments described in this section were designed to detect 
the presence of and to determine the angular dependence of anisotropy in 
the backscatter properties of tissues. Both the attenuation and the 
backscatter were measured along scan lines of samples cut from canine 
myocardium and from canine skeletal muscle, using the techniques described 
in B-3. The compensated integrated backscatter is reported here.I Results 
I The results of backscatter measurements on canine myocardium are shown in Figure 1. Here we see an angular variation of approximately 8 dB 
in the	 integrated backscatter. 
I The results of backscatter measurements on canine skeletal muscle are shown in Figure 2. For the oriented fibers of skeletal muscle, the 
angular variation of the integrated backscatter is approximately 2.5 dB. 
I Discussion 
I 
The backscatter properties of canine myocardium and skeletal muscle 
vary with the angle of interrogation, measured relative to the local 
I 
dominant fiber orientation. In addition, suspensions of small fibers have 
been constructed which exhibit similar angular variations, and the angular 
variations of these suspensions can be accurately predicted. 
I 
These variations of scattering properties can have profound effects 
on efforts to measure the ultrasonic parameters of tissue in vivo and on 
the interpretation of ultrasonic images of soft tissue structures. For 
I 
example, efforts to measure the attenuation coefficient of soft tissues 
using backscattered signals depend on the scattering process remaining 
constant with depth. If the region under examination crosses from an area 
with one fiber orientation into an area with a different fiber orientation, 
incorrect values of the attenuation will be inferred. 
I Conversely, the existence of such anisotropy of the backscatter from oriented tissues may provide an index to the degree of organization of the 
tissue, and could find applicability in diagnosis or serial monitoring of 
degenerative diseases which destroy the fibrillar structure of the tissue.I
 
I
 
I	 
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Figure 1. The measured integrated backscatter as a function of angle of 
insonification from canine myocardium. 
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B-S. Formalism for Two-Dimensional Spatial Moments 
Personnel:	 P. H. Johnson, BCL 
J. G. Miller, BCL I 
Support:	 RR 01362 
HL 17646 IHL 28998 
We have been considering applications of the two-dimensional spatial I 
moments of measured distributions of energy in ultrasonic beams (PR 20, 
B-4). In this section we summarize the formalism we have adopted for the 
several types of moments used. I 
-+ 
The general two-dimensional spatial moments of a function fer) is 
defined as I 
mpq - fAxP yq f(~)dx dy	 (5.1) I 
where A is the area of the receiving aperture. We say that the general 2­
dimensional moment m is of order n - p + q.pq I 
One special class of two-dimensional moments is the radial moments. 
The nth order radial moment M is defined as the integral of the function 
f(f) over the aperture A weigHted by the nth power of the radius vector ~ I 
f -+n -+ M - Ar f(r)dx dy.	 (5.2)n I 
-+nThe notation r expands as 
I 
1 , n=O 
-+ 
r , n-l I 
-+ -+ 
r·r , n-2 
-+n ) -+ -+ -+ 
r = (r·r)r , n-3	 (5.3) I 
-+ -+ 2(r·r) , n-4 I 
Examination	 of the weighting factor ~n reveals that the even-order radial I 
moments are	 scalars and the odd-order radial moments are vectors. 
An appealing property of the lower-order radial moments is that they 
yield to physical interpret~tion. The scalar zeroth-order radial moment is I 
the definite integral of fer) over the aperture A, the "tQtal energy" or 
"total mass," the most global characteristic of f(r). The vector I 
I
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I -+ 
I 
I 
first-order moment of fer) is related to the "centroid" or "center of 
gravity," ~ global property specifying the center of concentration of the 
functi~n fer). The scalar second-order radial moment represents the spread 
of fer) about the origin of coordinates, or the "moment of inertia." 
Third- and fourth-order radial moments are related to the "skewness" and 
"kurtosis" of the function, respectively. These interpretations provide 
much of the motivation for the use of radial moments in this work to 
characterize the distribution of ultrasonic energy. 
I The radial moments are defined relative to the origin of the particular coordinate system in use. Alternatively, the weighting factor 
of radial moments may be defined relative to any other point in space. If 
th~ point of reference is chosen to lie at the centroid of the functionI fer) defined as 
I c M-+l (5.4)M'o 
I • -+then the moments are referred to as rad~al central moments of fer). These 
are denoted as U and are given by 
I
n 
U f (; - c)n f(;)dx dy. (5.5)
n A
I In addition, general central moments in a form analogous to Equation (5.1) may be defined as 
I ~pq - fA(x-cX)p(y-Cy)qf(;)dx dy. (5.6) 
I A summary of the notation for the various types of moments defined 
I 
above is presented in Table 1. 
The different types of moments are interrelated by relatively simple 
expressions. An important set of relationships is the equality of all the 
moments of order zero 
I 
moo - MO - Uo - ~OO fAf(;)dX dy. (5.7) 
I Based on these equalities we use the several notations interchangeably, but 
in appropriate context. Another set of equalities exists in the case of 
one dimension, where the general moments become identical to theI corresponding radial moments, i.e. 
I m M n n in one dimension. (5.8) 
U~n 
I
n 
I 
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I
The relationships between the first order moments are contained in 
the definition of the centroid I 
-+M (m10 ,m01) MO -+C (5.9)1 I(5.10)TIl - (f'10' f'01) - O. 
-+Equation (5.9) defines the position of the centroid of f(r) relative to an I 
arbitrary origin of coordinates on A. Because the central moments are by 
definition calculated about the centroid, the first-order central moments 
are all equal to zero. I 
The second-order moments are related to each other and to 10wer­
order moments by I 
f'11 - - mOOCx Cm11 y If'20 - - mOOCx2 (5.11)m20 
2 If'02 - m02 - mOOCy 
U2 - f'20 + f'02 
-M2 m20 + m02 ' I 
Each of the scalar radial moments and the components of the vector radial 
moments and each of the general central moments can be expanded in terms of I 
the general moments given by Equation (5.1). The general moments mare 
the most readily computed quantities, so we choose these as the baji~ set 
of moments. In many applications, it is frequently most useful to consider 
the central moments. Thus, in practice we compute the m first, then find I 
the centroid and compute U and for orders n>2. pqIt 
n ~pq ­
I 
Summary of Moments 
Moment Type Non-CentraJ. Central I 
General 
Radial 
m pq 
M 
f'pq 
U I 
n n 
I 
Table 1. Summary of notation for various types of moments. 
I 
I 
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 B-6. Two-Dimensional Spatial Moments for Azimuthally Symmetric Beams 
I Personnel: P. H. Johnston, BCL J. G. Miller, BCL 
I Support: RR 01362
 HL 17646
 HL 28998 
"I 
I In this section we describe an approach for characterizing 
ultrasonic beams using two-dimensional spatial moments (PR 20. B-4). In 
particular, we present formulas derived for beams exhibiting azimuthal 
symmetry and linear divergence, such as those produced by circular 
piezoelectric transducers. 
I For this analysis, we consider our receiving aperture to be continuous, rather than discretely sampled. Further, we assume that the 
receiver is sensitive to the intensity of the beam rather than to the 
pressure. This assumption of phase irtsensitivity is based on the model ofI a practical receiving aperture consisting of point-like receiving elements, which can be considered sensitive to the local incident intensity. Under 
these assumptions. we express the measured energy flux at position 
~ 
R on the 
I receiving aperture as 
~ ~ ~ E(w,R) H(l)~(w,R)·n. (6.1) 
~ ~ 
I 
"
" 
I 
where ~(w,R) is the incident ultrasonic intensity, n is the unit normal to 
the surface of the receiving aperture. and H(w) represents the transfer 
function of the mechanical and electrical loading of the receiver. We 
compute the n~-order two-dimensional spatial radial moments of the 
distribution E(R) over the receiver according to 
I 
M fARnE(it)dA (6.2) 
I
n 
I 
where A is the area of the receiver. The energy flux is weighted in the 
moment integral by the vector distance 
~ 
R from the center of the receiving 
aperture raised to the nth power. 
I 
In the far field of a transmitting transducer or in the focus of a 
focused transmitter the phase fronts exhibit little curvature, and may be 
considered planar to a good approximation. Thus, the intensity incident 
upon a receiving aperture placed in either of these regions may be 
approximated by the plane waveform 
I 2 " llLL.: ki pc (6.3) I 
where p is the pressure and p and c are the density and speed of sound 
respectively in the medium at the face of the receiver, and k is a unitI
 
I 
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I

vector normal to the wavefronts. The two-dimensional spatial moments are 
expressed under this condition as 
I
-+n -+ 
M IA R EO(R)cosO dA (6.4)n 
" "	 I
where EO - \p,2/pc and	 n-k - cosO is the cosine of the angle of incidence 
of the beam. 
The lower-order moments of 
information about the beam such as the 
10 - M ' O 
the vector centroid 
-+M
-+ 1C M'o 
and the mean squared beam	 width 
2M2 U IMl 12W _-2.
U M M 2 o O o 
the energy distribution provide I 
total energy defined as 
I(6.5) 
I 
I
 
I
 
I
 
(6.6) 
(6.7) 
I 
The total energy 1 is useful for the determination of signal loss, i.e.0
attenuation, through a specimen. Deviations of the centroid C from zero 
indicate the effects of gross refraction as shown in Figure 1. In panel I(a) we show a lateral shift due to refraction by a specimen in which the 
faces are parallel to each other. The transmitted beam is refracted within 
the specimen and the beam exits the tissue slab shifted laterally but 
parallel to its original path. This is in contrast with the case shown in I 
panel (b) of Figure 1, where the tissue slab has a wedge shape. The 
refraction suffered by the beam upon exiting the tissue in this case does 
not bring the beam back parallel to its original direction, and the I
measured centroid will depend upon the range between the specimen and the 
receiving aperture. These qualitatively different conditions suggest that 
it is important to know not only the magnitude and direction of the 
centroid in the plane of the receiver, but also the angle of incidence 8. I 
The beam width W, or lateral extent of the energy distribution, may 
also be modified by propagation through tissue. Because tissue exhibits a Inonunity refractive index,	 a specimen will effectively act as a lens, with 
concomitant changes in beam shape related to the geometry of the 
Further, scattered waves from inhomogeneities in the tissue can 
with the transmitted wave to effectively broaden the received beam. 
-81­
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I 
The effects just outlined serve to present to a receiving aperture a 
transmitted beam which appears to have emanated from a transmitting 
transducer positioned at some location which differs from the actual 
I 
position of the source of the beam. Thus, providing that distortions of 
the beam are small, the nature of the beam at the receiving aperture may be 
considered to define a virtual transmitting transducer positioned such that 
it would produce the measured field in a homogeneous medium in the absence 
of a specimen. 
I 
I We now investigate some of the general features of the two­dimensional spatial moments of azimuthally symmetric beams and develop a 
scheme for the determination from these moments of the total transmitted 
energy, the direction of incidence of the beam, and the mean squared width 
of the beam. We mimic the refraction effects of a specimen by varying the 
I 
position of a simulated virtual transmitting transducer. In order to 
calculate the two-dimensional spatial moments of a transmitted beam across 
a receiving aperture, we must express the intensity distribution within the 
beam in terms of the coordinate system of the receiver. Let us fix a 
coordinate system (x,y,z) to the transmitting aperture and coordinates 
(X,Y,Z) to the receiving aperture. Beginning with these aperturesI coincident, we perform the following sequence of translations and rotations: 
I
 (a) translate (x,y,z) by (XO,Y ) in the Z-O plane
O(b) rotate result by angle ~ about the new z axis 
I
 (c) rotate result by angle (0) about the new y axis
 
(d) translate result by Zo along the new z axis 
I (e) invert sense of z axis so that positions of points on receiver 
are positive. 
I Figure 2 graphically depicts these coordinate transformations. The 
resulting transformations between receiver coordinates (X,Y,Z) and 
I
 transmitter coordinates (x,y,z) are given by
 
x - COSO[(X-Xo)CoS~ + (Y-Yo)Sin~] + Z sinO 
I 
y - [-(X-Xo)Sin~ + (Y-Yo)cos~] 
I 
z - Zo - sino[(X-Xo)COS~ + (Y - Yo)Sin~] - Z cosO (6.8) 
I and 
I
 x - X + cos~[x cosO + (ZoZ)Sino] - y sin~
o 
I
 Y - YO + sin~[x cosO + (Zo-Z)Sino] + y cos~
 
I 
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z - (Zo-z)cosO - x sinO (6.9) 
Because the elements of the receiving array lie on the p1an~ Z-O, Equation 
(6.9)	 requires that 
z - Zo - x tanO (6.10) 
and Equation (6.8) and Equation (6.9) reduce to 
x - cosO [(X-Xo)COS¢ + (Y-Yo)Sino] 
y - [-(X-Xo)SinO + (Y-Yo)cos¢] 
z - Zo - sinO [(X-Xo)COS¢ + (Y-Yo)Sin¢] (6.11) 
and 
x - X + x cos¢o	 cosO - y sin¢
 
sin¢
Y - YO	 + x cos 0 + y cos¢ 
(6.12) 
The spatial distribution of a beam produced by a circular-piston 
radiator has the form 
4J1 
2 (kar/z)1 ~(r) -	 -2 (6.13)2 
z	 (kar/z) 
A beam having a Gaussian intensity profile represents a more analytically 
tractable distribution than this. Gaussian beam shapes may be approximated 
experimentally by appropriately apodizing a transmitting transducZr with an 
amplitude weighting factor of approximately Gaussian shape. Here we 
present calculations of the two-dimensional spatial moments of a beam 
exhibiting an intensity profile given by 
a L2	 [ 2)~(r) -	 ~O ~ exp - 2 (6.14) 
a a 
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where the beam width a is a function of range z and frequency k 
U 
a - (6.15)I ka 
I The constant a represents the radius of the transmitting transducer, such 
I 
that the beam exhibits similar dependences as the Bessel function beam 
given in Equation (6.13). The parameter r may be interpreted as a fitting 
factor which allows one to match the Gaussian form with the beam width of a 
beam of B~ssel 2unction form. For example, r might represent the value for 
which 4J (r)/r - 1/2, that is r - 1.56. An alternative interpretation is 
I 
1 
I 
to cons~der air to be an effective radius for the transducer, where the 
value of r is determined by the form of an applied apodization function. 
For simplicity in what follows we consider a to be the effective radius and 
drop r. The normalization condition imposed on this beam is that the total 
power passing a plane perpendicular to the z axis is equal to the inten2ity 
at the transducer face ~o times the effective area of the transducer ~a . 
I In order to calculate the two-dimensional spatial moments of this beam it is convenient to change variables to transmitter coordinates. The 
I 
Gaussian beam smoothly falls off with r, and thus does not define 
boundaries to use as limits of integration. This means that the boundaries 
of the receiving aperture should be used. To facilitate computation, we 
note that 99% of the energy in this beam falls within a radius r z 3a. We 
take the receiving aperture to be much larger than this so that we may 
safely extend the limits of integration to infinity. Further, we see fromI Equation (6.10) that points on the receiving aperture lie at distance 
I
 z - Zo - r cos~ tan8 (6.16)
 
from the transmitter, where we have expressed x in polar coordinates randI ~. Thus, writing out explicitly the range dependence of Equation (6.14) we obtain 
k2 4 2 2 2 aI exp (- k a r J (6.17)~(r) - ~o (Zo- 2 
r cos~tan8) 
I 
I 
To investigate the behavior of the spatial moments of the Gaussian 
beam we note that r - aO«ZO in a typical experimental situation, so we may 
expand Equation (6.17) ~n a Taylor series with respect to z about Zo 
I a~ _1_ a
2 
;zr,. (z-Z )2 (6.18)~(z) z ~(ZO ) +­az (z-Zo) + 2' -"" Zo 0 + ... 
Zo . az
2 
I The first two partial derivatives of ~ evaluated at Zo are 
I
 
I
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a~ I _2~(ZO) (6.19)(-4- -1)az Z kaC700 C70 
2~(ZO) 4 2a2~ 
- 2 2 2 (2 r 4 - 7 r 2 + 3) (6.20) 
az
2 Z k a C70 C70 C700 
where the beam width C7 is ZO/ka. We refer to the terms of the expansion0Equation (6.18) as be~ng a zeroth, first, and second order and denote this 
order by superscripts 
~(z) z ~(O) + ~(1) + ~(2) (6.21) 
where 
2 2( 0) .iL­~ - ~O 2 exp (- r 2) (6.22) 
C7 C70 0 
~(1)_ 2~(0) ( L) r cos1/J tan9 (6.23)kaC7 1 - 2 
o C70 
4 4~(2) ~(O)_ ( L...... 2227 r + 3) r cos 1/J tan 9. (6.24)2 2
k2
2 4 2 
a C7 C7 C7o 0 0 
The nth spatial moment may be written in a corresponding series of 
increasing order as 
M - M (0) + M (1) + M (2) (6.25)
n n n n 
where 
(k) f211''''''''''' (k) [ ] n M - 0 JO d1/J JO r dr E X(r,1/J),Y(r,1/J) (6.26)n 
and 
E(k) _ H(w)~(k)(w). (6.27) 
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To estimate the relative magnitudes of the expansion terms of 
Equation (6.21) we observe that, assuming that r is of the order of a vew 
times 'aO 
2~(0)~(1)  and ~(2) ~(O)I - -- ~ (6.28) k2 2 a 
I For a typical laboratory transducer of effective radius a - 4 mm radiating 5 MHz ultrasound into a water bath (with speed of sound c - 1.5 mm/psec) we 
have ka - 2~fa/c - 84 and the first and second order terms are thus on the 
orderI 
~(1) _ 0.02~(0) and ~(2) _ 0.0001~(0). (6.29) 
I 
Thus, we retain only the first two terms in Equation (6.21) for our 
calculations of spatial moments for the Gaussian beam. We define the smallI quantity 
I _1_ I: - (6.30)k a 
and note that it corresponds to the angle of divergence of the beam. 
I 
I Calculation of the two-dimensional spatial moments for this Gaussian 
beam is straightforward, but tedious. A summary of the results of these 
calculations is given in Table 1. The total energy within the beam 1 is0
equal to the zeroth-order two-dimensional spatial moment MO' The integral 
I 
I 
yields EO times the effective area of the transmitter, according to the 
normalization condition. Thus, for any angle of incidence, the receiving 
aperture measures the total energ~ in the beam, as required by conservation 
of energy. The vector centroid C is found to be modified by a small shift 
proportional to the product of the divergence angle of the beam and the 
beam width. The dependence on po1ar ang1e is weak for small angles. The2
apparent mean squared beam width W increases with polar angle of 
incidence. 
I Other combinations of spatial moments provide further inf~rmation on the orientation of the beam relative to the receiving aperture. One such 
combination represents the difference between the spread of energy about 
the X axis and the spread about the Y axis. This quantity is referred toI here as the squared width difference, denoted by D. The corresponding 
I 
quantity defined about axes rotated by 45° is denoted by D. These two 
quantities are found to vary sinusoidally with twice the aZim~~a1 angle of 
incidence. Finally, we have defi~ed the skewness vector S as the third 
order spatial radial central moment U3/UO' 
These quantities tabulated in Table 1 provide a set ofI characterizable features of a transmitted ultrasonic beam. If the beam 
I 
exhibits azimuthal symmetry and linear divergence as modeled here, the 
expressions in the rightmost column offer a means for describing the beam 
more fully. We may take the ratio of the two squared width differences to 
obtain an estimate of the azimuthal angle of incidence 
I 
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DR I 
tan2,p - --D- (6.31) 
I 
Clearly, this can only determine the azimuthal angle to within an 
uncertainty of~. The X and Y components of skewness are proportional to 
cos,p and sin,p respectively, and are independent of (Xo'YO)' The sinusoidal Ibehavior of the skewness allows the removal of the ambiguity in the 
determination of azimuthal angle. The octants defined by the (X,Y) and 
(X Y ) axes are shown in Figure 3 with the signs of the squared widthRdifferences D and D~ and the skewness components Sx and Sy indicated. The I 
relative signs of-D and DR are the same in oppos~te octants, producing an 
ambiguity of ~ in azimuthal angle. However, the signs of the components of 
skewness change with the quandrants determined by (X,Y). Thus, if Sx<O, Ithe angle ,p lies in the first or the fourth quandrant, as determinea by 
whether Sy is negative or positive, respectively. A value of Sx greater 
than zero ~mp1ies that ,p lies in the second or third quandrarit, again 
determined by the sign of Sy being negative or positive, respectively. I 
Equation (6.31) also implies that I 
D (6.32)
cos2,p - [ 2J 1/22 ID + DR 
We substitutz this into the express~n for D and usz the result to 
eliminate tan 8 in the expression for Wand solve for GO ' yielding I 
G 2 _ TT 2 [D2 + DR2J 1/2o w- (6.33) I 
Finally, we solve for tan28 to obtain I 
2tan 8 -~ (6.34) I 
W2 _ [D2 + DR2Jl/2 
I 
Thus, for azimuthal symmetry and linear divergence, we may in principle 
determine the actual width and the angles of incidence of the beam. IAs shown by the results in Table 1, divergence of the u1trasoni~ 
beam produces a small deviation of the components of the centroid vector C 
from the correct value (XO'YO). Also, the X component of the skewness is proportional to the deviation of C from X Ix o 
2 ISx GO [ 2 )
--2- 3tan 8 + 4 , (6.35)CX-Xo 
I 
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I
 the proportionality constant being given in terms of the quantities 00 and 
I 
o which are fully determined by other moments-based quantities. THus we 
may compensate the centroid for this deviation to accurately locate the 
center of the beam as 
2SX 
x - - 2 (6.36)I Cxo 00 (3tan20 + 4) 
I and the corresponding result for the Y direction 
2 Sy I Y - Cy ­ (6.37)o 2 ( 2 ).00 3tan 0 + 4 
I 
The parameter e - l/ka corresponds to the angle of divergence of the 
beam. The skewness as defined in Table 1 offers a means for estimating e.I One way to express an estimate of e is 
2 I S I cosO (3 ) -1 
e - 3 --+ 1 (6.38)I 00 tanO cos 20 
I Further, the divergence angle is given by 
I ....L c e - (6.39)k a 2'1l' f a 
I where f is the frequency and c is the speed of sound in the medium. Thus, for example, for a given transmitting transducer with known effective 
I 
radius a, Equation (6.38) offers a means of extracting some information 
about the speed of sound of the media lying between the transmitter and 
receiving array. Alternatively, in a homogeneous medium Equation (6.38) 
could be used to infer the effective radius of the transmitting transducer. 
I We have described methods for describing a measured beam using two dimensional spatial moments. Specifically, we derived expressions for the 
I 
total energy, centroid, mean squared beam width, polar and azimuthal angles 
of incidence, and divergence angle of the beam. These are summarized in 
Table 2. These results may be considered to describe the beam from a 
virtual transmitting transducer located at some position possibly different 
from that of the actual transmitter. Implicit to this interpretation is 
the assumption that the transmitted beam retains its form as it isI refracted by the media between the actual transmitter and the receiver. We 
I 
note that when the transmitted beam loses its azimuthal symmetry during 
passage through a medium, although the expressions in Table 2 no longer 
hold, the quantities defined in terms of moments in Table 1 are still valid 
descriptors of the beam. 
I
 
I 
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Receiver Receiver
 
(0)
 (b)
 
Figure 1. Demonstration of two types of refraction conditions. In panel 
(a) the specimen has flat and parallel sides so the transmitted beam 
exits parallel to its incident direction. In the more general case (b) 
the surfaces of the specimen are nonparallel, and the beam exits at some 
angle to its original direction. 
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Figure 2. Pictorial representation of coordinate transformations between 
receiver coordinates (X,Y) and virtual transmitter coordinates (x,y). 
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Sr> 0 
Sz < 0 
XR 
Sr < 0 
Sz < 0Sr> 0 
Sz> 0 
YR 
Sr < 0 
Sz> 0 
Figure 3. Octants formed by the crossed axes (X,Y) and (Xn,Y ). AnalysisR
of squared beam width differences leaves an am~iguity in the 
determination of azimuthal angle which is removed by analysis of the 
signs of the skewness parameter. 
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B-7. A Pole-Zero Model for the Transfer Function of Soft Tissue 
Personnel: R. M. Arthur, BeL I 
Support: RR 01362 
I
Although soft tissue is both dispersive and inhomogeneous, 
conventional B-scan imaging systems focus signals received by phase­
sensitive, linear arrays as if tissue were a homogeneous medium with 
constant phase velocity. Previously we described two nearly equivalent I 
causal models for representing dispersion and inhomogeneity in tissue (PR 
16, B-5; PR 19, B-4). One, which is based on the Hilbert transform, 
assumes attenuation is a linear function of frequency. The other, a pole­ I 
zero model, can be synthesized from the magnitude of the frequency response 
of any experimental data. 
A single-pole matched experimental data reported in the literature I 
to within a few percent, which was comparable to a straight line fit. A 
single-pole model, however, has several advantages beyond its ability to 
match the magnitude of the frequency response of tissue. The pole location Iof the single-pole model is a relaxation frequency. This frequency was 
inversely proportional to the concentration of hemoglobin, directly 
proportional to the temperature of dog myocardium, and inversely 
proportional to the collagen content of dog myocardium. In addition phase I 
velocity can be predicted by the single-pole model. 
V(f) - 1/[Tb + tan
-1 (f/P)/2~f] , I 
where P is the pole location and T is the bulk propagation delay. The Ibprediction was within measurement error for hemoglobin solutions. In 
contrast to the Kramers-Kronig or Hilbert transform predictions for phase 
velocity, which depend on the logarithm of frequency, the single-pole Iprediction of phase velocity is well-behaved at both low and high 
frequencies and consistent with a linear-phase (constant velocity) model. 
I 
V(O) - P/(~bP + 1) =l/Tb ; V(aJ) - l/T .b 
IThe phase velocity of the single-pole model at both low and high 
frequencies is just the constant velocity of a conventional linear-phase 
tissue model. Finally the single-pole model has an equivalent circuit 
representation, which is a low-pass filter coupled with a delay. I 
This year we determined the attenuation functions for which the 
single-pole model is a good match. Attenuation of soft tissue is often 
described by a power function I 
{Ya(f) ,. a 
o I
 
I
 
I
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Figure 1. Attenuation predicted by a single-pole tissue model for linear 
(a) and quadratic (b) dependence of attenuation of frequency. In (a) ~-l 
and in (b) ~-2. The number next to each pair of curves is the 
attenuation coefficient a . 
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where a is the attenuation coefficient and f is frequency. a and -yare 
constantsOthat depend on the tissue type. For soft tissue -y is ~bout one; I 
it is about two for liquids. To test the limits of the sing1e~po1e model 
in the 0.1 to 10 MHz range, we matched a single-pole model to attenuation 
which was linearly and quadratically dependent on frequency. 
For the case in which attenuation was assumed to increase linearly II 
with frequency (Figure 1a), the RMS error in the single-pole approximation 
was a minimum equal to 2.0% of the full-scale attenuation for a 
O. 12/MHz . The RMS error approached an asymptote of 7.0% of full sca1eo as I 
a decreased. It was <7.0% for a <0.20/MHz. If, for example, the slope 
o~ attenuation ~ - 0.05/cm/MHz~ which is typical of dog myocardium, then 
the single-pole model could represent a layer up to 4 cm thick with an RMS I 
error of <7% over the 0.1 to 10 MHz range. Where attenuation was assumed 
to increase quadratically with frequency (Figure 1b), the RMS error in the 
single-pole approximation increased monotonically from near1Y2zero for 
small values of a to 7% of the full-scale value for a - 0.08/MHz. Again I 
the thickness ofOthe layer of tissue which can be desgribed within a given 
error depends on the type of tissue. 
I1.	 R. M. Arthur, and K. V. Gurumurthy, "A Single-Pole Model for the 
Propagation of Ultrasound in Soft Tissue," Journal of the Acoustical 
Society of America, vol. 77, pp. 1589-1597, 1985. I
 
I
 
B-8. The Transfer Function of Linear Transducer Arrays 
Personnel: R. M. Arthur, BCL I 
S. R. Broadstone, BCL 
M. L. Sieger, B.S., Electrical Engineering ISupport: RR 01362 
Washington University 
I 
Transducer behavior must be taken into account in order to make 
quantitative ultrasonic measurements(PR 20, B-5). Clearly, the content of 
the beam of a phased array is dependent on the beam profiles of the 
individual elements in that array. The energy transmitted or received by II 
a transducer element is dependent on signal frequency and on the angle of 
propagation or incidence. II
We'mapped the response of individual elements of an array by 
rotating the array within its image-plane. The axis of rotation passed 
through the center of the element face. The rotation was performed by a 
stepper motor under computer control. Another motor fixed the range I 
between the array element under study and a hydrophone or reflector. We 
measured the pressure field generated by an element of interest with the 
hydrophone. We also captured signals received by the element when the Itransmitted signal was scattered by a slotted tube. Broadband pulses were 
used to excite transducer elements in order to calibrate the element for 
quantitative pulse-echo imaging. The excitation pulse, the pressure field II
 
I
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recovered by a hyrophone, and the scattered signal received by the element 
itself were recorded as a function of hydrophone or scatterer range and 
angle. Signals were sampled at 50 MHz with 8 bits of precision. Spectra 
were determined by Fourier transform. We used this technique to measure 
elements of 3.5 and 5 MHz, 32-e1ement linear arrays, composed of piezo­
I electric material. 
I 
Typically beam profiles are determined by measuring the peak 
pressure received as a function of range and angle. Unfortunately, this 
approach does not describe the frequency content of the ultrasound 
I 
delivered to a particular region in the field of view, when the excitation 
is a pulse. One measure of the usable field of an array for broadband 
tissue characterization is the energy available within appropriate 
frequency bands at a given range and angle. By comparing pressures or 
I 
scattered signals to the excitation pulse we calculated the ability of the 
element to insonify a given region of its field of view. The energy in 
various frequency bands was calculated to find the energy present at a 
given range and viewing angle. Figure 1 shows the energy delivered in the 
2 to 5 MHz band at 7 cm from an element of a 3.5-MHz array as a function of 
off-axis angle. At 30 degrees, for example, the 2-5 MHz energy (a 3 MHzI band about the center frequency of the element) was 14 dB below the total 
I 
energy according to reflection from the slotted tube and 18 dB below as 
measured by the hydrophone. At 30 degrees the energy delivered by this 
element is in a 0.5 MHz band centered at 2.0 MHz. Clearly the field of 
view of this array for broadband tissue characterization is much more 
limited than it is for conventional imaging. If a signal energy 15 dB 
below that on axis is sufficient for generating an acceptable image, thenI the field of view of this array for conventional imaging is about ± 40 degrees. For broadband tissue characterization the field is reduced to 
about ± 15 degrees. 
I In addition we have attempted to infer transducer vibration modes by 
removing diffraction effects from the calibration studies described above. 
To characterize the transfer function of a given transducer we modeled each 
element as a collection of facets or sube1ements. The diffraction patternsI 1 
I 
of these facets was calculated using the impulse-response method of 
Lockwood and Willette. Facet motion was inferred from responses measured 
along scans in azimuth and elevation on a 1east-squares-error basis. 
Figure 2 shows the relative magnitudes of three frequencies delivered by a 
I 
I 
single element of a 3.5 MHz array as a function of off-axis angle in 
azimuth (a) and elevation (b). Also included is the 16-facet fit of those 
scans. Whereas there is general agreement between theoretical and measured 
quantities, the RMS error with 16 facets is not significantly better than 
the match obtained when the transducer element was assumed to be a uniform 
rectangular piston. This effect is due to our inability to precisely 
located the measurement points with respect to the element surface. The 
I 
1east-squares-error method fails if the location of a given field point 
with respect to other field points is not known to within a few ~m, which 
is the distance over which phase changes by 1 degree in soft tissue at 3.5 
I 
MHz. Presently we are exploring maximum likelihood techniques to assess 
facet motion field point by field point. These results can be averaged 
and perhaps used iteratively to infer facet motion. 
1.	 J. C. Lockwood, and J. G. Willette, "High-Speed Method for Computing 
the Exact Solution for the Pressure Variations in the Nearfie1d of a 
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Figure 1. Energy delivered by a single element of a 32-element array with 
a center frequency of 3.5 MHz. 
I
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Figure 2. Comparison of pressure magnitudes generated by a single element 
of a 3.5 MHz, 32-element array (dashed lines) and a l6-facet transducer 
model (solid lines). 
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 B-9. Adaptive Beamforming for Quantitative Imaging of Soft Tissue 
I Personnel: R. M. Arthur, BCL S. R. Broadstone, BCL 
I Support: RR 01362 
I 
Conventional ultrasonic imaging systems combine signals received by 
phase-sensitive linear arrays as if tissue were homogeneous. Estimates of 
I 
attenuation coefficient from such a beamformer are corrupted by the 
pertubation of wave fronts across the array caused by tissue 
inhomogeneities. Previously we proposed adaptive beamforming schemes in 
both the time and frequency domains which reduce phase cancellation across 
I 
I 
an array. The time-domain beamformer estimates the actual delay suffered 
at each element of the array by cross-correlating the received signal with, 
for example, the center frequency of the transmitted pulse. The frequency­
domain beamformer sums the magnitudes of the Fourier transforms of each 
element signal, after the signals have been aligned by a homogeneous-medium 
beamformer. As long as all the element signals are within the transform 
window, then any mismatch between the homogeneous-medium beamformer delays 
and the actual delays can be ignored. 
I Both the time- and frequency-domain beamformers were tested in simulations on simple laminar geometries. The slope of attenuation versus 
frequency of a model consisting of two 5-cm layers, whose attenuation 
coefficients differed by a factor of 5, was estimated with a linear arrayI composed of 21 point-like elements separated by 1 mm. Attenuation estimates were calculated for insonified volumes from 0 to 45 degrees off 
axis of the array. The homogeneous- medium beamformer error increased 
monotonically from 0 on axis to more than 80% at 45 degrees. Both adaptive 
beamformer estimates were within 1.6% of the value throughout the 45 degree 
viewing angle. This small error occurred because path length was found 
assuming that phase velocity was constant. 
~e are now completing circuitry to test beamforming algorithms with 
our processing environment. This circuitry is a simple extension of that
tl used to test single elements of an array. It uses a single transmit channel and a single receive channel, each composed of commercially~ (;1" available components. These channels are switched in turn by relays under 
computer control to each of the elements of the array. A single element is~,,;"'I, pulsed and or any other element'~ the signal received by that element	 in the!if' ~;	 array is recorded. The receiver circuitry is moved to the another element 
and the original element is pulsed again. This procedure is repeated until 
recordings have been made from all elements of the array. At this point 
~, ,
"1	 the transmit circuitry is switched to the next element and the wholZ 
;.	 protocol repeated. Thus if there are N elements in the array, we record N 
f	 
single-element signals. This approach permits us to perform all 
','";,' "',~51, I:.4'r..	 preprocessing steps off-line digitally. Thus we can precisely compare 
homogeneous and adaptive beamforming algorithms and test any other 
algorithms on tissue phantoms or tissue samples without buidling new 
acquisition circuitry.~,I Storage for the element signals from a 32-element array requires 2 
to 4 megabytes. Beamforming these signals to a 256 x 256 image reduces 
storage to 64 kilobytes. Beamforming and other preprocessing steps, such
.)'" 
/~?i~4t~~ 
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as correction for the angular response of the array elements takes place in 
the acquistion system based on a DEC LSI-11/23. After preprocessing, raw 
images are sent via serial line to our Masscomp workstation for further 
manipulation, quantitative assessment, comparison, and display. I
 
I
 
B-10. The Processing Environment for Ultrasonic Tissue Characterization I 
Personnel: R. M. Arthur, BCL 
S. R. Broadstone, BCL 
P. H. Johnston, BCL IJ. G. Miller, BCL 
J. G. Mottley, BCL 
L. J. Thomas, Jr., BCL I 
Support: RR 01362 
IIn the past year we added a Masscomp MCS-537 workstation to our 
processing environment (PR 20, B-7). It is a multiuser system for 
generating and manipulating images (see Figure 1). Previously the heart of 
our processing environment was a DEC LSI-11/23 microcomputer whose total I 
memory and user partitions within memory (56 kilobytes) are far too small 
to hold, much less manipulate, typical ultrasonic images (256 kilobytes). 
The workstation contains 2 megabytes of memory, special floating-point Ihardware, and an integral graphics processor with a high-resolution color 
display. It has significantly enhanced our ability to develop algorithms 
for extracting quantitative measures from ultrasonic signals and to display 
the resulting quantitative images. I 
The DEC LSI-11/23 is now dedicated to the acquisition of ultrasonic 
signals. Its main peripherals include: 1) a 111-megabyte Winchester drive, 
which this year replaced much smaller, obsolete drives; 2) an FPS 100E I 
array processor; 3) a 9-track, industry compatible tape drive for backup 
storage; and 4) an IEEE-488 bus for communication with the instrumentation 
that controls our ultrasonic transducers and collects their signals. The I 
array processor serves the function of the beamforming or other 
preprocessing hardware in conventional ultrasonic systems, but is much more 
flexible. We can tailor the processing, for example, such that beamforming 
delays are specific to the sample under insonification. I 
We also interfaced the acquisition system to a medium-resolution, 
gray-scale graphics system called digivision, which was designed and built Iin our laboratory. During the past year we streamlined the command 
structure and added a character generator to digivision. Although this 
unit is slow (90 seconds to fill the screen) it does permit display of raw 
images, so that we can see whether or not ultrasonic signals were acquired I 
properly. Generation of quantitative images is done at the Masscomp 
workstation. IWe added an Epson LQ-1500 dot-matrix printer, which serves both our 
acquisition system and the Masscomp workstation. It replaced a Versatec 
I
 
I
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 printer/plotter, which was needed elsewhere in the Resource, and a lO-year­
old line printer which could generate only upper-case fonts and which has 
I no graphics capability. The LQ-1SOO has both draft and letter-quality modes plus graphics capability. It permits us to generate finished papers 
and reports plus gray-scale representations of ultrasonic images. 
I
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Figure 1, Processing Environment for Ultrasonic Tissue Characterization. 
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I C. Quantitative Imaging: Radiation-Treatment Planning 
I The delta-volume method reported on previously (PR 19, PR 20) is now being implemented on a Modu1ex treatment planning system for use in a 
contract for evaluation of three-dimensional treatment planning. As a 
first step to extending dose calculation algorithms from Co-60 to higherI energy treatment beams, a series of experimental studies and measurements has been initiated. This work is being done under the auspices of MIR 
(Ma11inckrodt Institute of Radiology) and is to provide the experimental 
I
 groundwork
 
I
 
C-1. Dose 
I Personnel: 
I
 
Support: 
for dose calculations with high energy treatment beams. 
Calculation for Co-60 
J. W. Wong, Ph.D., Radiology 
W. B. Harms, B.S., Radiology 
J. A. Purdy, Ph.D., Radiology 
F. U. Rosenberger, BCL and Computer Systems Laboratory 
RR 01380 
I RR 01379
 CM 47696
 Ma11inckrodt Institute of Radiology 
I 
I The delta-volume dose calculation algorithm reported on last year 
(PR 20) is being implemented on a Modu1ex treatment planning system for use 
in a contract for evaluating three-D dose-calculation algorithms. The BCL 
MMS-X high-performance display system has been moved to the Radiation 
I 
Physics Department in MIR and connected to a Modu1ex treatment planning 
system. The MMS-X will be used to display outlines of patient anatomical 
features extracted from CT scans, to display treatment beam outlines, and 
to manipulate planned treatment beam positions, collimators, and blocks. 
After satisfactory beam specification, the beam parameters will be 
transmitted to the Modu1ex system for dose calculation. The three-DI display with real time control of viewing position and beam parameters is expected to prove very useful in beam placement by allowing direct viewing 
and control of beam parameters. 
I 
I 
I 
I 
I 
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C-2.	 Physics of High Energy Photon Dose Deposition in Heterogeneous 
Medium IPersonnel:	 J. W. Wong, Ph.D., Radiology 
J. A. Purdy, Ph.D., Radiology 
F. U. Rosenberger, BCL and Computer Systems Laboratory 
C. Y. Yu, M.S., Radiology I 
Support:	 RR 01380 
RR 01379 
Ma11inckrodt Institute of Radiology I 
A major goal in Radiation Treatment Planning (RTP) is to develop an I 
accurate method of photon dose calculations that can be applied to the wide 
range of photon energies and geometries encountered in radiotherapy. As 
mentioned in the last progress report, we had successfully completed the 
evaluation of our prototype delta-volume algorithm for photon-transport I 
calculations as tested with cobalt-GO experiments. 
Our present objective is to extend the delta-volume algorithm to Ihigher energy bremsstrahlung beams as generated by medical accelerators. 
Dose deposition at these energies can no longer be assumed to be local (as 
is the case with cobalt-GO) since the ejected secondary electrons travel 
several cm from the site of photon interactions. Consequently, the I 
presence of heterogeneities of human anatomies affect both photon- and 
electron-transport. Furthermore, high energy photon pair-production 
interactions which can account for more than 10% of the dose deposited must Ibe considered for more accurate dose calculations. Pair-productions are 
not accounted for in existing methods of dose calculations. 
During the last year, we have concentrated our effort in the I 
important initial phase of understanding the physics of the problem. Such 
knowledge is imperative in the development of an appropriate model that 
forms the basis of a practical and accurate algorithm. Germane to the Iarchitecture of the delta-volume algorithm in terms of boundary conditions 
is the measurement of minute dose perturbation due to the presence of a 
small inhomogeneity in the medium. These measurements have been made with 
the arrangements schematically shown in Figure 1 as small ring I 
inhomogeneities of various materials were cycled up and down about the 
detector axis. IFigure 2 shows the plot of the measured perturbation in fractional 
change of dose per volume of water displaced vs. the depth-position of the 
ring inhomogeneity for a 4-MV x-ray beam. The chamber is at a depth of 15 
cm on the central axis. The styrofoam and aluminum rings have identical I 
dimensions,	 with a radius of 2.75 cm, height of 2.0 cm and a thickness of 
0.5 cm. Their presence results in an increase or decrease in dose 
depending on their positions. Their effects are reversed in polarity but 
similar in magnitude. The quantitative difference is due to the non-linear I 
nature of the perturbation as compounded by the unequal change in density 
with respect to water for styrofoam and aluminum. The effects can be 
explained by photon-transport calculations, with the assumption of local I 
energy	 deposition, as were made in our earlier cobalt-GO studies. 
I
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 Surprising results were observed for the higher energy 18-MV x-ray 
beam as shown in Figure 3. The ring inhomogeneities now have a radius of 
I 
I 1.75 cm, height of 2 cm and thickness of 0.5 cm. The differences between aluminum, carbon and styrofoam are dramatic. At the p~sition of peak 
perturbation, the aluminum effect is about 30 times larger than that of 
styrofoam, This peak position is lateral to the detector and does not vary 
much with other ring configurations. Expected1y, this effect is primarily 
I 
due to perturbation in electron transport. However, comparing the results 
for aluminum and graphite (which has roughly the same electron density as 
aluminum but roughly the same atomic number as water), led us to believe 
that this "local" effect related directly to pair-production interactions. 
Using' styrofoam rings of various radii for measurements, we wereI able to construct iso-effect maps to provide a clearer picture of the dose 
I 
perturbations with respect to the position of the inhomogeneity in the 
medium. These are shown in Figure 4 for the photon energies of coba1t-60, 
4-MV, 6-MV and 18-MV x-rays. With the exception of the 4-MV x-ray results, 
the shapes of the iso-effect maps demonstrate the dominance of small angle 
interactions as photon energy increases. The exception of the 4-MV results 
may be due to the increased contribution of multiple photon scattering dueI to the substantial low energy component of the bremsstrahlung beam 
I 
spectrum. Figure 5 shows the iso-effect for the 18-MV x-rays with 
aluminum. Besides the expected reversal in polarity of the dose 
perturbations as compared to styrofoam, the large and yet v~ry local 
pair-production contributions are clearly shown. 
I 
Results from these studies are new findings which illustrate the 
complexities of the effect of inhomogeneity on bremsstrahlung beam 
I 
dosimetry. Models for pair-production are not readily available for the 
range of therapy photon energies, although it is shown here that 
pair-production interactions are significant and playa major role in the 
problem of electron transport. 
I 
We believe that elucidation of the many contributing factors to the 
overall dose perturbation is most important in the development of any model 
for dose calculation. For the next year we intend to: 
I (1) theoretically calculate these perturbation data by considering first-order, second-order photon transport and various electron transport models; 
I (2) deduce the importance of the many characteristics associated with therapy beams on dose calculations such as beam spectra and 
non-uniformity of the beam intensities; 
I (3) to continue our experimental measurements of dose perturbation with 
I 
single and multiple inhomogeneities in order to obtain better models 
for pair-production phenomena and to examine whether empirical 
solutions such as that given by Rossi for photon energies >50 MV can 
be modified to provide an adequate model for the interactions; and 
finally 
I (4) identify the more important components in dose perturbation in terms of photon- and electron-transport such that they can be treated 
appropriately in the development of a practical algorithm. 
I
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 O. Quantitative Imaging: Positron-Emission Tomography 
I Stimulated by the clinical impact of the EMI transmission 
I 
tomographic scanner in 1973, experimental studies were initiated in 
collaboration with the Oivision of Radiation Sciences to evaluate positron 
coincidence-detection as a method for emission reconstruction tomography. 
This collaborative activity resulted in a prototype scanner called PETT 
I 
I 
(Positron-Emission Transaxia1 Tomograph). Extensive studies in patients 
and animals were conducted with the PETT III scanner in collaboration with 
the divisions of Neurology and Cardiology. A subsequent scanner, PETT IV, 
utilized concepts developed with its predecessor but incorporated a novel 
technique for the simultaneous collection of four tomographic slices from a 
single set of detectors. Until its decommissioning this past year, PETT IV 
was located in the Cardiac Care Unit for use in the SCaR project for the 
I 
quantification of regions of myocardial ischemia and infarction (0-1, 0-2). 
Subsequent scanners have been developed that permit more rapid data 
collection and improved spatial resolution. One of these, PETT V, was used 
in experimental studies in dog hearts. PETT VI became operational during 
the summer of 1980 and employs fast detectors and an entirely circular 
motion for rapid data acquisition. Further experimental and clinicalI studies with this system occurred over this past year (0-3, 0-4). One of 
I 
the most exciting recent developments for emission tomography results 
because of new developments in crystal technology and high-speed 
electronics. These now permit the propagation time of each of the two 
photons created in an annihilation to be measured. Theoretical and 
experimental studies of tomography systems that utilize this new 
information continued, and the software and hardware needed to realize theI predicted benefits were developed. Super PETT-I, the first operational 
I 
system utilizing time-of-f1ight information, has now been moved to the 
Cardiac Care Unit to replace PETT IV for use in the SCaR project (0-1, 
0-2) . Studies to improve data acquisition and processing algorithms for 
Super PETT-I continued during the year (0-5 to 0-9). Work continued on a 
I 
new approach for estimating parameters in dynamic studies using list-mode 
data (0-10). A new time-of-f1ight instrument for neurological studies is 
under development (0-11, 0-12). A reconstruction algorithm for 
single-photon tomography is being studied for use with data collected with 
a mu1tiview gamma camera (0-13). 
I 
I 
I 
I 
I 
I 
I
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D-1. PETT Experimental Studies 
Personnel: S. R. Bergmann, M.D., Ph.D., Medicine 
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R. M. Knabb, Ph.D., Medicine 
J. Markham, BCL 
B. E. Sobel, M.D., Medicine IM. M. Ter-Pogossian, Ph.D., Radiology 
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IThe overall goal of this project is to implement and evaluate 
procedures required to translate into intact animals the results obtained 
with selected positron-emitting tracers used to characterize myocardial 
metabolism and perfusion in isolated hearts and anesthetized, open-chest I 
dog studies performed with Isolated Probe Data Acquisition System (A-6). 
Utilizing positron-emission tomography with PETT VI, the distribution of 
tracer and the time course of its uptake and clearance from myocardium can Ibe quantified. Such studies are intimately related to the clinical studies 
using positron-emission tomography (D-2). 
During the past year, using H 150 (t 2 - 2.1 min) we ~emonstrated I1that a modification of the tissue autoradio~raphic approach permitted 
quantification of myocardial blood flow in open-chest dogs by direct assay 
of myocardium and subsequently extended that study to non-invasive 
estimation with positron-emission tomography in intact dogs. In open-chest I 
ane!';thetized dogs, the single pass extraction fraction of H2
150 averaged 96 
± 5% at flows of 80-100 m1/100/min. This high extraction Eraction did not 
differ over the range 12-328 m1{!00 gm/min. Flow calculated after 60 sec I
of intravenous infusion of H 0 and direct analysis of tissue correlated2
well with results obtained with microspheres (r - .94, n - 9 dogs). 
Subsequently, the technique was adapted1gor use with PET by estimation of the myocardial content of radio1abe1ed H 0 after intravenous infusion of2 I 20-30 m1 i.v. The activity in the myocardium was corrected for vascular 
actiy!ty with the use of tomographic data obtained after the administration 
of C 0 by inhalation to label red blood cells. Tomograms obtained in vivo Iin 6 dogs with either normal or reduced regional b1ood~low correlated 
closely with tomographica11y detectable distribution of Ga-microspheres 
(r - .93) with post-mortem microsphere distribution (r - .95). The use of 
this technique with PET should permit rapid subsequential non-invasive I 
estimation of relative regional myocardial blood flow and should permit 
objective assessment of nutritional blood flow in patients in response to 
medical and surgical interventions designed to augment perfusion. I 
In an extension of the use of this technique, we performed an 
additional study to determine whether the method developed permits 
detection of the differences in blood flow in a dog preparation of I 
sub-critical coronary stenosis. Coronary stenoses were induced with a 
small Teflon cylinder placed in the left anterior descending coronary 
artery of closed-chest dogs. Regiona1 myocardial blood flow I3s assessed15 Itomographica11y with H 0 given intravenously and C 0 given by2inhalation. Blood flow distal to the stenosis was normal under conditions
 
of rest. However, significant reductions in the hyperemic response to
 I 
I
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I dipyridimo1e were detected consistently in regions distal to 50-70% 
diameter stenoses. Flow distal to the stenosis more than doubled in 
absolute terms (quantitatively determined with microspheres) in response to 
dipyridmo1e, but was only 43 ± 9% of the increase in flow in normal regions 
in the same dogs. Relative myocardial blood flow measured non-invasive1y 
with PET correlated closely with the distribution of radio1abe1ed1 mi~~ospheres in vitro (r - .88). Thus assessment of myocardial blood flow H 0 and PET in dogs at rest and with vasodilator-induced stress permits2 
1 
detection of physiologically significant coronary stenosis. The procedure 
d~ve1oped, therefore, should prove useful diagnostically for the detection 
of coronary insufficiency in patients, as well as for the assessment of 
clinical interventions designed to augment regional perfusion such as 
coronary thrombolysis or coronary artery bypass grafts. 
1 
I We previously demonstrated that PET can be used to estimate the 
salutary response to coronary thrombolysis. These studies have continued 
during the current project year. To determine whether calcium blockage 
enhances salvage achieved in myocardium after coronary thrombolysis, 
thrombi were induced in 26 dogs with an intracoronary copper coil. Ten 
dogs had permanent occlusions. Thrombi were lysed in eight dogs with1 intracoronary streptokinase two hours after occlusion. The remaining eight 
1 
dogs were given i.v. di1tiazem (15~g/kgfhr) for 24 hours beginning 30 min 
before streptokinase. Regional myocardial blood flow was quantified with 
microspheres during occlusion, one hour after thrombolysis, and 24 hours 
later. Infarct size (% LV) was quantified by assay of myocardial CK 
1 
depletion. Myocardial fatty-acid metabolism was assessed tomographica11y 
with C-pa1mitate. Infarct size was maximal in controls (28 ± 12%, mean ± 
SD) and diminished by thrombolysis alone (18 ± 13%). Addition of di1tiazem1 further reduced infarct size (9 ± 10%. P < .05 for each comparison). 
Myocardial blood flow was comparable in the three groups during occlusion. 
and di1tiazem did not influence myocardial blood flow wit£lreperfusion. 
Augmented salvage with di1tiazem was documented by increased C uptake at 
1 
24 hours (56% of normal vs. 40% for reperfusion alone). Thus the salvage 
of myocardium by thrombolysis is enhanced by calcium blockade with 
di1tiazem by a mechanism other than increased perfusion. and can be 
documented with sequential analysis of myocardial perfusion and metabolism 
using positron tomography. 
1 Although coronary thrombolysis restores macrovascu1ar patency, as we 
1 
have shown in open-chest dogs (A-6). even brief periods of ischemia 
followed by reperfusion impair myocardium metabolism. The prolonged 
effects of reperfusion on regional metabolism and nutritional perfusion, 
potentially compromised by the "no ref1ow" phenomenon, are uTlfS1ear. 
tfcording1y, we used positron emission tomography with H 0 and 
C-pa1mitate to sequentially assess myocardial perfusion and me~abo1ismI before and after angiographica11y documented lysis of occlusive coronary 
1 
thrombi (occlusion interval of 2.5 hrs) and again at 24 hours, one week, 
two weeks, and four weeks after reperfusion. Myocardial blood flow 
(percentage normal) decreased to 18 ± 4% (mean ± SD) during ischemia. It 
averaged 82 ± 25% one hour after thrombolysis, but was reduced again to 37 
± 16% 24 hours later. Flow one week after lysis was 70 ± 5%, and persisrrd 
unchanged for two-four weeks (62 ± 7% and 60 ± 18%). During ischemia, C1 activ\1r varied from 14-50% of normal despite comparable ischemic flows. 
1 
High C-uptake one hour after reperfusion presaged greater perfusion and 
palmitate uptake at four weeks (r - .75 and .87 respectively). Thus 
positron emission tomography permits non-invasive characterization of the 
1 -114­
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 long-te~effect\ff coronary thrombolysis on myocardium. Early assessment 
with H 0 and C-palmitate provides useful predictors of the subsequent 
fate o~myocardium after recanalization and should be useful for studies of 
experimental adjunctive therapy with reperfusion, as well as sequential I 
evaluation of the efficacy of thrombolysis in patients. 
The studies completed during the past year have demonstrated the I
utility of PET for evaluation of myocardial metabolism and perfusion, 
especially in sequentially evaluating the efficacy of interventions 
designed to improve myocardial metabolism and perfusion after coronary 
ischemia. The techniques developed in the project are currently being I 
implemented in patient studies designed to evaluate the efficacy of 
coronary thrombolysis utilizing Super PETT-I. IDuring the coming year, we plan to continue our evaluation of the 
effects of coronary thrombolysis on the restoration of myocardium perfusion 
and metabolism with PET to better characterize the response of this 
promising intervention. Furthermore, we plan to evaluate algorithms for I 
correction of the effects of partial volume and count spillover as well as 
institution of the evaluation of the EM algorithm for cardiac studies. 
This should enable measurements of perfusion in absolute terms. I 
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1 This project was designed to assess regional myocardial metabolism 
and perfusion quantitatively with positron-emission tomography (PET) in 
normal subjects and patients with coronary artery disease at rest and with1 stress induced with vasodilators or dynamic exercise. These studies were 
1 
also designed to employ PET to assess the efficacy of reperfusion induced 
by thrombolysis, balloon angiop1asty, surgical revascu1arization or their 
combination. 
Studies in this project have been performed with Super PETT I, a 
positron-emission tomograph which incorporates time-of-f1ight information
1 to provide seven simultaneous axial high resolution (7.5 mm FWHM) 
1 
reconstructions throughout the heart with data collections as brief as 30 
seconds, permitting dynamic acquisition in list mode. Drramic cardiac 
studies were performed after the i.v. injection of ZO mCi of C-pa1mitate 
in 11 normal subjects and eight patients with cardiac disease. Du~ing 
1 
1 
30-minute data collections, data density was sufficient to reconstruct 
images at 30-second time intervals during the first two minutes, one-minute 
time frames through 10 minutes, and two- to four-minute time frames 
thereafter providing high-time aCtivity curves with high temporal 
resolution. Myocardial accumulation of C-pa1mitate was homogeneous in 
controls, and depressed in zones of infarction. In some cases, depressed 
metabolism was evident in zones !~th persistent perfusion1~assessedwith 
1 
the intravenous infusion of HZ 0 and the inhalation of C 0 as validated 
in dogs). Peak radioactivity gerrra11y occurred between the fourth and 
sixth minutes and turnover of C-pa1mitate was monoexponentia1 from peak 
1 
activity through 1Z-15 minutes after injection, after which the 
time-activity curves (corrected for physical decay of the isotope) 
demonstrated a very long half-time. Regions of infarction demonstrated 
decreased content of palmitate and slightly longer disappearance times. 
1 
Assessment of myocardial perfusion was performed in nine normal 
subjects and 19 patients with cardiac disearS. Patients were studied after 
the bolus injection of 30-1001~Ci of HZ O. Data collection began 
immediately upon injection of HZ 0 and continued for at least 1Z0 seconds. 
Data were reconstructed from multiple time intervals to determine the1 optimum period for data collection and analysis. After a delay of 10 
1 
minutes to allow decay of the initial tI3cer, patients were studied again 
after the inhalation of 50-75 mCi of C 0 to label the cardiac blood pool. 
Data collection commenced approximately 30 seconds after the inhalation of 
1 
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and continued for five minutes. After reconstruction of axial 
matrices a pi~-by-pixel subtraction was performed of the tomograms 
acquired with C 0 from ~ tomograms reconstructed fro~5the data collected I 
after the infusion of H O.The distribution of H 0 (corrected for2 2 Iblood pool activity) was apparently homogeneous tliroughout ventricular myocardium in normal subjects, closely matchingl1he distribution of 
radioactivity observed after administration of C-palmitate. Among 
patients with transmural infarISion and a persistently occluded vessel, 
defects in accumulation of H2 0 were observed in regions corresponding to I £~e ECG locus of infarction and zones of decreased accumulation of 
C-palmitate. However, in some patients in whom the infarctl~lated 
artery had recanalized (spontaneously or with thrombolysis) H 0 was2
evident in the zone of prior myocardial infarction, with an apparent I 
mismatch between depressed accumulation of palmitate and restoration of 
myocardial perfusion. 
Positron-emission tomography continues to be employed in the I 
analysis of interventions designed to salvage ischemic myocardium. It is 
being used as an endpoint for studies of the efficacy of nifedipine, a 
calcium channel blocker, and for the salvage of ischemic myocardium in the I 
setting of acute myocardial infarction. The enrollment of patients in this 
study has now been completed with a total of over 50 patients studied. 
Data analysis is currently underway and should be completed shortly. 
Interim analyses have shown a tende~cy towards salvage of ischemic I 
myocardium with nifedipine. Patient studies continue with thrombolysis 
induced by tissue plasminogen activator or streptokinase administered 
within the first hours after infarction. At the present time the number of I 
patients studied is too small to permit definitive conclusions concerning 
the ultimate extent of salvage of ischemic myocardium provided by these 
interventions. 
To determine the relative sensitivity of PET and magnetic resonance I 
imaging (MRI) for the detection and characterization of cardiomyopathy, and 
to determine the impact of wall thickness and attendant partial volume 
effects on PET images, 11 patients (six males and five females) aged 20 to I 
75 years with congestive cardiomyopathy were studied with both modalities. 
All were studied with multi-planar ECG gated proton MRI employing a 
superconductive 0.35 Tessla magnet and s~fn echo technique (echo-delays of I 
30 and 60 msec) and PET performed with C-palmitate. PET revealed marked 
spatial heterogeneity of the accumulation of palmitate manifested by an 
increased number of discrete isocount zones during multiple threshold I 
analysis (17.3 ± 0.8) regions vs 11.8 ± 0.7 in normal controls, p < .01) 
indicative of heterogeneous accumulation of a tracer of metabolism not 
accounted for by regional wall thinning or partial-volume effects. In 
contrast, although MRI delineated cardiac dilation with considerably higher I 
spatial resolution, myocardial walls were of uniform thickness and 
myocardial signal intensity with MRI was visually relatively homogeneous 
with slight speckling. The standard deviation of the frequency 
distribution of signal intensity within myocardial reconstructions was I 
extremely narrow, averaging only 6.3 ± 1.1% of mean myocardial signal 
intensity. Thus, magnetic resonance imaging and positron emission 
tomographic delineation of metabolism provide complementary information I 
which, in concert, more thoroughly define the nature of underlying 
pathophysiology. 
I
 
I
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Clinical studies in progress are concerned with the further 
characterization of dynamic fatty acid metabolism in myocardium of normal 
subjects, patients with ischemic heart disease with and without reperfusion 
induced by coronary thrombolysis with rT-PA and patients with 
calgiom~gpathies. Studies of the distribution of myocardial perfusion with 
1 H 0/C 0 are being continued to acquire a larger data base of normal2subjects and patients with single or multi-vessel coronary artery disease. These patients are to be studied both at rest and after vasodilator stress 
with dipyridamole. Initial results are encouraging with myocardial
1 perfusion remaining homogeneous in normal subjects during vasodilator stress, but demonstrating stress induced perfusion defects in patients with 
obstructive coronary lesions, even in the absence of infarction. 
1 
1 0-3. In Vivo Measurements of Regional Blood Flow and Metabolism in Brain 
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1 Because of the previously noted (PR 20, 0-3) deficiencies of 
1 
1 
compartmental mode~s for estimating cerebral blood flow with PET using 
radioactive water as a tracer, we have been led to the formulation and 
testing of distributed models for this purpose. The distributed models we 
have investigated take into account longitudinal gradients of tracer 
concentration along the capillaries but assume that transverse gradients 
are zero. The resulting conservation conditions take the form of sets of 
partial differential equations in the concentrations, with axial distance 
1 
and time as independent variables and with capillary and cellular 
permeabilities, surface areas, volumes, and thermodynamic activity 
coefficients as parameters. 
1 
-118­
I
 
I
 
Using an analytical solution of these equations, we have compared 
the predictions of our model unit-impulse response with our data for the 
uptake and clearance of radiolabeled water in rhesus monkey brain following 
bolus injection of the tracer into an internal carotid artery of the I 
animal. The data are in the form of count-rate histograms obtained with a 
single scintillation detector collimated over the animal's head. The 
durations of the histogram data-collection intervals were made short enough I 
to ensure proper temporal resolution for the residual histories. 
Typically, a data set consisted of 70 points collected over 180 sec. Data 
were collected in four experiments for which cerebral blood flow, 
det~lm!£ed by an independent method, was varied from 0.53 to 1.33 ml I 
min g . Also measured independently were values of blood-brain-barrier 
permeab~\itY1surface-areaproduct; these were varied between 1.33 and 1.72 
ml min g . Since our data are for dose-normalized intracarotid Iinjections, they and the model unit-impulse responses are directly 
comparable. To quantify our comparisons, we devised.a statistical 
parameter-estimation procedure for fitting the model to the data. We 
obtained estimates of the parameter values using weighted nonlinear I 
least-squares approximation. The minimizttion we employed was a suitably 
modified version of that of Marquardt. In fitting our model, the final 
parameter estimates differed only slightly when different initial estimates Iwere used. Although a systematic search of the parameter space was not 
undertaken, each case was run with at least three different initial 
estimates. The low values attained for the standard deviation of the 
estimates also suggest that the solutions are unique. Fractional I 
deviations between parameters estimated from the data on the basis of the 
model varied from 3% to 11% for flow and from 2% to 32% for 
permeability-surface-area product. I 
Encouraged by these results, we plan to investigate the possibility 
of applying our model for measuring cerebral blood flow using 
positron-emission tomography (PET) in a clinical setting. New difficulties I 
are anticipated for this undertaking. Clinical practice precludes use of 
intracarotid injections; instead tracer can be only administered 
intravenously, resulting in temporal dispersion of tracer inflow to the 
cerebral vasculature. Moreover, the limited temporal resolution achievable I 
by current PET devices results in accumulation of only a few (typically ­
12) data points representing the history of the cumulative number of 
detected decay events. In practice, this limits the number of parameters I
that can be estimated from the data to one, or at most, two. In 
preparation for clinical trials of our model, we have devised algorithms 
for simulating response of an external detector following i.v. injections. 
For this, we have convolved simulated arterial radioactivity histories with I 
integrals of our model unit-impulse responses. We plan to study the 
performance of the resulting dispersed integrated residue curves as 
objective functions for parameter estimation in simulations and in further I
animal experiments in which we employ i.v. tracer administration and record 
real arterial radioactivity histories. Through use of sensitivity 
functions for the convolved and integrated model functions, we plan to 
identify optimum times for data collection such that one or two desired I 
parameters (blood flow and perhaps blood-brain-barrier permeability) can be 
estimated from the relatively small data sets, with the remaining 
parameters set to average values. I 
A specialized parameter estimation technique, designed to estimate 
kinetic parameters for PET studies of brain receptors, was implemented for I
 
I
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routine use. This technique utilizes a three-compartment model, describing 
the kinetics of spiperone in brain tissue, fg evaluate time-activity curvesI of regions of brain after injection of F-spiperone in baboons and patients. Parameters estimated from the model include the 
blood-brain-barrier permeability for spiperone and brain receptor density. 
I The parameter estimation method uses a specialized algorithm for the 
I 
first few iterations, then switches to a nonlinear least-squares 
approximation routine. Sensitivity analysis was employed to develop 
relationships between variations in the values of the parameters and 
I 
variations in the tissue-activity curves. These relationships can be 
expressed by a simple mathematical function, resulting in very rapid 
convergence. 
I
 
D-4. Maximum-Likelihood Image Reconstruction for PETT VI 
I Personnel: J. D. Gorman, BCL M. I. Miller, BCL 
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I D. L. Snyder, BCL A. G. Swift, M.A., Radiology 
Support: RR 01380
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I 
Recent important results obtained with the expectation-maximization 
(EM) algorithm solution to the maximum-likelihood equation for real PETT VII studies (PR 20, D-4) have prompted a series of simulation studies to 
I 
quantify algorithm performance. Software was developed to simulate PETT VI 
data collections and two simulation phantoms were created for use in 
simulation studies: a calibration pie phantom containing six regions of 
uniform activity, and a brain phantom, having a grey to white ratio of 4:1. 
Additional software was developed to evaluate PETT VI images. Metrics used 
to gauge algorithm performance werelresolution, signal-to-noise ratioI (SNR), contrast, and squared error. With these software tools, several 
I 
maximum-likelihood reconstruction techni~ues were investigated. The 
unconstrained maximum-likeliho~d algorithm and the constrained algorithm 
employing the "method of sieves" were of particular interest. 
I 
Initial studies were conducted to investigate and document the 
behavior of iterates obtained with the EM algorithm for unconstrained 
maximum-likelihood. The unconstrained maximum-likelihood images were shown 
I 
to have superior resolution and contrast, and tess squared error than 
images obtained with filtered backprojection. In fact, the measured 
resolution of brain-phantom reconstructions was 6.8 mm after 500 
iterations. This should be compared with a measured resolution of 12 to 17 
mm for filtered backprojection reconstructions. Moreover, unconstrained 
maximum-likelihood reconstructions of brain phantom data contained 94% of 
I
 
I
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the original contrast between grey and white matter regions, whereas the 
corresponding contrast in filtered backprojection images was only 50-63%. IThe expectation-maximization algorithm is iterative; the 
maximum-likelihood estimate is defined as the limit of the sequence of 
iterates obtained from the EM algorithm. Thus, although the iterative 
process eventually results in a maximum-likelihood estimate, intermediate Iiterations may contain biases associated with the convergence of the 
estimator. One indication of the presence of such biases is the fact that 
the resolution of images obtained by EM iteration changes with iteration. 
The measured resolution of pie phantom reconstructions was 9.4 mm after 50 I 
iterations and 5.9 mm after 1000 iterations. In regions of the 
reconstructions where there are discontinuities, we observe overshoot 
artifacts which diminish as the iteration process continues. These I
overshoot artifacts appear, for example, in pie-wedge corners in the 
reconstruction of simulated and real pie-phantom data after 100 iterations 
and are approximately 120% of the underlying intensity. Moreover, the EM 
algorithm is a gradient-based algorithm, implying a linear convergence I 
rate. Pixel values in the pie phantom change by less than 0.1% per 
iteration after 100 iterations. Thus, these artifacts may still be present 
after several hundred iterations. We have chosen to iterate until pixel I
changes fall below 0.05%; this requires between 500 and 1000 iterations for 
both the brain and pie phantoms. 
Also present in the unconstrained maximum-likelihood images is a I 
noise artifact. In both real and simulated data, estimates of uniform 
regions of activity are speckled, or contain peaks and valleys. This 
artifact results in decreased SNR and appears to be related to the Iintensity of the phantom. In one study we varied the number of counts 
collected in a simulated data collection. At an average intensity of 5340 
counts/pixel the SNR of the resulting reconstruction was 21 dB after 1000 
iterations, whereas for an intensity of 53.4 counts/pixel, the SNR fell to I 
6 dB. The effect of the convolution-kerne! sieve constraint employed in 
the algorithm derived by Snyder and Miller is to reduce the noise artifact 
present in the reconstructions. I 
We examined the reconstructions of several simulated p~e phantom 
data collections subject to kernel sieves which had kernel widths equal to 
75, 100, 125, and 150 percent of the full-width at half maximum (FWHM) of I 
the PETT VI detector resolution (1.17 cm). As the sieve parameter 
increased, the SNR of the reconstructions also increased, while the 
resolution decreased. The table below lists values of SNR, resolution, and Isieve parameter 
pixel after 1000 
phantom having an 
for the pie phantom simulation containing 53.4 counts per 
iterations. This simulation corresponded to a 20 cm pie 
average of lOOk counts. I 
I 
I 
I 
I
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SNR and Resolution vs Sieve Parameter 
for Pie Phantom SimulationI 
Sieve Pa~ameter SNR !..@l Resolution (nun) 
I 0.0 FWHM .5.1 5.8 0.75 FWHM 13.0 7.5 
1.0 FWHM 15.2 9.3I 1.25 FWHM 16.7 10.5 1.5 FWHM 17.8 13.6 
I 1. J. D. Gorman, "Quantitative Eva1uat1on of the Maximum-Likelihood Reconstruction Algorithm for PETT VI," Biomedical Computer Laboratory 
Working Note No. 73, September 1985. 
I 
I 2. Y. Vardi, L. A. Shepp, and L. Kaufman, "A Statistical Model for 
Positron Emission Tomography," Journal of the American Statistical 
Association, vol. 80, no. 389, pp. 8-37, March 1985. 
I 
3. D. L. Snyder and M. 1. Miller, "The Use of Sieves to Stabilize Images 
Produced with the EM Algorithm for Emission Tomography," to appear in 
the IEEE Transactions on Nuclear Science, 1985. 
I
 
D-5. Time-of-F1ight Data Acquisition System Development for Super PETT I 
I Personnel: D. C. Ficke, B.S., Radiology 
D. E. Beecher, BCL 
G. R. Hoffman, B.A., RadiologyI T. J. Holmes, D.Sc., Radiology D. G. Politte, M.S., Radiology 
M. M. Ter-Pogossian, Ph.D., Radiology 
I Support: RR 01380 HL 13851 
I Super PETT I has been relocated to the Coronary Care Unit and is 
routinely used for cardiac studies (D-2). 
I The gantry and custom electronics (PR 20, D-6) have been interfaced 
to a newly acquired Perkin Elmer 3230 host computer for system operation. 
The host configuration includes 4 Mbytes of main memory, floating-pointI hardware, writable control store, cache memory, and six selector channels 
I 
for high-speed communications. System peripherals include an 80-Mbyte 
fixed-media disk, two 300-Mbyte removable-media disks for list-mode data 
collection, and a Ramtek 9400 display system for image viewing. 
I 
The addition of the second list-mode data disk and the upgrade to 
high-speed protocol on the gantry interface now support a maximum 
continuous event transfer rate in excess of 400,000 events per second. 
I
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Single-pass list~mode processing for seven slices with a reduced 
angle reconstruction algorithm (D-6) is now possible with the available 
memory. Retrospective processing with respect to the constraints of gating I
 
and time segmenting is optional, requiring a preliminary pass on the 
list-mode data for parameter selection. 
I
 
I
D-6. A Reduced-Angle Reconstruction Algorithm for Super PETT I
 
Personnel:	 D. G. Politte, M.S., Radiology 
D. E. Beecher, BCL I
 
D. C. Ficke, B.S., Radiology 
G. R. Hoffman, B.A., Radi~logy 
I
Support:	 RR 01380
 
HL 13851
 
HL 17646
 I
 
A software system which executes an algorithm similar to 
confidence-weighting, but with the "reduced-angle" technique, has been in 
use for routine image-reconstructions during the past year. I
 
The motivations for use of this technique are that the required 
memory size and the reconstruction time are lessened. The required memory I
size is diminished because the measurement array now has 16 (angle) x 128
 
(distance) x 40 (time-of-flight) elements, whereas it formerly had 96
 
(angle) x 128 (distance) x 40 (time-of-flight) elements. Thus, the
 
measurement array for several slices may be built and stored in memory
 I
 
simultaneously, without additional passes through the list-mode data, as 
had been required previously. The reconstruction time is further reduced 
because the angle-dependent portions of the processing are performed only I
16 times instead of 96 times. 
Developments during the past year include: I
 
- The memory of the Perkin-Elmer 3230 host computer has been 
augmented so that only one pass through the list-mode data is 
necessary for most studies. The time to process seven slices of 
emission data with approximately one million counts per slice has I
 
been reduced from forty-five minutes to thirty minutes, assuming 
that the processing of the blank and transmission scans (used for 
calibration and data correction) has already been done. The I

corresponding time when the reduced-angle technique is not used is 
two and one-half hours. 
I
- The weighting function used has been found to be suboptimal. The 
advantage of the suboptimal weighting function is that the 
two-dimensional convolution which performs the weighting step may be 
implemented as two one-dimensional convolutions, with a resulting I

computational efficiency. The optimal weight, which has not been 
implemented, does not possess this property. Optimal weighting 
corresponds to true confidence-weighting when the measured angle is I
 
I
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I not known exactly, but is known to be uniformly distributed over a 
known range. 
I - The final filters which compute an image from a pre-image (when 
either optimal or suboptimal weighting functions have been used) 
have been derived. The latter has been implemented. 
I 
I A systematic simulation study has been undertaken to measure the 
effect of the suboptimal or the optimal reduced-angle techniques on image 
signa1-to-noise ratio and resolution, as a function of the number of angles 
and the reconstructed resolution of the image. It should be emphasized 
that the reduced-angle fechnique will not perform better than true 
confidence-weighting; the motivation for its use is its relativeI computational efficiency . 
I 1. D. L. Snyder, "Preimage Se1e6tion in Time-of-F1ight Emission Tomography," IEEE Transactions on Nuclear Science, vol. NS-30, no. 1, 
pp. 701-702, February 1983. 
I 
I D-7. The Use of Sieves to Stabilize Images Produced with the EM Algorithm for Emission Tomography 
I Personnel: D. L. Snyder, BCL M. I. Miller, BCL 
I Support: RR 01380
 RR 01379
 HL 13851
 
ECS 8215181
 
I 
I 
Images produced in emission tomography with the expectation­
maximization (EM) algorithm have been observed to become more 'noisy' as 
the algorithm converges towards the maximum-likelihood estimate. We argue 
I 
that there is an instability which is fundamental to maximum-likelihood 
estimation as it is usually applied and, therefore, is not a result of 
using the EM algorithm, which is bu\ one numerical implementation for 
producing maximum-likelihood estimates. We show how Grenader's method of 
sieves can be used with the EM algorithm to remove the instability and 
thereby decrease the 'noise' artifact introduced into the images withI little or no increase in computational complexity. 
I 1. D. L. Snyder and M. 1. Miller, "The Use of Sieves to Stabilize Images Produced with the EM Algorithm for Emission Tomography," Biomedical 
Computer Laboratory Monograph No. 464, April 1985. 
I
 
I
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D-8.	 Design Studies of Computational Alternatives for TOF-Based PET 
Reconstructions IPersonnel: S. M. Moore, BCL 
T. J. Holmes, D.Sc., Radiology 
Support: RR 01380 I 
HL 13851 
IUse of the maximum-like\i~ood (ML) algorithm for 
time-of-flight-based image reconstruction' is currently not feasible in a 
clinical setting due to excessive computational requirements. Phantom 
studies for algorithm evaluation performed on VAX-class computers require I 
on the order of one to three days to perform fifty iterations of the ML 
algorithm. Methods for reducing computation time include restructuring the 
algorithm to take advantage of the geometrical properties of the detection 
process and computing the estimates on high-performance or specialized I 
processors rather than on general purpose computers. 
The most time-consuming step in the present implementation of the I
algorithm is the application of a two-dimensional Gaussian filter to the 
current estimate of the radioactivity distribution and to the count data 
for each of the detector angles. By performing the filtering step in the 
data collection space (radial distance, TOF) rather than in the image I 
viewing space (x,y), it is possible to reduce the number of computations by 
a factor of 10. IEven with this reduction, image reconstruction cannot be performed 
on a super minicomputer system in a clinically acceptable time. Benchmark 
studies indicate that an array processor coupled to a supermini can reduce 
the time needed to reconstruct one slice to one hour. Special purpose I 
processors will be needed to achieve reconstruction times on the order of 
one minute for a single slice. Custom-designed VLSI circuits can be used 
to perform coordinate transformations which will allow the filtering steps Ito be performed in the <distance, TOF> space. Multiple processors can be 
used to process data collected at each angle in parallel rather than 
serially. With the appropriate architecture and taking advantage of custom 
VLSI designs, a clinical study consisting of seven sl~ces can be I 
reconstructed using the ML algorithm in less than five minutes. 
I1.	 L. A. Shepp and Y. Vardi, "Maximum-Likelihood Reconstruction for 
Emission Tomography," IEEE Transactions in Medical Imaging, vol. MI-l, 
no. 2, pp. 113-121, October 1982. I 
2.	 D. L. Snyder and D. G. Politte, "Image Reconstruction from List-Mode 
Data in an Emission Tomography System Having Time-of-Flight 
Measurements," IEEE Transactions on Nuclear Science, vol. NS - 30, pp. 
1843-1849, 1983. I 
3.	 S. M. Moore and T. J. Holmes, "M-L Algorithm: Computation Time 
Estimates for Custom Processor-Based Implementations," BCL Working INote	 No. 61, 1984. 
I
 
I
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 D-9.	 Effects of Positron-Emission Tomography Scintillation Detectors on 
Resolution and Sensitivity
I Personnel: D. C. Ficke, B.S., Radiology 
T. J. Holmes, D.Sc., Radiology 
M. M. Ter-Pogossian, Ph.D., RadiologyI Support: RR 01380
 
HL 13851
 
I 
The analYtic studies initiated in PR 20, D-ll have been continued 
and reported, including experimental results for a particular detectorI geometry which tend to validate the model used. In particular, the 
I 
normalized resolution uniformity of detectors being developed for Super 
PETT II (D-12) has been accurately predicted, thereby encouraging the 
application of the model to other detector geometries. 
The findings indicate that a triangular face added to the present 
Super PETT II detector should improve the system sensitivity, whileI reducing the total length of the detector should improve the resolution uniformity at the expense of reduced sensitivity. In conjunction, these 
modifications might yield an improved performance over the present design. 
I	 It should be noted that the analytic model used considers only the 
I 
first interaction of each photon, hence the absolute values obtained do not 
coincide with the measured results which include multiple interactions. 
Therefore, experimental verification is required. In addition, there may 
be technological problems in constructing a module with the triangular 
faced detectors. 
I 
I 
1. T. J. Holmes and D. C. Ficke, "Analysis of Positron-Emission 
Tomography Scintillation Detectors with Wedge Faces and Inter-Crystal 
Septa," IEEE Transactions on Nuclear Science, vol. NS-32, no. 1, pp. 
826-830. 
I 
I 
I 
I 
I 
I 
I	 
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D-10.	 Maximum-Likelihood Estimation of Parameters in Dynamic Tracer 
Studies IPersonnel: J. M. Ollinger, BCL 
D. L. Snyder, BCL 
Support: RR 01380 I 
RR 01379
 
ECS 8215181
 IThe advent of positron-emission tomography (PET) made possible for 
the first time non-invasive, regionally localized parameter estimation in 
dynamic tracer studies. Despite the hope that multicompartment models 
developed for single-probe experiments could be readily adapted for use I 
with PET, investigators find that this is often not the case due to the 
poor time resolution of the data available to them. Data are currently 
collected by reconstructing a series of images over the time course of the 
study, spatially integrating each image over a region of interest to form a I 
histogram of activity levels versus time, and then estimating parameters 
from this histogram. Since each image must span a time subinterval 
containing enough counts to yield an adequate image, the total number of I
subintervals in the histogram is limited. Since the compartmental models 
used for dynamic tracer studies frequently require that data be collected 
over a short time interval, and that parameters with short time constants 
be estimated, this limitation results in either degraded estimation I 
accuracy or in inability to perform the experiment. 
lSnyder proposed a method that s02ves this problem by using the EM I
algorithm of D~mpster, Laird, and Rubin to compute the maximum-likelihood 
parameter estimates from list-mode data, that is, from data which contain a 
record of each detected annihilation. The method can be decomposed into 
two algorithms, a weighting algorithm, which estimates a histogram of I 
activity levels from list-mode data, and an estimation algorithm, which 
computes parameter estimates from this histogram. The research effort 
during the past year has been directed at evaluating this method. I 
The weighting algorithm computes an approximate minimum-mean-square 
error estimate of the histogram based on the Poisson statistics of the 
list-mode data. This estimate cannot be computed exactly, since it depends I 
on the tracer concentration, which, being both unknown and non-stationary, 
must be approximated by a series of reconstructed images. The algorithm 
consists of first reconstructing images over each of a number of time Iintervals, identifying a region of interest in each image, if this is not 
already known, computing probability arrays for each interval, weighting 
each detected event with the probability that it occurred in the region of 
interest and, finally, summing the weighted events into a histogram. Since I 
the number of subintervals in the histogram is limited only by the time 
resolution of the list-mode data, the output histogram can have the same 
number of subintervals as if it were collected with a single probe. These 
high-resolution histograms can be used with either the maximum-likelihood I 
estimation algorithm discussed here or with any of the commonly used 
weighted least-squares algorithms. Initial results of the evaluation of 
this algorithm indicate that the final parameter estimates are I
significantly more accurate than those obtained by conventional methods 
when compared in terms of their bias and the standard deviation of their 
error. I
 
I
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The parameter-estimation algorithm is an iterative method o~ 
computing maximum-likelihood estimates. An evaluation of this algorithm 
indicates that its estimates are unbiased, that the variance of the error 
I 
is near the theoretical minimum as given by the Cramer-Rao bound, and that 
the algorithm converges even for very poor starting values. Furthermore, 
in every simulation, the algorithm converged either to a unique maximum 
close to the true value, or to an easily recognized local maximum where two 
or more parameter values were equal. The major drawback to the algorithm 
is its linear convergence rate, which can be quite slow. Our first 
I approach to resolving this problem was to implement a line-search along the ascent direction given by the EM algorithm. Initial results are promising, 
showing a speed improvement of a factor of two. 
I In the next year we plan to complete the evaluation of the weighting 
I 
algorithm, extend it to include the effects of randoms and attenuation, and 
to evaluate it using real data.. We intend to further investigate the 
uniqueness of the estimation algorithm and to try other methods for 
accelerating convergence. 
I 1. D. L. Snyder, "Parameter Estimation for Dynamic Studies in Emission Tomography Systems Uaving List-Mode Data," IEEE Transactions on 
Nuclear Science, no. 2, pp. 925-932, April 1984. 
I 2. A. P. Dempster, N. M. Laird, and D. B. Rubin, "Maximum Likelihood from 
Incomplete Data via the EM Algorithm," J. R. Statistical Society, vol. 
39, pp. 1-38, 1977. 
I 
I 3. J. M. Ollinger and D. L. Snyder, "A Preliminary Evaluation of the Use 
of the EM Algorithm for Estimating Parameters in Dynamic Tracer 
Studies," IEEE Trans. on Nuclear Science, no. 1, pp. 848-854, February 
1985. 
I
 
I D-ll. Slice Processor Selection for Super PETT II Personnel: D. E. Beecher, BCL 
D. C. Ficke, B.S., Radiology
I D. G. Politte, M.S., Radiology 
Support: RR 01380 
HL 13851I 
I 
Careful analysis of the collection and processing requirements for 
Super PETT II have demonstrated the need for fast, distributed processors 
I 
for each slice in the new generation machine called Super PETT II. 
Selection of the processor to fulfill these needs was based on the 
price/performance of several commercially available products. The final 
selection was the Perkin-Elmer 3205 processor with one to two megabytes of 
main memory, depending on the scanner it will support (i.e. a head or a 
body unit). Each slice of the scanner is supported by a single 3205 
I
 
I 
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processor capable of collecting up to one million counts per second for 
that particular slice. IWe have successfully implemented a multi-processor system to support 
Super PETT II. The configuration is as shown in PR 20, D-16, Figure 2. We 
expect this system to be fully operational by the beginning of calendar 
year 1986. I
 
I
 
D-12. Super PETT II Detector Design IPersonnel:	 D. C. Ficke, B.S., Radiology 
G. L. Engel, BCL 
R. O. Gregory, BCL 
T. J. Holmes, D.Sc., Radiology I 
J. T. Hood,	 Sr., B.S., Radiology 
M. M. Ter-Pogossian, Ph.D., Radiology ISupport:	 RR 01380 
HL 13851 
I 
The detector module described in PR 20, D-17 has been refined and 
targeted for use in Super PETT II, which is now under development. The 
critical components of the module consist of eight barium fluoride Iscintillation detectors (7x24x45mm) which are grown, cut, and polished on 
all surfaces by Harshaw Chemical; and five Hamamatsu R2076 photomultiplier 
tubes with associated divider networks. Reflection of the scintillation is 
achieved with 0.1 mm centered Teflon and inter-crystal scattering is I 
reduced with the use of 1.25 mm tungsten septa. The critical components 
are assembled into an aluminum housing with light-tight adhesives to form 
the finished module. Approximately 20% of the required 285 modules for two 
instruments have been assembled and tested. I 
Previous work on a novel detector employing a micro-channel plate 
and a special high-gain amplifier has been discontinued. Local facilities I 
at Washington University and at commercial firms were found to be 
inadequate for achieving reliable photocathode deposition. The primary 
difficulty was deterioration of the photoemissive characteristic with time. 
It became clear that with other stringent requirements for detector I 
fabrication, the expense would be prohibitive if pursued with commercial 
firms elsewhere. I 
I 
I 
I 
I
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Computed-Tomography
I Personnel: M. I. Miller, BCL 
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I Support: RR 01380 
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A mathematical model is formulated for a gamma camera used toI observe single-photon emissions from multiple view angles. The model 
I 
accounts for the statistics of radioactive decays, nonuniform attenuation, 
and a depth-dependent point-spread function. The maximum-likelihood method 
of statistics is used with,the model to derive an algorithm for estimating 
the distribution of radioactivity. 
The approach we take differs in three fundamental ways fromI classical methods of SPECT reconstruction. It is not based on 
I 
modifications of the conventional filtered back-projection algorithm or on 
linear, least-squares theory; rather it is based upon a Poisson process 
model that accurately describes both the emission process as well as the 
detection process. Maximum-likelihood estimation is then subsequently used 
with this model to derive the reconstruction algorithm. The algorithm we 
proposed permits the depth-dependent point-spread function to be includedI irl the reconstruction which conventional methods can not do. Finally, the 
I 
algorithm we propose accounts for the attenuation of photons due to 
absorption and scattering in tissues; we make no assumptions about the 
physical medium or geometry of attenuation. 
I 
I 
I 
I 
I 
I 
I 
I	 
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E. Systems for Specialized Biomedical Studies 
The reports in this section are, in general, applications of 
fundamental technology developed at BCL. Inevitably they have only one I 
common factor; - each is emerging from the laboratory and awaiting entry to 
the clinic. IThe use of modeling techniques to describe the blood acid-base 
relationships in vivo should encourage greater quantification and account 
for significant discrepancies that occur in the theory and practice of the 
management of acid-base abnormalities. I 
Work continues on a device that should increase our understanding of 
EEGs and special hardware arid software has been devised to aid in other 
areas of neurology, especially the evoked response potentials in relation I 
to rapid eye movements. 
The use of computers to obtain an overall genetic description of I
certain yeasts continues to be pursued and offers exciting prospects. 
The ability of computers to perform complex statistical calculation 
is being exploited in the analysis of autoradiographs of materials made in I 
electron microscopy. 
Finally, the study of peripheral vision by means of color perimetry Iis continuing on a limited clinical basis. 
I 
E-l. Further Development of a Toposcope System for Electroencephalograms I 
Personnel: H. W. Shipton, BCL and Electrical Engineering 
Support: RR 07054 I 
The frequency and phase indicating toposcope (described in PR 18, IC-7) has been used on a variety of EEG data, mostly recorded off-line. The 
object was not to establish a meaningful experimental protocol but rather 
to get a "feel" for the instrument. It became clear that the problems 
noted in PR 18 section C-7 seriously limited the use of the method I 
especially when using photic stimulation. 
A major upgrade of the system is now in hand: Memory size.has been 
increased to 2K x 8 bits per channel, the AID converters have been replaced I 
and a "spongy lock" between the clocks has been devised to overcome 
problems of stimulus synchronization. As an interesting side-light on this 
project there is an on-going controversy over the basic instrumental I
technology. The P.I. believes that this is one of the few cases where a 
hard-wired hybrid system has a considerable edge over a software (general 
purpose computer) approach. I
 
I
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There has been a world-wide resurgence of interest in toposcopic 
displays, most of which are applications of computer graphics technology. 
Most of these systems are probably not capable of posing or solving basic 
I 
physiological questions although they may well have clinical utility. Use 
of this system should clarify and refine questions about the nature and 
function of what have been called the "intrinsic rhythms of the brain." 
I
 
E-2. DNA Restriction-Mapping 
I Personnel: J. R. Cox, Jr., BCL and Computer Science M. V. Olson, Ph.D., Genetics 
J. S. Turner, Ph.D., Computer Science 
I Support: RR 01380
 
GM 28232
 
Washington University
 
I 
I The DNA-mapping project, under the direction of M. V. Olson of the 
Department of Genetics is directed towards global physical mapping of the 
DNA in the yeast Saccharomyces cerevisiae. This goal is of immediate 
practical value, since yeast has become a major experimental model in 
molecular biology, and also is of methodological interest since the most 
complex DNA's that have yet been successfully mapped are only a few percentI as complex as yeast DNA. 
I 
The basic approach involves generating l5-kb (1 kb - 1000 base 
pairs) segments of yeast DNA by random breakage, and then cloning these 
segments by recombinant-DNA techniques. Each cloned segment is digested 
with restriction enzymes to obtain a set of approximately 8 sub-fragments 
whose sizes are characteristic of the DNA sequences present in theI particular clone analyzed. The sizes of the sub-fragments are measured by 
I 
electrophoresis and entered into a computerized data base. The original 
plan called for analyzing 5000 random clones, which corresponds to a 
sampling redundancy of 5. It is expected that this redundancy will allow 
the ordering of most of the sub-fragments in the source DNA; this ordering 
I 
information is obtained by inferring the way in which the clones must 
overlap in order to produce the lists of sub-fragment sizes that are 
associate with them. 
I 
Experimental progress during the past year has involved completion 
of the electrophoretic measurements and creation of the 5000-clone 
database. Preliminary examination of the database indicates that overlaps 
I 
between clones are readily detected and that the sampling redundancy indeed 
appears to be approximately 5 (i.e. a particular sub-fragment can generally 
be found in approx. 5 clones, which are non-identical but can be ordered to 
produce a topologically consistent map for the sub-fragment order in the 
source DNA). 
I Collaborative effort with the BCL has shifted from a past emphasis 
I 
on the quantification of the electrophoretic measurements to an analysis of 
algorithms for global analysis of the data set. Two aspects of the problem 
have received emphasis. On the one hand, local-searching strategies have 
I 
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been developed and implemented that allow the data for sets of 
approximately 3-50 clones from a local region of the source DNA to be 
analyzed. The key to these strategies is a tree-searching algorithm with 
judicious pruning that allows the most plausible pairing schemes between I 
the sub-fragment lists for two clones to be recovered without elaboration 
of all conceivable schemes. Extensive experience with a FORTRAN 
implementation of this algorithm has validated its suitability for I
analyzing data of the quality present in the data set. However, a more 
difficult problem concerns the optimum way of pre-selecting sets of clones 
that are appropriate for analysis by the local-searching programs. A 
number of laboratory methods have been developed that are contributing to I 
our ability to carry out this pre-selection with the use of supplementary 
data, but we have also been pursuing computational approaches that do not 
require supplementary data. I 
The problem of global analysis of the data is intrinsically 
difficult. We have developed a formal proof that the computational problem 
is NP-complete, implying that there is unlikely to be an efficient I 
algorithm that is assured of finding a solution if one exists. Given the 
scale of the problem (~OOO clones, 40000 sub-fragments), algorithms that 
require more than "O"(n ) in computing time, where n is the number of Iclones, are unlikely to be practical. For this reason, work has focused on 
a greedy algorithm, whose dominant characteristic is that it builds up the 
source map starting with the clone overlaps that are the least likely to be 
fortuitous and moves towards overlaps with progressively decreasing I 
statistical significance. Analysis of the computational complexity of the 
approach suggests that it should be feasible to implement, but its accuracy 
cannot be reliably predicted without actual experience analyzing real data. 
We plan to develop and test an implementation during the next year. Major I 
emphasis will be on developing a productive interplay between the 
computational activities and the experimental program so that a variety of 
laboratory resources will be available to test the accuracy of maps that I 
are predicted by the data analysis. 
I 
E-3. A Quantitative Model for In Vivo Acid-Base Relations I 
Personnel: L. J. Thomas, Jr., BeL 
Support: Washington University I 
Work is in progress on a new model to represent the acid-base Irelations of the blood in vivo. The model will account for steady-state 
equilibrium between the blood and interstitial flpid (plus lymph) I the 
transition from mixed-venous to arterial blood, and for intracellular 
buffering as well as acid production. The object is to achieve a precisZ I 
representation of the composition of arterial blood in vivo. Earlier work 
had modeled the in vitro behavior of arterial blood in order to quantify 
acid-base abnormalities. Subsequently, improved estimations of the Ireaction constants for carbamino formation and revised estimates for the 
upper portion of the oxyhemoglobin dissociation curve have been added to 
the extensive information available about the physicochemical behavior of I 
I
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blood. Also, major advances have been made in understanding the factors 
affecting the relations between intracellular and extrace11uar pH. More 
importantly, classical methods for quantifying acid-base abnormalities have 
fallen into disfavor because they were based on the in vitro behavior of 
blood and more precise clinical methods have shown discrepancies with 
actual in vivo behavior. As a result, clinical applications in recentI years have reverted to semiquantitative empirical methods that in many cases lead to errors at least as large as those of the classical methods. 
I In order to evaluate its potential, a preliminary version of the new model has been programmed on the IBC VAX 11/750. Even though neither the 
transition from mixed-venous to arterial blood nor the release of acids 
from the intracellular space were included, the preliminary model comparedI very favorably with data from the literature for acute in vivo titration 
I 
with carbon dioxide. Discrepancies in base excess from several 
mi11iequiva1ents/1iter (based on in vitro methods) were reduced an order of 
magnitude to a few tenths of a meq/1iter for hypercapnea up to CO tensions2
of 90 mmHg. In hypocapnea, the preliminary model deviated from in vivo 
titration results almost exactly in accordance with the demonstrated 
release of lactic acid from the intracellular space during hyperventilationI by awake subjects. These results encourage further work to complete and 
I 
evaluate the model. If it proves to be satisfactory, it will provide the 
basis for reinstating truly quantitative methods for evaluating acid-base 
abnormalities. 
I 1. A. Roos and L. J. Thomas, Jr., "The In-Vitro and In-Vivo Carbon Dioxide Dissociation Curves of True Plasma: A Theoretical Analysis," 
Anesthesiology, vol. 28, pp. 1048-1063, 1967. 
I 2. L. J. Thomas, Jr., "Algorithms for Selected Blood Acid-Base and Blood Gas Calculations," Journal of Applied Physiology, vol. 33, 
pp. 154-158, 1972. 
I
 
I E-4. Iso1ated-Scinti11ation-Probe Data Acquisition System 
I Personnel: D. E. Beecher, ~CL H. D. Ambos, Medicine 
R. E. Hermes, BCL 
I Support: RR 01380 HL 13851
 
HL 17646
 
Software development for the Probe Data Acquisition System (PR 19, 
E-8, PR 20, E-6) is now in the final stages of testing. Six major modules 
have been designed, written, and are either fully operational or in final 
testing. The modules are: 
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File Setup: completed and fully tested.
 
File Update: completed and fully tested.
 
Collection: completed and fully tested.
 
Report Generation: completed and fully tested.
 I 
Curve Analysis I: in final testing stage.
 
Curve Analysis II: in final testing stage.
 IThe major new features of this system are the addition of user­
definable protocols and the ability to interactively manipulate the uptake 
curves in the Curve Analysis portions of the system. The final system 
should be installed for routine service shortly. I
 
I
 
E-5. Software Development for Neurological Sciences I 
Personnel:	 D. E. Beecher, BCL 
D. G. Barr,	 Radiation Sciences 
P. T. Fox, M.D., Neurology and Radiology IM. A. Mintun, M.D., Neurology 
Support:	 RR 01380 
NS 06833 I 
McDonnell Center for Studies of Higher Brain Function 
IWork continues on the alteration of existing software and the 
creation of new software for visual evoked potentials measured by PET 
scanners. There are now three major visual stimulus programs. I 
The existing checkerboard and moving box stimulus software underwent 
minor modifications to make them more user-definable and tailored to 
specific investigator's needs. A Ramtek 9400 display is used as the 
stimulus generator. I 
A third random-box stimulus was developed to study rapid eye 
movement. The software is very flexible and stimulates by alternating Iboxes at a fixed or random rate. 
Altered versions of the above three programs were developed 
utilizing high task priority to minimize iriterference from other users. I 
All three are currently being used in research projects, involving visual 
evoked potentials. I 
I 
I 
I 
I
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I E-6. Maximum-Likelihood Estimation Applied to Electron-Microscopic 
Autoradiography 
I Personnel: M. I. Miller, BCL 
D. R. Fuhrmann, BCL 
K. B. Larson, BCLI B. Roysam, BCL J. E. Saffitz, M.D., Pathology and Medicine 
D. L. Snyder, BCL and Electrical Engineering 
I	 L. J. Thomas, Jr., BCL 
Support:	 RR 01380
 
HL 17646
I 
I 
A new method for analysis of electron microscope autoradiographs has 
been described which is based on the maximum-likelihood method of 
statistics for estimating the intensities of radioactivity in organelle 
I 
structures. A Poisson statistical model describing the autoradiographic 
grain distributions is adopted, which we prove results from the underlying 
Poisson nature of the radioactive decays as well as the additive errors 
I 
introduced during the formation of grains. Within the model, an iterative 
procedure derived from the expectation-maximization algorithm of 
mathematical statistics is used to generate the maximum-likelihood 
estimates. The algorithm has the properties that at every stage of the 
I 
iteration process the likelihood of the data increases; and for all initial 
non-zero starting points the algorithm converges to the maximum-likelihood 
estimates of the organelle intensities. 
I 
The maximum-likelihood approach differs from the mast-analysis 
method, and other published quantitative algorithms in the following ways: 
I 
1) In deriving estimates of the radioactivity intensities the maximum­
likelihood algorithm requires the actual locations of the grains as 
well as the micrograph geometries; each m~crograph is digitized so 
that both the grain locations as well as the geometries of the 
organelle structures can be used. 
I 2) The maximum-likelihood algorithm iteratively computes the minimum­
I 
mean-squared-error estimate of the underlying emission locations 
that resulted in the observed grain distributions, from which 
intensity estimates are generated; this algorithm does not minimize 
a Chi-squared-error statistic. 
3) The maximum-likelihood approach is based on a Poisson model and isI therefore valid for low-count experiments; there are no minimum constraints on data collection for any single organelle compartment. 
I 4) The maximum-likelihood algorithm requires the form of the point­spread function describing the emission spread, a probability matrix 
based on the use of overlay masks is not required. 
I 5) The maximum-likelihood algorithm does not change for different 
I 
organelle geometries; arbitrary geometries are incorporated by 
maximizing the likelihood-function subject to the geometry 
constraints. 
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I 
We have performed a preliminary evaluation of the quantitative 
accuracy of the maximum-likelihood and mask-analysis algorithms. Based on 
two different phantoms in which we compared the squared-error resulting 
from the two algorithms, we find that the new maximum-likelihood approach I 
provides substantially improved estimates of the radioactivity intensities 
of thp. phantoms. I
 
I
 
E-7. Color Perimetry Studies 
Personnel:	 W. M. Hart, Jr., M.D., Ph.D., Ophthalmology I 
Support:	 RR 01380 
EY 03703 
Washington University I 
The microcomputer-based color perimetry system was used during the Ilast project year for ongoing clinical studies of patients with glaucoma 
and diseases of the retina and optic nerve. Unexpected resulcs were 
obtained, demonstrating that visual field defects in these diseases can be 
mapped by color contrast perimetry in the visual field at locations exactly I 
matching those for defects detected by conventional luminance increment 
perimetry. While use of the color contrast technique seems to have failed 
to produce any greater sensitivity or specificity for the detection and Idiagnosis of disease, the results have r.evertheless provided interesting 
insights into the pathogenesis of the types of color vision defects that 
occur in patients with ocular diseases. In addition, the possibility 
remains that a form of testing may yet be devised with the use of the color I 
technique that would provide a higher level of sensitivity. For this 
purpose, software changes will need to be made in the system during the 
next project year to allow variations in test parameters that cannot now be 
achieved. I 
I 
I 
I 
I 
I 
I 
I
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I
 F. Resource Development Activities 
I Resource development activities are those which contribute to the goals of more than one major program of the laboratory, add~ess the needs 
of individual users who can benefit from the expertise of the BCL staff and 
the inventory of computing and specialized test equipment, or identify newI technologies which may become appropriate foundations for new experimental 
I 
tools. Service to users does not follow the usual computation-center 
pattern with an established fee schedule and a highly centralized facility. 
Rather, senior laboratory staff members consider requests for assistance 
from investigators who must address a particular biomedical computing 
problem. If an appropriate technology exists, investigators may be 
referred to commercial vendors or fee-for-service organizations when theseI are available. In other cases, problems may be approached by the 
I 
laboratory provided that the effort complements other activities of the 
laboratory. Many times the project can be assigned to a staff member with 
appropriate experience and completed in a short time. The investigator 
then has his or her results, and a short note describing the work will 
appear in the annual report and perhaps the open literature. A few 
projects, however, may develop into major initiatives within theI laboratory. Most of the major projects began in this fashion and the opportunities that supporting activities provide are valued. 
I A goal of the IPAQ activity (F-l) is to provide a software development environment which promotes portability to our local and 
I 
national collaborators. Continuing studies and measurements on broadband 
cable transmission (F-3) support both local and campus-wide networking 
projects. System development aids primarily benefit BCL staff, but may 
also be used by others (F-2, F-S, F-6, F-7). 
I Many digital hardware designs are one-time, special purpose projects. Others may have wide appeal and construction of multiple copies 
may result, 
I 
I 
I 
I 
I 
I 
I 
I 
as in the case of the TERRANET local network. 
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F-1.	 A Distributed Facility for Image Presentation. Analysis and 
Quantification (IPAQ) IPersonnel:	 G. J. Blaine, BCL 
D. E. Beecher, BCL 
K. W. Clark, BCL 
J. R. Cox, Jr., BCL I 
R. E. Hermes, BCL 
S. M. Moore, BCL 
F. U. Rosenberger, BCL and Computer Systems Laboratory I 
Support:	 RR 01380 
RR 01379 
Washington University I 
Decentralized computing organized along departmental and research 
laboratory lines characterizes the environment which continues to evolve at I 
most major medical research institutions. This is particularly true in 
quantitative imaging where many projects have diverse image-data sources 
(modalities), different data-acquisition requirements, and dissimilar I
methods for the extraction of quantitative information. Rather naturally, 
diverse computing styles and equipment choices have evolved. For example, 
our major collaborative research groups support installations tailored to 
their specific measurement and picture transformation needs, for which I 
display peripherals from a variety of manufacturers (DeAnza, Ramtek, and 
Lexidata) are tightly coupled to different computers (DEC 730, 750, 780, 
PE 3230, 3242). Commonality is limited to little more than the popularity Iof Vax-class computers and a FORTRAN programming environment. Furthermore, 
the lack of common program-development tools and display-support software 
has minimized the opportunities for sharing developments across research 
programs and has necessitated large host-specific investments by those I 
Resource researchers and collaborators who participate in modeling and 
algorithm development. IAlgorithm, development is often characterized by computationally 
demanding and memory-intensive tasks which must compete with concurrent 
usage of the existing computing resources for data acquisition and analysis 
activities. The limited computational capacity available for algorithm I 
development and pressures for expediting the research process biases the 
investigator's attention toward ad hoc approaches to improvements in 
execution performance, often at the expense of fundamental algorithm 
studies which are more likely to yield long term benefits. I 
The broad goal of this core research and development activity is to 
create an environme~t for biomedical image presentation, analysis and Iquantification (IPAQ) which: 
1)	 is focused on fundamental algorithm developments that individual 
biological scientists may not have the time, patience or resources I 
to pursue; 
2)	 provides an integrated approach to expedite the development and I
export to the local and national communities of new algorithms for 
improved quantification of biological information; 
I
 
I
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I 3) improves access for purposes of algorithm development to data from 
the diverse imaging modalities to encourage modality integration; 
and, 
4)	 protects existing investments in decentralized and specialized 
biomedical research systems. 
1 
1 A series of study efforts led to the definition of an architecture 
and system components capable of addressing the needs of quantative 
imaging. The components of the distributed IPAQ facility are to include: 
1) acquisition nodes consisting of the specialized imaging resources at the 
sites of the collaborations; 2) a computation-oriented node to support 
development and initial evaluation of algorithms within the Resource;1 3) high-performance computation/display nodes which are tailored to export 
1 
specialized computation and/or picture presentation; and 4) a high­
bandwidth network to interconnect our development activities with the 
collaborative research, (F-3). 
Software 
I We have chosen the UNIX operating system for supporting our software development activities. The choice of this system was motivated by several 
factors: 
1 a) UNIX runs on a variety of machines, and software-development tools 
can be easily moved among those machines running UNIX; 
I b) many software-development and maintenance tools already exist on the UNIX system; 
I c) workstation development trends strongly support the choice of UNIX as the operating system; and 
'I d) software portability to other operating environments, VMS, RSX, and OS/32, can be achieved by recompi1ation of appropriately constrained module	 implementations. 
I The widespread use and availability of FORTRAN and C compilers suggests application and support of both these languages. The "C" 
1 
programming language will be used both in the development of tools and in 
the implementation of support routines. Creation of consistent, structured 
picture-presentation techniques within the IPAQ facility will require 
special attention to the data types produced at any given node on the 
network. Further review of existing standards both nationally and within 
Washington University will provide the basis for our work in this area.1 Computation-Oriented Node 
I The computation and memory-intensive tasks associated with algorithm research and development necessitate availability of a computing system of 
adequate power whose management is sensitive and responsive to the research 
requirements. Our approach is to establish this computation-oriented node1 within the Resource. 
I 
The node must supply adequate primary memory, secondary storage and 
processing speed to allow computation-intensive tasks (as those 
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characterizing emission tomography algorithms, D-7) to be conducted in a 
time-fra~e deemed reasonable to accomplish the research goals. Benchmark I 
studies , providing both frequency and time domain computation time­
estimates, indicate the adequacy of a VAX-750 class processor augmented by 
a floating point accelerator and an array processor. General-purpose 
interactive usage will be severely limited on the computation-node in order I 
to maintain flexibility for dedicating the whole computation capability of 
the node to its designated task of algorithm research. A responsive 
environment for program development, documentation, and image presentation I 
will be supported on our MASSCOMP workstations and appropriately connected 
to the computation-node via the picture-based local area network. 
Efforts in the next reporting period will focus on a review, I 
selection and purchase of a general purpose processor(s) and an array 
processor to form the hardware base of the computation-oriented node. 
System integration, software importation/installation and system evaluation 
will be given substantial attention. I 
1.	 L. J. Thomas, Jr., Principal Investigator, "A Resource for Biomedical IComputing," Biomedical Research Technology Program Renewal Proposal, 
Washington University Institute for Biomedical Computing, St. Louis, 
MO, December 1984. I 
2.	 S. M. Moore and T. J. Holmes, "M-L Algorithm: Computation Time 
Estimates for Array Processor-Based Implementation," BCL Working Note 
No. 60, September 1984. I
 
I
 
F-2. MASSCOMP Workstations IPersonnel: R. E. Hermes, BCL 
G. J. Blaine, BCL 
S. R. Phillips, BCL ISupport: RR 01380 
IThe laboratory has utilized a MASSCOMP MCS-500 for about a year now 
(PR 20, F-10). The system is Motorola 68010 based, uses UNIX as an 
operating system and supports a modest number of simultaneous users. IThe system has been upgraded significantly during the past year with 
the addition of the MASSCOMP array processor and floating point units, an 
SMD disk controller with an 80 megabyte CDC Storage Module drive, a 52 
megabyte Winchester disk, an additional megabyte of memory, and eight I 
additional serial communication ports. The increased disk capacity was 
required for storage of large data sets used for algorithm evaluation. The 
array processor and floating point units have helped reduce computation Itimes. 
I
 
I
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I System performance has been good for computationally demanding 
tasks, offering comparable performance to the Institutes multiuser VAX 
11/750. Frequently, tasks requiring hours or days of compute time (D-7, 
D-lO) have been run on the system with little impact on other system users. 
The tightly coupled MASSCOMP graphics processor has aided inI algorithm evaluation and development studies by providing for quick display 
I 
of algorithm results. MASSCOMP windowing software for the graphics 
processor provides a valuable mechanism by which results from different 
algorithm implementations may be viewed simultaneously for comparison. 
A second MASSCOMP workstation was recently acquired to support text 
processing requirements of the laboratory. This includes support for the 
I MUSE word-processing system as well as NROFF and TROFF support for 
I 
technical document preparation. The system includes two megabytes of 
memory, a 52 megabyte Winchester, and eleven serial communication lines. 
In addition to text processing, programs can be developed and tested and 
later executed on the larger MASSCOMP configuration. 
I 
The systems currently communicate via serial lines using UUCP, users 
use either directly connected terminals or terminals connected via 
TERRANET. Intersystem communiation between these systems and the local VAX 
installation is over TERRANET. The VAX is a central node providing access 
to other systems outside the laboratory as well as a connection to a laserI printer for high quality text output. 
I
 
F-3. A Picture Communication System for RadiologyI Personnel: 
I
 
I
 
I
 Support:
 
I
 
G. J. Blaine, BCL 
J. C. Chabut, BCL 
J. R. Cox, Jr., BCL and Computer Science 
R. L. Hill, BCL and Radiology 
R. G. Jost, M.D., Radiology 
A. Kumar, B.Tech., Radiology 
S. R. Phillips, BCL 
A. P. Rueter, B.S., Radiology 
RR 01380 
RR 01379 
Mallinckrodt Institute of Radiology 
Washington University 
I 
A pilot cable system to transport analog and digital radiology 
pictures and support terminal-to-computer digital data transmission has 
been designed and installed (PR 20, F-6, PR 19, F-7, F-8). A dual-cable 
I 
400 MHz system utilizes "off-the - shelf" cable televis ion components to 
provide approximately 50 channels, achieved by frequency multiplexing 
channels of 6 MHz each. The system provides a workbench environment for 
I 
the evaluation of commercial digital transmission equipment in addition to 
supporting experiments related to digital picture networking and archiving 
studies. 
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Studies and subsequent designs have been directed at communicating 
radiological images using channels based on frequency division of the 400 
MHz channel. Multiple shared-transmit/receive channels were shown to have 
favorable cost-delay characteristics. Most of the MIR efforts have been I 
directed at accessing and displaying images related to an on-line clinical 
database containing both picture and text information. ICharacteristics of the cable TV medium for communi~ating digital 
pictures were reviewed, and nominal values were tabulated. A method for 
evaluating the impact of white Gaussian noise, burst noise, and sinusoidal 
interference was developed and the design and implementation of a low cost I 
(parts cost <$500) bit error tester was completed. Measurements were 
conducted for noncoherent FSK broadband modems (1 Mb/s rate) used either 
independently or in conjunction with the MIR cable TV network. IExperimental results indicate that digital pictures can be successfully 
communicated with the modems at signa1-to-noise ratios in excess of 29 dB. 
Development of a low-cost frame-buffer (512 x 512 x 8 bits/pixel) I 
continued. A 1 MHz serial synchronous interface was designed and 
implemented. A second prototype was constructed and initial experiments 
were conducted using a parallel load from a VAX 11/750 - DR 750 DMA Iinterface into one unit, and 1 MHz serial transmission over the broadband 
network to the second. Effort is currently directed to improving 
robustness of the transfer. I 
1.	 C. D. Shum, J. R. Cox, and G. J. Blaine, "Design Analysis of a Wide­ IBand Picture Communication System," IEEE 1984 International Symposium 
on Medical Images and Icons - ISMII '84, Arlington, VA, pp. 66-77, 
July	 1984. I2.	 J. C. Chabut, "An Examination of FSK-Based Digital Picture 
Communication Over the CATV Medium," Master of Science thesis, 
Department of Electrical Engineering, Washington University, 
St. Louis, MO, August 1985. I
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F-4. An Experimental Local-Area Network: TERRANET I 
Personnel: S. M. Moore, BCL 
G. J. Blaine, BCL 
R. E. Hermes, BCL IS. R. Phillips, BCL 
D. A. Schwab, BCL 
Support: RR 01380 I 
Washington University 
ITERRANET is now an integral part of the day-to-day operations of 
BCL. TERRANET provides termina1-to-computer and computer-to-computer 
communications for most multiuser computer systems in the laboratory. I
 
I
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I Nearly every office is equipped with a terminal tied to a TERRANET port; in 
addition, several public ports are available within BCL. Intersystem 
communication via TERRANET is used to transfer text and data files. The 
initial TERRANET network (30 ports) has been augmented by a second parallel 
network. Communication between networks is accomplished through the use of 
3 gateway ports on each network. Current resources on the two networksI include 22 terminals, 13 ports to 4 distinct computer systems, and 9 modem or other network gateway connections. 
I The hardware design of both tap and insert units has remained unchanged over the last year. Software updates were made to all terminal 
I 
units during the installation of the second network to bring each unit up 
to the most current revision level. Software in gateway units was also 
updated to reflect changes made to software in terminal units during the 
I 
past two years. Additional changes to software and hardware have been 
identified which will better facilitate networking machines and will be 
implemented as time permits. 
I
 
F-S. Systems Support for Programming and Image Processing 
I Personnel: R. E. Hermes, BCL S. Husodo, BCL 
S. M. Moore, BCL 
I R. J. Paisley, BCL S. R. Phillips, BCL 
T. D. Scholz, BCL 
I Support: RR 01380 
I Systems support (both hardware and software) is a critical component of the the overall research environment. Until very recently, scientific 
programming support was supplied by a pair of Digital PDP II/34's running 
RSXllM. These systems are configured with disk and tape storage devicesI which provide common data interchange media with other systems within the 
I 
university. In addition, one system hosts a Lexidata 3400 color display 
system, for which a general purpose image display utility package was 
recently completed. The package allows for display of images of arbitrary 
size, interactive manipulation of color tables, and supplies a simple 
windowing system for display of multiple images simultaneously. Several 
investigators have found this package to be a valuable aid to theirI research activities. 
I 
Recently, emphasis has been placed on software development for the 
MASSCOMP systems (F-2). MASSCOMP supplies a vast number of data 
manipulation and display libraries. Effort has been devoted to utilizing 
I 
these libraries to provide a set of data display utilities which are easy 
to use. In addition, work continues toward the definition of an image and 
data storage format and the importation of image and data manipulation 
packages (F-l). These include the acquisition of the CORE graphics system 
from Precision Visuals and the importation of the University of North 
I
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Carolina V-Shell, the Cornell PDS system, and the Brigham Young University 
MOVIE.BYU display package. IData communication has become a critical part of the local computing 
environment. Investigators often do program development on different 
machines, require a variety of hardware resources, and require data from 
many different sources. Software has been developed and is supported for I 
intersystem data communication and data type conversion for systems with 
dissimilar data storage formats (F-6). 
I
 
I
F-6. Data Formats for Inter-Machine Transfer 
Personnel: S. M. Moore, BCL 
D. E. Beecher, BCL I 
R. E. Hermes, BCL 
RR 01380 I 
Transferring data between computer systems requires not only a 
communications channel (physical connection, magnetic tape) but also a I 
common data format. Simple data formats such as text files, program source 
code and integer data are easily handled. Studying biomedical images 
acquired on a foreign machine requires additional effort as the floating Ipoint format j.s usually machine dependent. 
Studies for evaluating the ML algorithm were moved from a Perkin 
Elmer system at the Division of Radiation Sciences to a Masscomp system at I 
BCL. Images and programs used in the evaluation were written to magnetic 
tape by the PE machine, read by a VAX 750 using standard UNIX utilities, 
and transferred via TERRANET to the Masscomp system. A floating point 
number on a PE machine is represented by a 24 bit fraction, a 7 bit I 
exponent and a sign bit. The fraction is interpreted as 6 hexadecimal 
digits with a radix point to the left of the most significant digit. The 
exponent is stored in "excess-64" format; the value stored is the true I
value of the exponent plus 64. The magnitude of a floating point number 
is: 
FRACTION x 16(EXPONENT - 64) I 
The sign bit is a for a positive number and 1 for a negative number. A 
program written in "C" on the Masscomp interpreted this format and created I
numbers consistent with Masscomp floating point format. 
Floating point numbers on a Masscomp follow the IEEE standard which
 
is based on a binary rather than a hexadecimal system. Any positive number
 I 
x can be represented by a unique pair of values, an integer e and a real 
number g, where 1 ~ g < 2. The relationship between x, e, and g is: 
e Ix - 2 x g 
I
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I On the Masscomp, the values stored on the exponent (E) and significant (F) 
fields are (e + 127) and (g - 1), respectively. The exponent is a biased 
value and the significant is a fraction between o and 1. The sign bit 
gives the sign of the number as described above. A zero value is encoded 
by setting both the exponent and significant to O. 
I As the communications network connectivity is established with our 
I 
collaborators, similar interpretation programs will be written for each 
node. Efforts are now in progress to establish a standard file structure 
which will facilitate data transfer, manipulation and display within the 
IPAQ environment (F-1). 
I
 
I F-7. A Fortran Interface for the H-P 745A Plotter Personnel: T. O. Videen, BCL 
D. E. Beecher, BCL 
I Support: RR 01380 
I A software library was developed to handle most of the primitive 
I 
plotting functions available in HP Graphics Language through FORTRAN 
subroutines. This library, consisting of over 60 subroutines, will speed 
the development of programs which use the HP 7475A plotter for graphic 
display of data. 
A general purpose plotting program has been written which allowsI users to plot data in custom-designed plots. The program is interactive 
I 
and allows each user to select nearly all of the characteristics of a plot. 
Each user may save default parameters so as to rapidly recreate a 
particular format on future plots. This program allows any user to create 
publication-quality plots of his own data, complete with centered titles, 
labeled axes, error bars, and legends. 
I 
I 
I 
I 
I 
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VI. INDUSTRIAL COLLABORATION 
Industrial collaboration provides a mechanism for the deployment of I 
laboratory developments. In addition, it benefits our staff by keeping us 
abreast of the practical considerations of reliability, maintainability, 
and cost. During the past year, our collaboration was quite diversified, Iinvolving: (1) foreign corporations, (2) a small American biotech start-up 
company, and (3) a major American pharmaceutical corporation. 
1. The TERRANET system, which provides a simple, low-cost I 
interconnect to support terminal-to-computer and computer-to-computer 
communications at modest speeds (up to 9600 bps), is currently being 
produced and marketed in Japan under a licensing agreement with Computer IServices Corporation (CSK) , a major facilities management consulting firm 
headquartered in Tokyo (PR 20, VI). Recently, BCL loaned a six-unit 
demonstration unit to the Biodata Informatica and Technologia, Ltd., of 
Brazil for display at the Brazilia Informatics Conference and Exhibit. I 
Washington University is now negotiating a licensing agreement which would 
allow production and sale in Brazil. I2. BCL personnel have continued to work closely with Biosensor 
Corporation (Brooklyn Center, Minnesota) to complete the transfer, 
implementation and refinement of the entire set of frequency-domain-based 
Argus algorithms (A-l) into a microprocessor-based real-time ambulatory I 
patient ECG monitoring device (PR 20, VI). Within the past year, algorithm 
refinements for enhanced PVC couplet and run detection, atrial fibrillation 
detection, and signal-quality assurance testing were developed by BCL and 
implemented by Biosensor. I 
As each ECG complex is detected, analyzed, and classified, the 
patient monitor records beat counts and digital sample data for significant I
events. Information saved by the monitor is sent to a "central station" 
computer which prints ECG strips and tables of beat counts. The patient 
devices are capable of monitoring for up to 120 continuous hours. Data in 
the monitor may be "dumped" directly to the central station or transmitted I 
transtelephonically, typically at 8-hour intervals. 
Biosensor markets three embodiments of their Argus-based device: I(1) the Multiday System, featuring a central station supporting up to eight 
monitors and designed for trans telephonic transmission and monitoring 
periods up to five days; (2) the Uniday System, featuring simplified 
central station software for monitoring periods up to 24 hours for which a I 
monitor's data are dumped directly to the central station; and (3) the 
Multiscan System, for which monitor data are transmitted to a 
Biosensor-owned central station. I 
3. For a year and a half, BCL has analyzed long-term ECG recordings 
for a Mead-Johnson (Evansville, Indiana) sponsored "Multicenter Placebo­
Controlled Study of Trazadone's Effects in Depressed Cardiac Patients." I 
The study was described last year (PR 20, VI). BCL's contract to analyze 
these recordings expires in October 1985. I
 
I
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I VII. TRAINING ACTIVITIES AND SEMINARS 
I Training activities of the Biomedical Computer Laboratory are 
directed toward the goals of informing the local and national scientific 
communities about resource projects and facilities and of instructing aI broad spectrum of people in the application of advanced computer-techniques 
I 
to problems in clinical medicine and biological research. Training 
activities include the teaching of formal courses at the School of Medicine 
and the School of Engineering as well as supervision of graduate students 
by Laboratory staff. Both individual and small-group training about 
resource facilities are made available to the biomedical scientist. 
National workshops and symposia on topics of interest and importance to theI resource and community are supported. 
I 
The bringing together of biomedical scientists, engineers, and 
computer scientists provides important cross-fertilization between 
disciplines. In these settings, students and staff find the need and 
I 
opportunity to test the relevance of theory and the usefulness of 
technology in applications to real problems. Also, the biomedical 
scientists are aided in learning new techniques for acquiring useful 
I 
information. To this end, some of the courses offered are addressed to 
biologists without strong technical backgrounds who want and need a 
below-the-surfaceappreciation of biomedical computing. Laboratory 
personnel also participate in regularly scheduled conferences in the 
clinical departments where both the biological and technological issues are 
examined. 
I Seminars and presentations relating to resource projects and 
applications are conducted by Laboratory staff as well as scientists and 
engineers from the national community. During the year the followingI activities were supported: 
I
 Seminars
 
"Regional Metabolism and 
Blood-Flow Studies"I July 12, 1984 
I "3D Image Display" 
July 12, 1984I 
I
 "TERRANET Update"
 
July 19, 1984 
I
 
I
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Joanne Markham 
Biomedical Computer Laboratory 
Washington University 
St. Louis, Missouri 
David E. Beecher 
Biomedical Computer Laboratory 
Washington University 
St. Louis, Missouri 
Steven M. Moore 
Biomedical Computer Laboratory 
Washington University 
St. Louis, Missouri 
"Image Presentat..ion, Analysis 
and Quantification: Plans for 
July 19, 1984 
"Radiation Treatment Planning" 
August 2, 1984 
"Data Acquisition for Neuro­
physiology" 
August 9, 1984 
"Design Considerations for 
Positron Emission and Trans­
mission Tomographs Used for 
Industrial Applications" 
November 5, 1984 
"Reflections on the Nuclear 
Science Symposium" 
November 7, 1984 
"Some Current Thoughts About the 
Use of Maximum-Likelihood 
Estimation in PET, SPECT, and EMA" 
January 7, 1985 
"MCF: A Technical View" 
February 13, 1985 
I
 
I
 
I
G. James Blaine 
Biomedical Computer Laboratory 
Washington University 
St. Louis, Missouri I
 
Lewis J. Thomas, Jr. 
F. U. Rosenberger I
 
John Wong 
I
Harold W. Shipton 
Biomedical Computer Laboratory 
Washington University 
St. Louis, Missouri 
Hannu H. Heusala I
University of Oulu 
Oulu, Finland 
I
 
I
David C. Ficke 
Department of Radiology 
John D. Gorman 
Michael I. Miller 
John M. Ollinger 
Donald L. Snyder 
Biomedical Computer Laboratory 
Washington University 
St. Louis, Missouri 
Donald L. Snyder 
Michael I. Miller 
Biomedical Computer Laboratory 
Washington University 
St. Louis, Missouri 
Simon Igielnik 
Medical Computing Facilities 
Washington University 
St. Louis, Missouri 
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I "Maximum Entropy, Miniur..un Cross 
Entropy and Maximum-Likelihood 
Estimation: Their RelationshipI to Tomographic Imaging and Other Problems" 
I February 20, 1985 
"CONVEX Computer Presentation"I March 20, 1985 
I "Effects of Electrical Stimulation 
I 
of Efferent Fibers Projecting to 
the Cochlea: Auditory-Nerve Fiber 
Response Properties" 
March 27, 1985 
I 
I 
"Data Collection and Preprocessing 
Considerations in Time-of-Flight 
Positron-Emission Tomography" 
March 27, 1985 
I 
"Quantitative Analysis of Rate­
Place Coding in the Auditory-Nerve"
I March 28, 1985 
I "An Examination of FSK-Based Digital Picture Communication 
Over the Cable TV Medium" 
I June 19, 1985 
I 
I 
I 
I 
I 
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Michael I. Miller 
Donald L. Snyder 
Biomedical Computer Laboratory 
Washington University 
St. Louis, Missouri 
William Ott 
CONVEX Computers 
Dallas, Texas 
Raimond L. Winslow 
The Johns Hopkins University 
Baltimore, Maryland 
Timothy J. Holmes 
Department of Radiology 
Washington University 
St. Louis, Missouri 
Raimond L. Winslow 
The Johns Hopkins University 
Baltimore, Maryland 
John Chabut 
Biomedical Computer Laboratory 
Washington University 
St. Louis, Missouri 
I
 
I
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Other Activities 
A Lecture Series in support of Biomedical Engineering 3/2 Intensive Course I 
Sponsored by the Program in Biomedical Engineering
 
Sever Institute of Technology
 
Washington University
 I 
"An Engineer Looks at the Brain" 
and 
a film - "The Brain" 
January 1, 1985 
"Biomedical Instrumentation and 
Transducers" 
January 2, 1985 
"Computers, Cardiologists and 
Cardiograms" 
January 3, 1985 
"Biophysical Measurements" 
January 9, 1985 
"Computers: Communication and 
Storage" 
January 12, 1985 
Harold W. Shipton 
Biomedical Computer Laboratory IWashington University 
St. Louis, Missouri 
I 
R. Martin Arthur 
Department of Electrical IEngineering 
Biomedical Computer Laboratory 
Washington University 
St. Louis, Missouri I 
Lewis J. Thomas, Jr. IBiomedical Computer Laboratory 
Washington University 
St. Louis, Missouri I 
Harold W. Shipton 
Biomedical Computer Laboratory 
Washington University I 
St. Louis, Missouri 
IG. James Blaine 
Biomedical Computer Laboratory 
Washington University 
St. Louis, Missouri I 
I 
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IX. MONOGRAPHS AND WORKING NOTES 
IThe Biomedical Computer Laboratory's Monograph Series was established 
to systematize the many reports, reprints, program descriptions and other 
documents written at BCL or supported in part by the Laboratory's 
facilities or staff. I 
A forum, much less formal than our monograph series, has been 
instituted to serve as a repository for materials such as: research notes, 
system and component documentation, technical survey notes and I 
prepublication drafts. A Working Note File is maintained for access by 
anyone associated with the Washington University Computer Labs. 
Distribution for outside use can be made available with the consent of the Icontributing author. 
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